IXGDF,IGNORE,USUBJID,COMPOUND,STUDY,STUDYDES,PART,EXTENS,CENTER,SUBJECT,INDNAME,TRTNAME,TRTNAMER,VISIT,VISNAME,BASE,SCREEN,DATEDAY,DATETIME,DURATION,NT,TIME,TIMEUNIT,TYPENAME,NAME,VALUE,VALUETXT,UNIT,ULOQ,LLOQ,ROUTE,INTERVAL,NRDOSES,COMMENT
1,,X3401_0100_0001,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,1,Healthy Volunteers,Placebo,Placebo,1,VISIT 1 - Screening,0,1,28-08-2015,09:43,0,-168,-167.883,Hours,Demographics,Age,34,,Years,NaN,NaN,,NaN,NaN,NaN
2,,X3401_0100_0001,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,1,Healthy Volunteers,Placebo,Placebo,1,VISIT 1 - Screening,0,1,28-08-2015,09:43,0,-168,-167.883,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
3,,X3401_0100_0001,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,1,Healthy Volunteers,Placebo,Placebo,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:35,0,-1,-1,Hours,Body,BMI,26,,kg/m2,NaN,NaN,,NaN,NaN,NaN
4,,X3401_0100_0001,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,1,Healthy Volunteers,Placebo,Placebo,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:35,0,-1,-1,Hours,Body,Bodyweight,89,,kg,NaN,NaN,,NaN,NaN,NaN
5,,X3401_0100_0001,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,1,Healthy Volunteers,Placebo,Placebo,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:35,0,-1,-1,Hours,Body,Height,185,,cm,NaN,NaN,,NaN,NaN,NaN
6,,X3401_0100_0001,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,1,Healthy Volunteers,Placebo,Placebo,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:31,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
7,,X3401_0100_0001,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,1,Healthy Volunteers,Placebo,Placebo,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:35,0,0,0,Hours,Dose,Dose HS02,0,,ug,NaN,NaN,oral,NaN,NaN,NaN
8,,X3401_0100_0001,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,1,Healthy Volunteers,Placebo,Placebo,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:40,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
9,,X3401_0100_0001,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,1,Healthy Volunteers,Placebo,Placebo,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:50,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
19,,X3401_0100_0002,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,2,Healthy Volunteers,1mg oral single dose,1mg oral single dose,1,VISIT 1 - Screening,0,1,23-07-2015,09:53,0,-168,-167.3496667,Hours,Demographics,Age,29,,Years,NaN,NaN,,NaN,NaN,NaN
20,,X3401_0100_0002,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,2,Healthy Volunteers,1mg oral single dose,1mg oral single dose,1,VISIT 1 - Screening,0,1,23-07-2015,09:53,0,-168,-167.3496667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
21,,X3401_0100_0002,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,2,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,30-07-2015,08:13,0,-1,-1,Hours,Body,BMI,18.79,,kg/m2,NaN,NaN,,NaN,NaN,NaN
22,,X3401_0100_0002,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,2,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,30-07-2015,08:13,0,-1,-1,Hours,Body,Bodyweight,65,,kg,NaN,NaN,,NaN,NaN,NaN
23,,X3401_0100_0002,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,2,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,30-07-2015,08:13,0,-1,-1,Hours,Body,Height,186,,cm,NaN,NaN,,NaN,NaN,NaN
25,,X3401_0100_0002,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,2,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-07-2015,09:13,0,0,0,Hours,Dose,Dose HS02,1000,,ug,NaN,NaN,oral,NaN,NaN,NaN
37,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,1,VISIT 1 - Screening,0,1,23-07-2015,09:26,0,-168,-167.6663333,Hours,Demographics,Age,28,,Years,NaN,NaN,,NaN,NaN,NaN
38,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,1,VISIT 1 - Screening,0,1,23-07-2015,09:26,0,-168,-167.6663333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
39,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,30-07-2015,08:05,0,-1,-1,Hours,Body,BMI,24.69,,kg/m2,NaN,NaN,,NaN,NaN,NaN
40,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,30-07-2015,08:05,0,-1,-1,Hours,Body,Bodyweight,80,,kg,NaN,NaN,,NaN,NaN,NaN
41,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,30-07-2015,08:05,0,-1,-1,Hours,Body,Height,180,,cm,NaN,NaN,,NaN,NaN,NaN
42,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-07-2015,09:01,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
43,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-07-2015,09:05,0,0,0,Hours,Dose,Dose HS02,1000,,ug,NaN,NaN,oral,NaN,NaN,NaN
44,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-07-2015,09:10,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
45,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-07-2015,09:20,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,1.53,,ng/ml,NaN,1,,NaN,NaN,NaN
46,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-07-2015,09:35,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,3.5,,ng/ml,NaN,1,,NaN,NaN,NaN
47,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-07-2015,10:05,0,1,1,Hours,Concentration,Plasma concentration HS02,3.8,,ng/ml,NaN,1,,NaN,NaN,NaN
48,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-07-2015,11:05,0,2,2,Hours,Concentration,Plasma concentration HS02,3.33,,ng/ml,NaN,1,,NaN,NaN,NaN
49,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-07-2015,13:05,0,4,4,Hours,Concentration,Plasma concentration HS02,2.91,,ng/ml,NaN,1,,NaN,NaN,NaN
50,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-07-2015,21:05,0,12,12,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
51,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,3,VISIT 3,0,0,31-07-2015,09:05,0,24,24,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
52,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,4,VISIT 4,0,0,01-08-2015,09:05,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
53,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,5,VISIT 5,0,0,03-08-2015,09:05,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
54,,X3401_0100_0003,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,3,Healthy Volunteers,1mg oral single dose,1mg oral single dose,6,VISIT 6,0,0,06-08-2015,09:05,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
55,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,1,VISIT 1 - Screening,0,1,08-08-2015,09:12,0,-168,-168.083,Hours,Demographics,Age,25,,Years,NaN,NaN,,NaN,NaN,NaN
56,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,1,VISIT 1 - Screening,0,1,08-08-2015,09:12,0,-168,-168.083,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
57,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,15-08-2015,08:16,0,-1,-1,Hours,Body,BMI,24.68,,kg/m2,NaN,NaN,,NaN,NaN,NaN
58,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,15-08-2015,08:16,0,-1,-1,Hours,Body,Bodyweight,68,,kg,NaN,NaN,,NaN,NaN,NaN
59,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,15-08-2015,08:16,0,-1,-1,Hours,Body,Height,166,,cm,NaN,NaN,,NaN,NaN,NaN
60,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:12,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
61,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:16,0,0,0,Hours,Dose,Dose HS02,1000,,ug,NaN,NaN,oral,NaN,NaN,NaN
62,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:21,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,1.38,,ng/ml,NaN,1,,NaN,NaN,NaN
63,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:31,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,2.12,,ng/ml,NaN,1,,NaN,NaN,NaN
64,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:46,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,3.59,,ng/ml,NaN,1,,NaN,NaN,NaN
65,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,10:16,0,1,1,Hours,Concentration,Plasma concentration HS02,5.42,,ng/ml,NaN,1,,NaN,NaN,NaN
66,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,11:16,0,2,2,Hours,Concentration,Plasma concentration HS02,5.26,,ng/ml,NaN,1,,NaN,NaN,NaN
67,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,13:16,0,4,4,Hours,Concentration,Plasma concentration HS02,3.91,,ng/ml,NaN,1,,NaN,NaN,NaN
68,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,21:16,0,12,12,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
69,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,3,VISIT 3,0,0,16-08-2015,09:16,0,24,24,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
70,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,4,VISIT 4,0,0,17-08-2015,09:16,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
71,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,5,VISIT 5,0,0,19-08-2015,09:16,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
72,,X3401_0100_0004,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,4,Healthy Volunteers,1mg oral single dose,1mg oral single dose,6,VISIT 6,0,0,22-08-2015,09:16,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
73,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,1,VISIT 1 - Screening,0,1,14-08-2015,09:42,0,-168,-168.133,Hours,Demographics,Age,29,,Years,NaN,NaN,,NaN,NaN,NaN
74,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,1,VISIT 1 - Screening,0,1,14-08-2015,09:42,0,-168,-168.133,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
75,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,21-08-2015,08:49,0,-1,-1,Hours,Body,BMI,25.68,,kg/m2,NaN,NaN,,NaN,NaN,NaN
76,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,21-08-2015,08:49,0,-1,-1,Hours,Body,Bodyweight,86,,kg,NaN,NaN,,NaN,NaN,NaN
77,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,21-08-2015,08:49,0,-1,-1,Hours,Body,Height,183,,cm,NaN,NaN,,NaN,NaN,NaN
78,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,09:45,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
79,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,09:49,0,0,0,Hours,Dose,Dose HS02,1000,,ug,NaN,NaN,oral,NaN,NaN,NaN
80,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,09:54,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
81,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,10:04,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,1.68,,ng/ml,NaN,1,,NaN,NaN,NaN
82,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,10:19,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,20,,ng/ml,NaN,1,,NaN,NaN,NaN
83,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,10:49,0,1,1,Hours,Concentration,Plasma concentration HS02,2.21,,ng/ml,NaN,1,,NaN,NaN,NaN
84,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,11:49,0,2,2,Hours,Concentration,Plasma concentration HS02,3.07,,ng/ml,NaN,1,,NaN,NaN,NaN
85,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,13:49,0,4,4,Hours,Concentration,Plasma concentration HS02,1.33,,ng/ml,NaN,1,,NaN,NaN,NaN
86,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,09:49,0,12,12,Hours,Dose,Dose HS02,0,,ug,NaN,NaN,oral,NaN,NaN,NaN
87,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,3,VISIT 3,0,0,22-08-2015,09:49,0,24,24,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
88,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,4,VISIT 4,0,0,23-08-2015,09:49,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
89,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,5,VISIT 5,0,0,25-08-2015,09:49,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
90,,X3401_0100_0005,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,5,Healthy Volunteers,1mg oral single dose,1mg oral single dose,6,VISIT 6,0,0,28-08-2015,09:49,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
91,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,1,VISIT 1 - Screening,0,1,06-08-2015,09:42,0,-168,-168.0496667,Hours,Demographics,Age,35,,Years,NaN,NaN,,NaN,NaN,NaN
92,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,1,VISIT 1 - Screening,0,1,06-08-2015,09:42,0,-168,-168.0496667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
93,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,13-08-2015,08:44,0,-1,-1,Hours,Body,BMI,21.37,,kg/m2,NaN,NaN,,NaN,NaN,NaN
94,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,13-08-2015,08:44,0,-1,-1,Hours,Body,Bodyweight,70,,kg,NaN,NaN,,NaN,NaN,NaN
95,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,13-08-2015,08:44,0,-1,-1,Hours,Body,Height,181,,cm,NaN,NaN,,NaN,NaN,NaN
96,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,09:40,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
97,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,09:44,0,0,0,Hours,Dose,Dose HS02,1000,,ug,NaN,NaN,oral,NaN,NaN,NaN
98,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,09:49,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
99,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,09:59,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,1.28,,ng/ml,NaN,1,,NaN,NaN,NaN
100,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,10:14,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,2.2,,ng/ml,NaN,1,,NaN,NaN,NaN
101,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,10:44,0,1,1,Hours,Concentration,Plasma concentration HS02,2.78,,ng/ml,NaN,1,,NaN,NaN,NaN
102,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,11:44,0,2,2,Hours,Concentration,Plasma concentration HS02,2.21,,ng/ml,NaN,1,,NaN,NaN,NaN
103,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,13:44,0,4,4,Hours,Concentration,Plasma concentration HS02,1.53,,ng/ml,NaN,1,,NaN,NaN,NaN
104,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,21:44,0,12,12,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
105,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,3,VISIT 3,0,0,14-08-2015,09:44,0,24,24,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
106,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,4,VISIT 4,0,0,15-08-2015,09:44,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
107,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,5,VISIT 5,0,0,17-08-2015,09:44,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
108,,X3401_0100_0006,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,6,Healthy Volunteers,1mg oral single dose,1mg oral single dose,6,VISIT 6,0,0,20-08-2015,09:44,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
109,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,1,VISIT 1 - Screening,0,1,17-08-2015,09:50,0,-168,-168.0163333,Hours,Demographics,Age,28,,Years,NaN,NaN,,NaN,NaN,NaN
110,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,1,VISIT 1 - Screening,0,1,17-08-2015,09:50,0,-168,-168.0163333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
111,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,24-08-2015,08:50,0,-1,-1,Hours,Body,BMI,26.86,,kg/m2,NaN,NaN,,NaN,NaN,NaN
112,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,24-08-2015,08:50,0,-1,-1,Hours,Body,Bodyweight,88,,kg,NaN,NaN,,NaN,NaN,NaN
113,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,24-08-2015,08:50,0,-1,-1,Hours,Body,Height,181,,cm,NaN,NaN,,NaN,NaN,NaN
114,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,09:46,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
115,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,09:50,0,0,0,Hours,Dose,Dose HS02,2000,,ug,NaN,NaN,oral,NaN,NaN,NaN
116,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,09:55,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,1.74,,ng/ml,NaN,1,,NaN,NaN,NaN
117,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:05,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,2.99,,ng/ml,NaN,1,,NaN,NaN,NaN
118,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:20,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,5.55,,ng/ml,NaN,1,,NaN,NaN,NaN
119,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:50,0,1,1,Hours,Concentration,Plasma concentration HS02,7.8,,ng/ml,NaN,1,,NaN,NaN,NaN
120,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,11:50,0,2,2,Hours,Concentration,Plasma concentration HS02,7.06,,ng/ml,NaN,1,,NaN,NaN,NaN
121,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,13:50,0,4,4,Hours,Concentration,Plasma concentration HS02,5.26,,ng/ml,NaN,1,,NaN,NaN,NaN
122,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,21:50,0,12,12,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
123,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,3,VISIT 3,0,0,25-08-2015,09:50,0,24,24,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
124,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,4,VISIT 4,0,0,26-08-2015,09:50,0,48,48,Hours,Concentration,Plasma concentration HS02,500,,ng/ml,NaN,1,,NaN,NaN,NaN
125,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,5,VISIT 5,0,0,28-08-2015,09:50,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
126,,X3401_0100_0007,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,7,Healthy Volunteers,2mg oral single dose,2mg oral single dose,6,VISIT 6,0,0,31-08-2015,09:50,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
132,,X3401_0100_0008,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,8,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-09-2015,09:59,0,0,0,Hours,Dose,Dose HS02,2000,,ug,NaN,NaN,oral,NaN,NaN,NaN
133,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,1,VISIT 1 - Screening,0,1,28-08-2015,09:38,0,-168,-168.0663333,Hours,Demographics,Age,29,,Years,NaN,NaN,,NaN,NaN,NaN
134,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,1,VISIT 1 - Screening,0,1,28-08-2015,09:38,0,-168,-168.0663333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
135,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:41,0,-1,-1,Hours,Body,BMI,25.8,,kg/m2,NaN,NaN,,NaN,NaN,NaN
136,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:41,0,-1,-1,Hours,Body,Bodyweight,79,,kg,NaN,NaN,,NaN,NaN,NaN
137,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:41,0,-1,-1,Hours,Body,Height,175,,cm,NaN,NaN,,NaN,NaN,NaN
138,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:37,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
139,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:41,0,0,0,Hours,Dose,Dose HS02,2000,,ug,NaN,NaN,oral,NaN,NaN,NaN
140,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:46,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,1.23,,ng/ml,NaN,1,,NaN,NaN,NaN
141,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:56,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,2.38,,ng/ml,NaN,1,,NaN,NaN,NaN
142,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:11,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,4.8,,ng/ml,NaN,1,,NaN,NaN,NaN
143,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:41,0,1,1,Hours,Concentration,Plasma concentration HS02,6.72,,ng/ml,NaN,1,,NaN,NaN,NaN
144,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,11:41,0,2,2,Hours,Concentration,Plasma concentration HS02,5.09,,ng/ml,NaN,1,,NaN,NaN,NaN
145,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,13:41,0,4,4,Hours,Concentration,Plasma concentration HS02,3.96,,ng/ml,NaN,1,,NaN,NaN,NaN
146,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,21:41,0,12,12,Hours,Concentration,Plasma concentration HS02,1.6,,ng/ml,NaN,1,,NaN,NaN,NaN
147,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,3,VISIT 3,0,0,05-09-2015,09:41,0,24,24,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
148,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,4,VISIT 4,0,0,06-09-2015,09:41,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
149,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,5,VISIT 5,0,0,08-09-2015,09:41,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
150,,X3401_0100_0009,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,9,Healthy Volunteers,2mg oral single dose,2mg oral single dose,6,VISIT 6,0,0,11-09-2015,09:41,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
151,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,1,VISIT 1 - Screening,0,1,04-08-2015,09:14,0,-168,-168.0163333,Hours,Demographics,Age,32,,Years,NaN,NaN,,NaN,NaN,NaN
152,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,1,VISIT 1 - Screening,0,1,04-08-2015,09:14,0,-168,-168.0163333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
153,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,11-08-2015,08:14,0,-1,-1,Hours,Body,BMI,28.74,,kg/m2,NaN,NaN,,NaN,NaN,NaN
154,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,11-08-2015,08:14,0,-1,-1,Hours,Body,Bodyweight,87,,kg,NaN,NaN,,NaN,NaN,NaN
155,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,11-08-2015,08:14,0,-1,-1,Hours,Body,Height,174,,cm,NaN,NaN,,NaN,NaN,NaN
156,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,09:10,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
157,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,09:14,0,0,0,Hours,Dose,Dose HS02,2000,,ug,NaN,NaN,oral,NaN,NaN,NaN
158,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,09:19,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,1.57,,ng/ml,NaN,1,,NaN,NaN,NaN
159,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,09:29,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,2.05,,ng/ml,NaN,1,,NaN,NaN,NaN
160,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,09:44,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,4.46,,ng/ml,NaN,1,,NaN,NaN,NaN
161,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,10:14,0,1,1,Hours,Concentration,Plasma concentration HS02,4.62,,ng/ml,NaN,1,,NaN,NaN,NaN
162,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,11:14,0,2,2,Hours,Concentration,Plasma concentration HS02,5.55,,ng/ml,NaN,1,,NaN,NaN,NaN
163,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,13:14,0,4,4,Hours,Concentration,Plasma concentration HS02,3.29,,ng/ml,NaN,1,,NaN,NaN,NaN
164,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,21:14,0,12,12,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
165,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,3,VISIT 3,0,0,12-08-2015,09:14,0,24,24,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
166,Unsure if correct,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,4,VISIT 4,0,0,13-08-2015,09:14,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
167,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,5,VISIT 5,0,0,15-08-2015,09:14,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
168,,X3401_0100_0010,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,10,Healthy Volunteers,2mg oral single dose,2mg oral single dose,6,VISIT 6,0,0,18-08-2015,09:14,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
169,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,1,VISIT 1 - Screening,0,1,29-07-2015,10:07,0,-168,-167.7163333,Hours,Demographics,Age,30,,Years,NaN,NaN,,NaN,NaN,NaN
172,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,05-08-2015,08:49,0,-1,-1,Hours,Body,Bodyweight,79,,kg,NaN,NaN,,NaN,NaN,NaN
173,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,05-08-2015,08:49,0,-1,-1,Hours,Body,Height,177,,cm,NaN,NaN,,NaN,NaN,NaN
174,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,09:45,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
175,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,09:49,0,0,0,Hours,Dose,Dose HS02,2000,,ug,NaN,NaN,oral,NaN,NaN,NaN
176,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,09:54,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,1.27,,ng/ml,NaN,1,,NaN,NaN,NaN
177,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,10:04,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,3.45,,ng/ml,NaN,1,,NaN,NaN,NaN
178,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,10:19,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,4.91,,ng/ml,NaN,1,,NaN,NaN,NaN
179,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,10:49,0,1,1,Hours,Concentration,Plasma concentration HS02,6.92,,ng/ml,NaN,1,,NaN,NaN,NaN
180,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,11:49,0,2,2,Hours,Concentration,Plasma concentration HS02,7.36,,ng/ml,NaN,1,,NaN,NaN,NaN
181,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,13:49,0,4,4,Hours,Concentration,Plasma concentration HS02,4.2,,ng/ml,NaN,1,,NaN,NaN,NaN
182,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,21:49,0,12,12,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
183,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,3,VISIT 3,0,0,06-08-2015,09:49,0,24,24,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
184,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,4,VISIT 4,0,0,07-08-2015,09:49,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
185,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,5,VISIT 5,0,0,09-08-2015,09:49,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
186,,X3401_0100_0011,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,11,Healthy Volunteers,2mg oral single dose,2mg oral single dose,6,VISIT 6,0,0,12-08-2015,09:49,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
187,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,1,VISIT 1 - Screening,0,1,26-08-2015,09:13,0,-168,-168.783,Hours,Demographics,Age,28,,Years,NaN,NaN,,NaN,NaN,NaN
188,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,1,VISIT 1 - Screening,0,1,26-08-2015,09:13,0,-168,-168.783,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
189,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:59,0,-1,-1,Hours,Body,BMI,21.46,,kg/m2,NaN,NaN,,NaN,NaN,NaN
190,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:59,0,-1,-1,Hours,Body,Bodyweight,68,,kg,NaN,NaN,,NaN,NaN,NaN
191,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:59,0,-1,-1,Hours,Body,Height,178,,cm,NaN,NaN,,NaN,NaN,NaN
192,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:55,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
193,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:59,0,0,0,Hours,Dose,Dose HS02,2000,,ug,NaN,NaN,oral,NaN,NaN,NaN
194,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,10:04,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
195,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,10:14,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,3.8,,ng/ml,NaN,1,,NaN,NaN,NaN
196,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,10:29,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,5.1,,ng/ml,NaN,1,,NaN,NaN,NaN
197,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,10:59,0,1,1,Hours,Concentration,Plasma concentration HS02,3.96,,ng/ml,NaN,1,,NaN,NaN,NaN
198,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,11:59,0,2,2,Hours,Concentration,Plasma concentration HS02,5.96,,ng/ml,NaN,1,,NaN,NaN,NaN
199,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,13:59,0,4,4,Hours,Concentration,Plasma concentration HS02,4.45,,ng/ml,NaN,1,,NaN,NaN,NaN
200,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,21:59,0,12,12,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
201,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,3,VISIT 3,0,0,03-09-2015,09:59,0,24,24,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
202,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,4,VISIT 4,0,0,04-09-2015,09:59,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
203,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,5,VISIT 5,0,0,06-09-2015,09:59,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
204,,X3401_0100_0012,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,12,Healthy Volunteers,2mg oral single dose,2mg oral single dose,6,VISIT 6,0,0,09-09-2015,09:59,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
205,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,1,VISIT 1 - Screening,0,1,28-07-2015,09:26,0,-168,-168.583,Hours,Demographics,Age,36,,Years,NaN,NaN,,NaN,NaN,NaN
206,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,1,VISIT 1 - Screening,0,1,28-07-2015,09:26,0,-168,-168.583,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
207,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-08-2015,09:00,0,-1,-1,Hours,Body,Bodyweight,66,,kg,NaN,NaN,,NaN,NaN,NaN
208,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,09:56,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
209,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,10:00,0,0,0,Hours,Dose,Dose HS02,5000,,ug,NaN,NaN,oral,NaN,NaN,NaN
210,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,10:05,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,5.93,,ng/ml,NaN,1,,NaN,NaN,NaN
211,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,10:15,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,11,,ng/ml,NaN,1,,NaN,NaN,NaN
212,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,10:30,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,21.3,,ng/ml,NaN,1,,NaN,NaN,NaN
213,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,11:00,0,1,1,Hours,Concentration,Plasma concentration HS02,26.4,,ng/ml,NaN,1,,NaN,NaN,NaN
214,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,12:00,0,2,2,Hours,Concentration,Plasma concentration HS02,23.6,,ng/ml,NaN,1,,NaN,NaN,NaN
215,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,14:00,0,4,4,Hours,Concentration,Plasma concentration HS02,8.08,,ng/ml,NaN,1,,NaN,NaN,NaN
216,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,22:00,0,12,12,Hours,Concentration,Plasma concentration HS02,1.28,,ng/ml,NaN,1,,NaN,NaN,NaN
217,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,3,VISIT 3,0,0,05-08-2015,10:00,0,24,24,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
218,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,4,VISIT 4,0,0,06-08-2015,10:00,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
219,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,5,VISIT 5,0,0,08-08-2015,10:00,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
220,,X3401_0100_0013,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,13,Healthy Volunteers,5mg oral single dose,5mg oral single dose,6,VISIT 6,0,0,11-08-2015,10:00,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
221,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,1,VISIT 1 - Screening,0,1,02-08-2015,09:25,0,-168,-168.6496667,Hours,Demographics,Age,34,,Years,NaN,NaN,,NaN,NaN,NaN
222,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,1,VISIT 1 - Screening,0,1,02-08-2015,09:25,0,-168,-168.6496667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
223,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,09-08-2015,09:03,0,-1,-1,Hours,Body,BMI,22.92,,kg/m2,NaN,NaN,,NaN,NaN,NaN
224,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,09-08-2015,09:03,0,-1,-1,Hours,Body,Bodyweight,71,,kg,NaN,NaN,,NaN,NaN,NaN
225,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,09-08-2015,09:03,0,-1,-1,Hours,Body,Height,176,,cm,NaN,NaN,,NaN,NaN,NaN
226,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,09:59,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
227,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,10:03,0,0,0,Hours,Dose,Dose HS02,5000,,ug,NaN,NaN,oral,NaN,NaN,NaN
228,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,10:08,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,4.28,,ng/ml,NaN,1,,NaN,NaN,NaN
229,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,10:18,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,10.8,,ng/ml,NaN,1,,NaN,NaN,NaN
230,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,10:33,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,19.2,,ng/ml,NaN,1,,NaN,NaN,NaN
231,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,11:03,0,1,1,Hours,Concentration,Plasma concentration HS02,19.6,,ng/ml,NaN,1,,NaN,NaN,NaN
232,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,12:03,0,2,2,Hours,Concentration,Plasma concentration HS02,14,,ng/ml,NaN,1,,NaN,NaN,NaN
233,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,14:03,0,4,4,Hours,Concentration,Plasma concentration HS02,0.01,,ng/ml,NaN,1,,NaN,NaN,NaN
234,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,22:03,0,12,12,Hours,Concentration,Plasma concentration HS02,1.12,,ng/ml,NaN,1,,NaN,NaN,NaN
235,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,3,VISIT 3,0,0,10-08-2015,10:03,0,24,24,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
236,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,4,VISIT 4,0,0,11-08-2015,10:03,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
237,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,5,VISIT 5,0,0,13-08-2015,10:03,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
238,,X3401_0100_0014,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,14,Healthy Volunteers,5mg oral single dose,5mg oral single dose,6,VISIT 6,0,0,16-08-2015,10:03,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
239,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,1,VISIT 1 - Screening,0,1,05-08-2015,09:41,0,-168,-168.3996667,Hours,Demographics,Age,29,,Years,NaN,NaN,,NaN,NaN,NaN
240,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,1,VISIT 1 - Screening,0,1,05-08-2015,09:41,0,-168,-168.3996667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
241,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,12-08-2015,09:04,0,-1,-1,Hours,Body,BMI,22.23,,kg/m2,NaN,NaN,,NaN,NaN,NaN
242,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,12-08-2015,09:04,0,-1,-1,Hours,Body,Bodyweight,65,,kg,NaN,NaN,,NaN,NaN,NaN
243,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,12-08-2015,09:04,0,-1,-1,Hours,Body,Height,171,,cm,NaN,NaN,,NaN,NaN,NaN
244,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,12-08-2015,10:00,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
245,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,12-08-2015,10:04,0,0,0,Hours,Dose,Dose HS02,5000,,ug,NaN,NaN,oral,NaN,NaN,NaN
246,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,12-08-2015,10:09,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,1.74,,ng/ml,NaN,1,,NaN,NaN,NaN
247,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,12-08-2015,10:19,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,4.32,,ng/ml,NaN,1,,NaN,NaN,NaN
248,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,12-08-2015,10:34,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,7.66,,ng/ml,NaN,1,,NaN,NaN,NaN
249,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,12-08-2015,11:04,0,1,1,Hours,Concentration,Plasma concentration HS02,10.3,,ng/ml,NaN,1,,NaN,NaN,NaN
250,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,12-08-2015,12:04,0,2,2,Hours,Concentration,Plasma concentration HS02,8.02,,ng/ml,NaN,1,,NaN,NaN,NaN
251,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,12-08-2015,14:04,0,4,4,Hours,Concentration,Plasma concentration HS02,7.42,,ng/ml,NaN,1,,NaN,NaN,NaN
252,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,12-08-2015,22:04,0,12,12,Hours,Concentration,Plasma concentration HS02,3,,ng/ml,NaN,1,,NaN,NaN,NaN
253,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,3,VISIT 3,0,0,13-08-2015,10:04,0,24,24,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
254,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,4,VISIT 4,0,0,14-08-2015,10:04,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
255,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,5,VISIT 5,0,0,16-08-2015,10:04,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
256,,X3401_0100_0015,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,15,Healthy Volunteers,5mg oral single dose,5mg oral single dose,6,VISIT 6,0,0,19-08-2015,10:04,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
257,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,1,VISIT 1 - Screening,0,1,21-08-2015,10:05,0,-168,-167.3663333,Hours,Demographics,Age,24,,Years,NaN,NaN,,NaN,NaN,NaN
258,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,1,VISIT 1 - Screening,0,1,21-08-2015,10:05,0,-168,-167.3663333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
259,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-08-2015,08:26,0,-1,-1,Hours,Body,BMI,24.44,,kg/m2,NaN,NaN,,NaN,NaN,NaN
260,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-08-2015,08:26,0,-1,-1,Hours,Body,Bodyweight,74,,kg,NaN,NaN,,NaN,NaN,NaN
261,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-08-2015,08:26,0,-1,-1,Hours,Body,Height,174,,cm,NaN,NaN,,NaN,NaN,NaN
262,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,09:22,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
263,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,09:26,0,0,0,Hours,Dose,Dose HS02,5000,,ug,NaN,NaN,oral,NaN,NaN,NaN
264,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,09:31,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,3.7,,ng/ml,NaN,1,,NaN,NaN,NaN
265,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,09:41,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,8.26,,ng/ml,NaN,1,,NaN,NaN,NaN
266,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,09:56,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,14.4,,ng/ml,NaN,1,,NaN,NaN,NaN
267,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,10:26,0,1,1,Hours,Concentration,Plasma concentration HS02,14.6,,ng/ml,NaN,1,,NaN,NaN,NaN
268,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,11:26,0,2,2,Hours,Concentration,Plasma concentration HS02,17.7,,ng/ml,NaN,1,,NaN,NaN,NaN
269,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,13:26,0,4,4,Hours,Concentration,Plasma concentration HS02,8.57,,ng/ml,NaN,1,,NaN,NaN,NaN
270,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,21:26,0,12,12,Hours,Concentration,Plasma concentration HS02,1.99,,ng/ml,NaN,1,,NaN,NaN,NaN
271,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,3,VISIT 3,0,0,29-08-2015,09:26,0,24,24,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
272,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,4,VISIT 4,0,0,30-08-2015,09:26,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
273,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,5,VISIT 5,0,0,01-09-2015,09:26,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
274,,X3401_0100_0016,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,16,Healthy Volunteers,5mg oral single dose,5mg oral single dose,6,VISIT 6,0,0,04-09-2015,09:26,0,168,168,Hours,Concentration,Plasma concentration HS02,1.01,,ng/ml,NaN,1,,NaN,NaN,NaN
275,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,1,VISIT 1 - Screening,0,1,24-08-2015,09:19,0,-168,-168.7496667,Hours,Demographics,Age,25,,Years,NaN,NaN,,NaN,NaN,NaN
276,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,1,VISIT 1 - Screening,0,1,24-08-2015,09:19,0,-168,-168.7496667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
277,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,31-08-2015,09:03,0,-1,-1,Hours,Body,BMI,29.05,,kg/m2,NaN,NaN,,NaN,NaN,NaN
278,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,31-08-2015,09:03,0,-1,-1,Hours,Body,Bodyweight,90,,kg,NaN,NaN,,NaN,NaN,NaN
279,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,31-08-2015,09:03,0,-1,-1,Hours,Body,Height,176,,cm,NaN,NaN,,NaN,NaN,NaN
280,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,09:59,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
281,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,10:03,0,0,0,Hours,Dose,Dose HS02,5000,,ug,NaN,NaN,oral,NaN,NaN,NaN
282,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,10:08,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,3.86,,ng/ml,NaN,1,,NaN,NaN,NaN
283,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,10:18,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,8.88,,ng/ml,NaN,1,,NaN,NaN,NaN
284,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,10:33,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,17,,ng/ml,NaN,1,,NaN,NaN,NaN
285,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,11:03,0,1,1,Hours,Concentration,Plasma concentration HS02,18.3,,ng/ml,NaN,1,,NaN,NaN,NaN
286,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,12:03,0,2,2,Hours,Concentration,Plasma concentration HS02,19.8,,ng/ml,NaN,1,,NaN,NaN,NaN
287,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,14:03,0,4,4,Hours,Concentration,Plasma concentration HS02,9.5,,ng/ml,NaN,1,,NaN,NaN,NaN
288,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,22:03,0,12,12,Hours,Concentration,Plasma concentration HS02,3.34,,ng/ml,NaN,1,,NaN,NaN,NaN
289,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,3,VISIT 3,0,0,01-09-2015,10:03,0,24,24,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
290,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,4,VISIT 4,0,0,02-09-2015,10:03,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
291,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,5,VISIT 5,0,0,04-09-2015,10:03,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
292,,X3401_0100_0017,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,17,Healthy Volunteers,5mg oral single dose,5mg oral single dose,6,VISIT 6,0,0,07-09-2015,10:03,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
293,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,1,VISIT 1 - Screening,0,1,22-08-2015,10:11,0,-168,-167.283,Hours,Demographics,Age,23,,Years,NaN,NaN,,NaN,NaN,NaN
294,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,1,VISIT 1 - Screening,0,1,22-08-2015,10:11,0,-168,-167.283,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
295,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,29-08-2015,08:27,0,-1,-1,Hours,Body,BMI,23.41,,kg/m2,NaN,NaN,,NaN,NaN,NaN
296,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,29-08-2015,08:27,0,-1,-1,Hours,Body,Bodyweight,81,,kg,NaN,NaN,,NaN,NaN,NaN
297,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,29-08-2015,08:27,0,-1,-1,Hours,Body,Height,186,,cm,NaN,NaN,,NaN,NaN,NaN
298,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,09:23,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
299,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,09:27,0,0,0,Hours,Dose,Dose HS02,5000,,ug,NaN,NaN,oral,NaN,NaN,NaN
300,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,09:32,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,20,,ng/ml,NaN,1,,NaN,NaN,NaN
301,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,09:42,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,40,,ng/ml,NaN,1,,NaN,NaN,NaN
302,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,09:57,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,60,,ng/ml,NaN,1,,NaN,NaN,NaN
303,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,10:27,0,1,1,Hours,Concentration,Plasma concentration HS02,80,,ng/ml,NaN,1,,NaN,NaN,NaN
304,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,11:27,0,2,2,Hours,Concentration,Plasma concentration HS02,100,,ng/ml,NaN,1,,NaN,NaN,NaN
305,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,13:27,0,4,4,Hours,Concentration,Plasma concentration HS02,120,,ng/ml,NaN,1,,NaN,NaN,NaN
306,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,21:27,0,12,12,Hours,Concentration,Plasma concentration HS02,140,,ng/ml,NaN,1,,NaN,NaN,NaN
307,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,3,VISIT 3,0,0,30-08-2015,09:27,0,24,24,Hours,Concentration,Plasma concentration HS02,160,,ng/ml,NaN,1,,NaN,NaN,NaN
308,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,4,VISIT 4,0,0,31-08-2015,09:27,0,48,48,Hours,Concentration,Plasma concentration HS02,180,,ng/ml,NaN,1,,NaN,NaN,NaN
309,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,5,VISIT 5,0,0,02-09-2015,09:27,0,96,96,Hours,Concentration,Plasma concentration HS02,200,,ng/ml,NaN,1,,NaN,NaN,NaN
310,,X3401_0100_0018,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,18,Healthy Volunteers,5mg oral single dose,5mg oral single dose,6,VISIT 6,0,0,05-09-2015,09:27,0,168,168,Hours,Concentration,Plasma concentration HS02,220,,ng/ml,NaN,1,,NaN,NaN,NaN
311,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,1,VISIT 1 - Screening,0,1,23-08-2015,09:01,0,-168,-169.1663333,Hours,Demographics,Age,27,,Years,NaN,NaN,,NaN,NaN,NaN
312,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,1,VISIT 1 - Screening,0,1,23-08-2015,09:01,0,-168,-169.1663333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
313,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,30-08-2015,09:10,0,-1,-1,Hours,Body,BMI,26.2,,kg/m2,NaN,NaN,,NaN,NaN,NaN
314,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,30-08-2015,09:10,0,-1,-1,Hours,Body,Bodyweight,83,,kg,NaN,NaN,,NaN,NaN,NaN
315,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,30-08-2015,09:10,0,-1,-1,Hours,Body,Height,178,,cm,NaN,NaN,,NaN,NaN,NaN
316,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,10:06,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
317,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,10:10,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
318,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,10:15,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,6.89,,ng/ml,NaN,1,,NaN,NaN,NaN
319,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,10:25,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,15.3,,ng/ml,NaN,1,,NaN,NaN,NaN
320,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,10:40,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,23.9,,ng/ml,NaN,1,,NaN,NaN,NaN
321,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,11:10,0,1,1,Hours,Concentration,Plasma concentration HS02,41.1,,ng/ml,NaN,1,,NaN,NaN,NaN
322,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,12:10,0,2,2,Hours,Concentration,Plasma concentration HS02,38.2,,ng/ml,NaN,1,,NaN,NaN,NaN
323,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,14:10,0,4,4,Hours,Concentration,Plasma concentration HS02,27.3,,ng/ml,NaN,1,,NaN,NaN,NaN
324,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,22:10,0,12,12,Hours,Concentration,Plasma concentration HS02,5.28,,ng/ml,NaN,1,,NaN,NaN,NaN
325,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,3,VISIT 3,0,0,31-08-2015,10:10,0,24,24,Hours,Concentration,Plasma concentration HS02,1.98,,ng/ml,NaN,1,,NaN,NaN,NaN
326,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,4,VISIT 4,0,0,01-09-2015,10:10,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
327,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,5,VISIT 5,0,0,03-09-2015,10:10,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
328,,X3401_0100_0019,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,19,Healthy Volunteers,10mg oral single dose,10mg oral single dose,6,VISIT 6,0,0,06-09-2015,10:10,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
329,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,1,VISIT 1 - Screening,0,1,29-08-2015,09:46,0,-168,-168.4496667,Hours,Demographics,Age,29,,Years,NaN,NaN,,NaN,NaN,NaN
330,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,1,VISIT 1 - Screening,0,1,29-08-2015,09:46,0,-168,-168.4496667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
331,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,05-09-2015,09:12,0,-1,-1,Hours,Body,BMI,25.14,,kg/m2,NaN,NaN,,NaN,NaN,NaN
332,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,05-09-2015,09:12,0,-1,-1,Hours,Body,Bodyweight,77,,kg,NaN,NaN,,NaN,NaN,NaN
333,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,05-09-2015,09:12,0,-1,-1,Hours,Body,Height,175,,cm,NaN,NaN,,NaN,NaN,NaN
334,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-09-2015,10:08,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
335,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-09-2015,10:12,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
336,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-09-2015,10:17,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,5.15,,ng/ml,NaN,1,,NaN,NaN,NaN
337,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-09-2015,10:27,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,11.3,,ng/ml,NaN,1,,NaN,NaN,NaN
338,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-09-2015,10:42,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,19.1,,ng/ml,NaN,1,,NaN,NaN,NaN
339,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-09-2015,11:12,0,1,1,Hours,Concentration,Plasma concentration HS02,35.8,,ng/ml,NaN,1,,NaN,NaN,NaN
340,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-09-2015,12:12,0,2,2,Hours,Concentration,Plasma concentration HS02,26.7,,ng/ml,NaN,1,,NaN,NaN,NaN
341,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-09-2015,14:12,0,4,4,Hours,Concentration,Plasma concentration HS02,18.5,,ng/ml,NaN,1,,NaN,NaN,NaN
342,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-09-2015,22:12,0,12,12,Hours,Concentration,Plasma concentration HS02,7.55,,ng/ml,NaN,1,,NaN,NaN,NaN
343,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,3,VISIT 3,0,0,06-09-2015,10:12,0,24,24,Hours,Concentration,Plasma concentration HS02,2.19,,ng/ml,NaN,1,,NaN,NaN,NaN
344,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,4,VISIT 4,0,0,07-09-2015,10:12,0,48,48,Hours,Concentration,Plasma concentration HS02,130,,ng/ml,NaN,1,,NaN,NaN,NaN
345,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,5,VISIT 5,0,0,09-09-2015,10:12,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
346,,X3401_0100_0020,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,20,Healthy Volunteers,10mg oral single dose,10mg oral single dose,6,VISIT 6,0,0,12-09-2015,10:12,0,168,168,Hours,Concentration,Plasma concentration HS02,1.01,,ng/ml,NaN,1,,NaN,NaN,NaN
347,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,1,VISIT 1 - Screening,0,1,01-08-2015,09:43,0,-168,-167.683,Hours,Demographics,Age,34,,Years,NaN,NaN,,NaN,NaN,NaN
348,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,1,VISIT 1 - Screening,0,1,01-08-2015,09:43,0,-168,-167.683,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
349,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,08-08-2015,08:23,0,-1,-1,Hours,Body,BMI,23.81,,kg/m2,NaN,NaN,,NaN,NaN,NaN
350,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,08-08-2015,08:23,0,-1,-1,Hours,Body,Bodyweight,78,,kg,NaN,NaN,,NaN,NaN,NaN
351,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,08-08-2015,08:23,0,-1,-1,Hours,Body,Height,181,,cm,NaN,NaN,,NaN,NaN,NaN
352,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,09:19,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
353,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,09:23,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
354,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,09:28,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,3.74,,ng/ml,NaN,1,,NaN,NaN,NaN
355,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,09:38,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,8.66,,ng/ml,NaN,1,,NaN,NaN,NaN
356,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,09:53,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,15.7,,ng/ml,NaN,1,,NaN,NaN,NaN
357,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,10:23,0,1,1,Hours,Concentration,Plasma concentration HS02,19.6,,ng/ml,NaN,1,,NaN,NaN,NaN
358,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,11:23,0,2,2,Hours,Concentration,Plasma concentration HS02,21.9,,ng/ml,NaN,1,,NaN,NaN,NaN
359,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,13:23,0,4,4,Hours,Concentration,Plasma concentration HS02,22,,ng/ml,NaN,1,,NaN,NaN,NaN
360,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,21:23,0,12,12,Hours,Concentration,Plasma concentration HS02,7.86,,ng/ml,NaN,1,,NaN,NaN,NaN
361,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,3,VISIT 3,0,0,09-08-2015,09:23,0,24,24,Hours,Concentration,Plasma concentration HS02,3.82,,ng/ml,NaN,1,,NaN,NaN,NaN
362,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,4,VISIT 4,0,0,10-08-2015,09:23,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
363,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,5,VISIT 5,0,0,12-08-2015,09:23,0,96,96,Hours,Concentration,Plasma concentration HS02,1.08,,ng/ml,NaN,1,,NaN,NaN,NaN
364,,X3401_0100_0021,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,21,Healthy Volunteers,10mg oral single dose,10mg oral single dose,6,VISIT 6,0,0,15-08-2015,09:23,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
365,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,1,VISIT 1 - Screening,0,1,26-08-2015,09:57,0,-168,-167.533,Hours,Demographics,Age,26,,Years,NaN,NaN,,NaN,NaN,NaN
366,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,1,VISIT 1 - Screening,0,1,26-08-2015,09:57,0,-168,-167.533,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
367,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:28,0,-1,-1,Hours,Body,BMI,26.28,,kg/m2,NaN,NaN,,NaN,NaN,NaN
368,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:28,0,-1,-1,Hours,Body,Bodyweight,88,,kg,NaN,NaN,,NaN,NaN,NaN
369,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:28,0,-1,-1,Hours,Body,Height,183,,cm,NaN,NaN,,NaN,NaN,NaN
370,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:24,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
371,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:28,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
372,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:33,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,2.41,,ng/ml,NaN,1,,NaN,NaN,NaN
373,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:43,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,10.6,,ng/ml,NaN,1,,NaN,NaN,NaN
374,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:58,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,16.3,,ng/ml,NaN,1,,NaN,NaN,NaN
375,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,10:28,0,1,1,Hours,Concentration,Plasma concentration HS02,25.3,,ng/ml,NaN,1,,NaN,NaN,NaN
376,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,11:28,0,2,2,Hours,Concentration,Plasma concentration HS02,205,,ng/ml,NaN,1,,NaN,NaN,NaN
377,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,13:28,0,4,4,Hours,Concentration,Plasma concentration HS02,18.6,,ng/ml,NaN,1,,NaN,NaN,NaN
378,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,21:28,0,12,12,Hours,Concentration,Plasma concentration HS02,5.34,,ng/ml,NaN,1,,NaN,NaN,NaN
379,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,3,VISIT 3,0,0,03-09-2015,09:28,0,24,24,Hours,Concentration,Plasma concentration HS02,2.13,,ng/ml,NaN,1,,NaN,NaN,NaN
380,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,4,VISIT 4,0,0,04-09-2015,09:28,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
381,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,5,VISIT 5,0,0,06-09-2015,09:28,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
382,,X3401_0100_0022,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,22,Healthy Volunteers,10mg oral single dose,10mg oral single dose,6,VISIT 6,0,0,09-09-2015,09:28,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
383,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,1,VISIT 1 - Screening,0,1,12-08-2015,09:38,0,-168,-167.8496667,Hours,Demographics,Age,24,,Years,NaN,NaN,,NaN,NaN,NaN
384,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,1,VISIT 1 - Screening,0,1,12-08-2015,09:38,0,-168,-167.8496667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
385,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,19-08-2015,08:28,0,-1,-1,Hours,Body,BMI,27.44,,kg/m2,NaN,NaN,,NaN,NaN,NaN
386,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,19-08-2015,08:28,0,-1,-1,Hours,Body,Bodyweight,85,,kg,NaN,NaN,,NaN,NaN,NaN
387,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,19-08-2015,08:28,0,-1,-1,Hours,Body,Height,176,,cm,NaN,NaN,,NaN,NaN,NaN
388,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,09:24,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
389,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,09:28,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
390,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,09:33,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,9.05,,ng/ml,NaN,1,,NaN,NaN,NaN
391,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,09:43,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,26.4,,ng/ml,NaN,1,,NaN,NaN,NaN
392,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,09:58,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,34,,ng/ml,NaN,1,,NaN,NaN,NaN
393,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,10:28,0,1,1,Hours,Concentration,Plasma concentration HS02,47,,ng/ml,NaN,1,,NaN,NaN,NaN
394,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,11:28,0,2,2,Hours,Concentration,Plasma concentration HS02,37.1,,ng/ml,NaN,1,,NaN,NaN,NaN
395,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,13:28,0,4,4,Hours,Concentration,Plasma concentration HS02,24.5,,ng/ml,NaN,1,,NaN,NaN,NaN
396,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,21:28,0,12,12,Hours,Concentration,Plasma concentration HS02,7.79,,ng/ml,NaN,1,,NaN,NaN,NaN
397,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,3,VISIT 3,0,0,20-08-2015,09:28,0,24,24,Hours,Concentration,Plasma concentration HS02,1.16,,ng/ml,NaN,1,,NaN,NaN,NaN
398,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,4,VISIT 4,0,0,21-08-2015,09:28,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
399,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,5,VISIT 5,0,0,23-08-2015,09:28,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
400,,X3401_0100_0023,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,23,Healthy Volunteers,10mg oral single dose,10mg oral single dose,6,VISIT 6,0,0,26-08-2015,09:28,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
401,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,1,VISIT 1 - Screening,0,1,12-08-2015,09:37,0,-168,-168.2163333,Hours,Demographics,Age,18,,Years,NaN,NaN,,NaN,NaN,NaN
402,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,1,VISIT 1 - Screening,0,1,12-08-2015,09:37,0,-168,-168.2163333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
403,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,19-08-2015,08:49,0,-1,-1,Hours,Body,BMI,22.4,,kg/m2,NaN,NaN,,NaN,NaN,NaN
404,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,19-08-2015,08:49,0,-1,-1,Hours,Body,Bodyweight,75,,kg,NaN,NaN,,NaN,NaN,NaN
405,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,19-08-2015,08:49,0,-1,-1,Hours,Body,Height,183,,cm,NaN,NaN,,NaN,NaN,NaN
406,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,09:45,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
407,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,09:49,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
408,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,09:54,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,4.33,,ng/ml,NaN,1,,NaN,NaN,NaN
409,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,10:04,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,12,,ng/ml,NaN,1,,NaN,NaN,NaN
410,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,10:19,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,19.4,,ng/ml,NaN,1,,NaN,NaN,NaN
411,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,10:49,0,1,1,Hours,Concentration,Plasma concentration HS02,30.3,,ng/ml,NaN,1,,NaN,NaN,NaN
412,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,11:49,0,2,2,Hours,Concentration,Plasma concentration HS02,33,,ng/ml,NaN,1,,NaN,NaN,NaN
413,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,13:49,0,4,4,Hours,Concentration,Plasma concentration HS02,22.7,,ng/ml,NaN,1,,NaN,NaN,NaN
414,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,19-08-2015,21:49,0,12,12,Hours,Concentration,Plasma concentration HS02,8.35,,ng/ml,NaN,1,,NaN,NaN,NaN
415,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,3,VISIT 3,0,0,20-08-2015,09:49,0,24,24,Hours,Concentration,Plasma concentration HS02,2.66,,ng/ml,NaN,1,,NaN,NaN,NaN
416,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,4,VISIT 4,0,0,21-08-2015,09:49,0,48,48,Hours,Concentration,Plasma concentration HS02,2.41,,ng/ml,NaN,1,,NaN,NaN,NaN
417,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,5,VISIT 5,0,0,23-08-2015,09:49,0,96,96,Hours,Concentration,Plasma concentration HS02,1.27,,ng/ml,NaN,1,,NaN,NaN,NaN
418,,X3401_0100_0024,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,24,Healthy Volunteers,10mg oral single dose,10mg oral single dose,6,VISIT 6,0,0,26-08-2015,09:49,0,168,168,Hours,Concentration,Plasma concentration HS02,1.24,,ng/ml,NaN,1,,NaN,NaN,NaN
419,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,1,VISIT 1 - Screening,0,1,28-08-2015,09:44,0,-168,-167.583,Hours,Demographics,Age,32,,Years,NaN,NaN,,NaN,NaN,NaN
420,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,1,VISIT 1 - Screening,0,1,28-08-2015,09:44,0,-168,-167.583,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
421,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:18,0,-1,-1,Hours,Body,BMI,22.55,,kg/m2,NaN,NaN,,NaN,NaN,NaN
422,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:18,0,-1,-1,Hours,Body,Bodyweight,78,,kg,NaN,NaN,,NaN,NaN,NaN
423,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:18,0,-1,-1,Hours,Body,Height,186,,cm,NaN,NaN,,NaN,NaN,NaN
424,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:14,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
425,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:18,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
426,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:23,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,11.9,,ng/ml,NaN,1,,NaN,NaN,NaN
427,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:33,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,34.1,,ng/ml,NaN,1,,NaN,NaN,NaN
428,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:48,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,55.4,,ng/ml,NaN,1,,NaN,NaN,NaN
429,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:18,0,1,1,Hours,Concentration,Plasma concentration HS02,50.8,,ng/ml,NaN,1,,NaN,NaN,NaN
430,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,11:18,0,2,2,Hours,Concentration,Plasma concentration HS02,52.3,,ng/ml,NaN,1,,NaN,NaN,NaN
431,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,13:18,0,4,4,Hours,Concentration,Plasma concentration HS02,32,,ng/ml,NaN,1,,NaN,NaN,NaN
432,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,21:18,0,12,12,Hours,Concentration,Plasma concentration HS02,10.6,,ng/ml,NaN,1,,NaN,NaN,NaN
433,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,3,VISIT 3,0,0,05-09-2015,09:18,0,24,24,Hours,Concentration,Plasma concentration HS02,1.96,,ng/ml,NaN,1,,NaN,NaN,NaN
434,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,4,VISIT 4,0,0,06-09-2015,09:18,0,48,48,Hours,Concentration,Plasma concentration HS02,1.68,,ng/ml,NaN,1,,NaN,NaN,NaN
435,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,5,VISIT 5,0,0,08-09-2015,09:18,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
436,,X3401_0100_0025,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,25,Healthy Volunteers,20mg oral single dose,20mg oral single dose,6,VISIT 6,0,0,11-09-2015,09:18,0,168,168,Hours,Concentration,Plasma concentration HS02,1.17,,ng/ml,NaN,1,,NaN,NaN,NaN
437,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,1,VISIT 1 - Screening,0,1,30-07-2015,09:35,0,-168,-167.5663333,Hours,Demographics,Age,23,,Years,NaN,NaN,,NaN,NaN,NaN
438,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,1,VISIT 1 - Screening,0,1,30-07-2015,09:35,0,-168,-167.5663333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
439,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,06-08-2015,08:08,0,-1,-1,Hours,Body,BMI,27.15,,kg/m2,NaN,NaN,,NaN,NaN,NaN
440,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,06-08-2015,08:08,0,-1,-1,Hours,Body,Bodyweight,87,,kg,NaN,NaN,,NaN,NaN,NaN
441,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,06-08-2015,08:08,0,-1,-1,Hours,Body,Height,179,,cm,NaN,NaN,,NaN,NaN,NaN
442,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,09:04,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
443,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,09:08,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
444,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,09:13,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,9.36,,ng/ml,NaN,1,,NaN,NaN,NaN
445,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,09:23,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,22,,ng/ml,NaN,1,,NaN,NaN,NaN
446,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,09:38,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,33.1,,ng/ml,NaN,1,,NaN,NaN,NaN
447,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,10:08,0,1,1,Hours,Concentration,Plasma concentration HS02,54.2,,ng/ml,NaN,1,,NaN,NaN,NaN
448,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,11:08,0,2,2,Hours,Concentration,Plasma concentration HS02,50.3,,ng/ml,NaN,1,,NaN,NaN,NaN
449,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,13:08,0,4,4,Hours,Concentration,Plasma concentration HS02,41,,ng/ml,NaN,1,,NaN,NaN,NaN
450,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,21:08,0,12,12,Hours,Concentration,Plasma concentration HS02,11.7,,ng/ml,NaN,1,,NaN,NaN,NaN
451,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,3,VISIT 3,0,0,07-08-2015,09:08,0,24,24,Hours,Concentration,Plasma concentration HS02,3.11,,ng/ml,NaN,1,,NaN,NaN,NaN
452,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,4,VISIT 4,0,0,08-08-2015,09:08,0,48,48,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
453,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,5,VISIT 5,0,0,10-08-2015,09:08,0,96,96,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
454,,X3401_0100_0026,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,26,Healthy Volunteers,20mg oral single dose,20mg oral single dose,6,VISIT 6,0,0,13-08-2015,09:08,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
455,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,1,VISIT 1 - Screening,0,1,22-08-2015,09:06,0,-168,-168.883,Hours,Demographics,Age,28,,Years,NaN,NaN,,NaN,NaN,NaN
456,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,1,VISIT 1 - Screening,0,1,22-08-2015,09:06,0,-168,-168.883,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
457,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,29-08-2015,08:58,0,-1,-1,Hours,Body,BMI,20.09,,kg/m2,NaN,NaN,,NaN,NaN,NaN
458,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,29-08-2015,08:58,0,-1,-1,Hours,Body,Bodyweight,68,,kg,NaN,NaN,,NaN,NaN,NaN
459,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,29-08-2015,08:58,0,-1,-1,Hours,Body,Height,184,,cm,NaN,NaN,,NaN,NaN,NaN
460,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,09:54,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
461,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,09:58,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
462,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,10:03,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,13.9,,ng/ml,NaN,1,,NaN,NaN,NaN
463,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,10:13,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,32.6,,ng/ml,NaN,1,,NaN,NaN,NaN
464,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,10:28,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,50.5,,ng/ml,NaN,1,,NaN,NaN,NaN
465,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,10:58,0,1,1,Hours,Concentration,Plasma concentration HS02,62.4,,ng/ml,NaN,1,,NaN,NaN,NaN
466,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,11:58,0,2,2,Hours,Concentration,Plasma concentration HS02,54.4,,ng/ml,NaN,1,,NaN,NaN,NaN
467,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,13:58,0,4,4,Hours,Concentration,Plasma concentration HS02,31.8,,ng/ml,NaN,1,,NaN,NaN,NaN
468,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,21:58,0,12,12,Hours,Concentration,Plasma concentration HS02,7.49,,ng/ml,NaN,1,,NaN,NaN,NaN
469,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,3,VISIT 3,0,0,30-08-2015,09:58,0,24,24,Hours,Concentration,Plasma concentration HS02,2.32,,ng/ml,NaN,1,,NaN,NaN,NaN
470,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,4,VISIT 4,0,0,31-08-2015,09:58,0,48,48,Hours,Concentration,Plasma concentration HS02,3.09,,ng/ml,NaN,1,,NaN,NaN,NaN
471,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,5,VISIT 5,0,0,02-09-2015,09:58,0,96,96,Hours,Concentration,Plasma concentration HS02,2.61,,ng/ml,NaN,1,,NaN,NaN,NaN
472,,X3401_0100_0027,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,27,Healthy Volunteers,20mg oral single dose,20mg oral single dose,6,VISIT 6,0,0,05-09-2015,09:58,0,168,168,Hours,Concentration,Plasma concentration HS02,1.65,,ng/ml,NaN,1,,NaN,NaN,NaN
473,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,1,VISIT 1 - Screening,0,1,29-07-2015,09:53,0,-168,-167.9496667,Hours,Demographics,Age,32,,Years,NaN,NaN,,NaN,NaN,NaN
474,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,1,VISIT 1 - Screening,0,1,29-07-2015,09:53,0,-168,-167.9496667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
475,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,05-08-2015,08:49,0,-1,-1,Hours,Body,BMI,27.28,,kg/m2,NaN,NaN,,NaN,NaN,NaN
476,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,05-08-2015,08:49,0,-1,-1,Hours,Body,Bodyweight,77,,kg,NaN,NaN,,NaN,NaN,NaN
477,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,05-08-2015,08:49,0,-1,-1,Hours,Body,Height,168,,cm,NaN,NaN,,NaN,NaN,NaN
478,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,09:45,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
479,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,09:49,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
480,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,09:54,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,6.09,,ng/ml,NaN,1,,NaN,NaN,NaN
481,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,10:04,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,15.7,,ng/ml,NaN,1,,NaN,NaN,NaN
482,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,10:19,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,29.7,,ng/ml,NaN,1,,NaN,NaN,NaN
483,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,10:49,0,1,1,Hours,Concentration,Plasma concentration HS02,50.3,,ng/ml,NaN,1,,NaN,NaN,NaN
484,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,11:49,0,2,2,Hours,Concentration,Plasma concentration HS02,46.5,,ng/ml,NaN,1,,NaN,NaN,NaN
485,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,13:49,0,4,4,Hours,Concentration,Plasma concentration HS02,40.9,,ng/ml,NaN,1,,NaN,NaN,NaN
486,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,21:49,0,12,12,Hours,Concentration,Plasma concentration HS02,8.98,,ng/ml,NaN,1,,NaN,NaN,NaN
487,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,3,VISIT 3,0,0,06-08-2015,09:49,0,24,24,Hours,Concentration,Plasma concentration HS02,2.65,,ng/ml,NaN,1,,NaN,NaN,NaN
488,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,4,VISIT 4,0,0,07-08-2015,09:49,0,48,48,Hours,Concentration,Plasma concentration HS02,1.69,,ng/ml,NaN,1,,NaN,NaN,NaN
489,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,5,VISIT 5,0,0,09-08-2015,09:49,0,96,96,Hours,Concentration,Plasma concentration HS02,1.7,,ng/ml,NaN,1,,NaN,NaN,NaN
490,,X3401_0100_0028,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,28,Healthy Volunteers,20mg oral single dose,20mg oral single dose,6,VISIT 6,0,0,12-08-2015,09:49,0,168,168,Hours,Concentration,Plasma concentration HS02,1.45,,ng/ml,NaN,1,,NaN,NaN,NaN
491,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,1,VISIT 1 - Screening,0,1,26-08-2015,09:23,0,-168,-167.883,Hours,Demographics,Age,31,,Years,NaN,NaN,,NaN,NaN,NaN
492,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,1,VISIT 1 - Screening,0,1,26-08-2015,09:23,0,-168,-167.883,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
493,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:15,0,-1,-1,Hours,Body,BMI,22.59,,kg/m2,NaN,NaN,,NaN,NaN,NaN
494,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:15,0,-1,-1,Hours,Body,Bodyweight,74,,kg,NaN,NaN,,NaN,NaN,NaN
495,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:15,0,-1,-1,Hours,Body,Height,181,,cm,NaN,NaN,,NaN,NaN,NaN
496,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:11,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
497,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:15,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
498,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:20,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,9.71,,ng/ml,NaN,1,,NaN,NaN,NaN
499,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:30,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,26.9,,ng/ml,NaN,1,,NaN,NaN,NaN
500,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:45,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,48.4,,ng/ml,NaN,1,,NaN,NaN,NaN
501,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,10:15,0,1,1,Hours,Concentration,Plasma concentration HS02,65.3,,ng/ml,NaN,1,,NaN,NaN,NaN
502,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,11:15,0,2,2,Hours,Concentration,Plasma concentration HS02,57.9,,ng/ml,NaN,1,,NaN,NaN,NaN
503,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,13:15,0,4,4,Hours,Concentration,Plasma concentration HS02,33.6,,ng/ml,NaN,1,,NaN,NaN,NaN
504,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,21:15,0,12,12,Hours,Concentration,Plasma concentration HS02,9.91,,ng/ml,NaN,1,,NaN,NaN,NaN
505,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,3,VISIT 3,0,0,03-09-2015,09:15,0,24,24,Hours,Concentration,Plasma concentration HS02,1.88,,ng/ml,NaN,1,,NaN,NaN,NaN
506,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,4,VISIT 4,0,0,04-09-2015,09:15,0,48,48,Hours,Concentration,Plasma concentration HS02,2.96,,ng/ml,NaN,1,,NaN,NaN,NaN
507,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,5,VISIT 5,0,0,06-09-2015,09:15,0,96,96,Hours,Concentration,Plasma concentration HS02,1.49,,ng/ml,NaN,1,,NaN,NaN,NaN
508,,X3401_0100_0029,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,29,Healthy Volunteers,20mg oral single dose,20mg oral single dose,6,VISIT 6,0,0,09-09-2015,09:15,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
509,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,1,VISIT 1 - Screening,0,1,08-08-2015,09:50,0,-168,-167.7163333,Hours,Demographics,Age,27,,Years,NaN,NaN,,NaN,NaN,NaN
510,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,1,VISIT 1 - Screening,0,1,08-08-2015,09:50,0,-168,-167.7163333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
511,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,15-08-2015,08:32,0,-1,-1,Hours,Body,BMI,23.81,,kg/m2,NaN,NaN,,NaN,NaN,NaN
512,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,15-08-2015,08:32,0,-1,-1,Hours,Body,Bodyweight,78,,kg,NaN,NaN,,NaN,NaN,NaN
513,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,15-08-2015,08:32,0,-1,-1,Hours,Body,Height,181,,cm,NaN,NaN,,NaN,NaN,NaN
514,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:28,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
515,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:32,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
516,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:37,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,12.9,,ng/ml,NaN,1,,NaN,NaN,NaN
517,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:47,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,32.9,,ng/ml,NaN,1,,NaN,NaN,NaN
518,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,10:02,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,43.1,,ng/ml,NaN,1,,NaN,NaN,NaN
519,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,10:32,0,1,1,Hours,Concentration,Plasma concentration HS02,53.6,,ng/ml,NaN,1,,NaN,NaN,NaN
520,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,11:32,0,2,2,Hours,Concentration,Plasma concentration HS02,57,,ng/ml,NaN,1,,NaN,NaN,NaN
521,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,13:32,0,4,4,Hours,Concentration,Plasma concentration HS02,43.7,,ng/ml,NaN,1,,NaN,NaN,NaN
522,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,21:32,0,12,12,Hours,Concentration,Plasma concentration HS02,11.7,,ng/ml,NaN,1,,NaN,NaN,NaN
523,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,3,VISIT 3,0,0,16-08-2015,09:32,0,24,24,Hours,Concentration,Plasma concentration HS02,2.97,,ng/ml,NaN,1,,NaN,NaN,NaN
524,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,4,VISIT 4,0,0,17-08-2015,09:32,0,48,48,Hours,Concentration,Plasma concentration HS02,1.14,,ng/ml,NaN,1,,NaN,NaN,NaN
525,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,5,VISIT 5,0,0,19-08-2015,09:32,0,96,96,Hours,Concentration,Plasma concentration HS02,1.31,,ng/ml,NaN,1,,NaN,NaN,NaN
526,,X3401_0100_0030,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,30,Healthy Volunteers,20mg oral single dose,20mg oral single dose,6,VISIT 6,0,0,22-08-2015,09:32,0,168,168,Hours,Concentration,Plasma concentration HS02,1.21,,ng/ml,NaN,1,,NaN,NaN,NaN
527,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,1,VISIT 1 - Screening,0,1,31-07-2015,09:44,0,-168,-168.1663333,Hours,Demographics,Age,23,,Years,NaN,NaN,,NaN,NaN,NaN
528,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,1,VISIT 1 - Screening,0,1,31-07-2015,09:44,0,-168,-168.1663333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
529,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,07-08-2015,08:53,0,-1,-1,Hours,Body,BMI,23.89,,kg/m2,NaN,NaN,,NaN,NaN,NaN
530,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,07-08-2015,08:53,0,-1,-1,Hours,Body,Bodyweight,74,,kg,NaN,NaN,,NaN,NaN,NaN
531,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,07-08-2015,08:53,0,-1,-1,Hours,Body,Height,176,,cm,NaN,NaN,,NaN,NaN,NaN
532,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,07-08-2015,09:49,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
533,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,07-08-2015,09:53,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
534,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,07-08-2015,09:58,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,14.8,,ng/ml,NaN,1,,NaN,NaN,NaN
535,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,07-08-2015,10:08,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,37.2,,ng/ml,NaN,1,,NaN,NaN,NaN
536,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,07-08-2015,10:23,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,60,,ng/ml,NaN,1,,NaN,NaN,NaN
537,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,07-08-2015,10:53,0,1,1,Hours,Concentration,Plasma concentration HS02,87.5,,ng/ml,NaN,1,,NaN,NaN,NaN
538,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,07-08-2015,11:53,0,2,2,Hours,Concentration,Plasma concentration HS02,70.3,,ng/ml,NaN,1,,NaN,NaN,NaN
539,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,07-08-2015,13:53,0,4,4,Hours,Concentration,Plasma concentration HS02,79.2,,ng/ml,NaN,1,,NaN,NaN,NaN
540,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,07-08-2015,21:53,0,12,12,Hours,Concentration,Plasma concentration HS02,28.5,,ng/ml,NaN,1,,NaN,NaN,NaN
541,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,3,VISIT 3,0,0,08-08-2015,09:53,0,24,24,Hours,Concentration,Plasma concentration HS02,9.63,,ng/ml,NaN,1,,NaN,NaN,NaN
542,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,4,VISIT 4,0,0,09-08-2015,09:53,0,48,48,Hours,Concentration,Plasma concentration HS02,2.83,,ng/ml,NaN,1,,NaN,NaN,NaN
543,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,5,VISIT 5,0,0,11-08-2015,09:53,0,96,96,Hours,Concentration,Plasma concentration HS02,2.48,,ng/ml,NaN,1,,NaN,NaN,NaN
544,,X3401_0100_0031,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,31,Healthy Volunteers,50mg oral single dose,50mg oral single dose,6,VISIT 6,0,0,14-08-2015,09:53,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
545,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,1,VISIT 1 - Screening,0,1,25-07-2015,09:56,0,-168,-168.2163333,Hours,Demographics,Age,29,,Years,NaN,NaN,,NaN,NaN,NaN
546,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,1,VISIT 1 - Screening,0,1,25-07-2015,09:56,0,-168,-168.2163333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
547,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,01-08-2015,09:08,0,-1,-1,Hours,Body,BMI,26.23,,kg/m2,NaN,NaN,,NaN,NaN,NaN
548,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,01-08-2015,09:08,0,-1,-1,Hours,Body,Bodyweight,85,,kg,NaN,NaN,,NaN,NaN,NaN
549,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,01-08-2015,09:08,0,-1,-1,Hours,Body,Height,180,,cm,NaN,NaN,,NaN,NaN,NaN
550,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-08-2015,10:04,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
551,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-08-2015,10:08,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
552,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-08-2015,10:13,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,47.2,,ng/ml,NaN,1,,NaN,NaN,NaN
553,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-08-2015,10:23,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,114,,ng/ml,NaN,1,,NaN,NaN,NaN
554,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-08-2015,10:38,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,152,,ng/ml,NaN,1,,NaN,NaN,NaN
555,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-08-2015,11:08,0,1,1,Hours,Concentration,Plasma concentration HS02,173,,ng/ml,NaN,1,,NaN,NaN,NaN
556,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-08-2015,12:08,0,2,2,Hours,Concentration,Plasma concentration HS02,145,,ng/ml,NaN,1,,NaN,NaN,NaN
557,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-08-2015,14:08,0,4,4,Hours,Concentration,Plasma concentration HS02,101,,ng/ml,NaN,1,,NaN,NaN,NaN
558,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-08-2015,22:08,0,12,12,Hours,Concentration,Plasma concentration HS02,19.5,,ng/ml,NaN,1,,NaN,NaN,NaN
559,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,3,VISIT 3,0,0,02-08-2015,10:08,0,24,24,Hours,Concentration,Plasma concentration HS02,9.4,,ng/ml,NaN,1,,NaN,NaN,NaN
560,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,4,VISIT 4,0,0,03-08-2015,10:08,0,48,48,Hours,Concentration,Plasma concentration HS02,5.28,,ng/ml,NaN,1,,NaN,NaN,NaN
561,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,5,VISIT 5,0,0,05-08-2015,10:08,0,96,96,Hours,Concentration,Plasma concentration HS02,4.82,,ng/ml,NaN,1,,NaN,NaN,NaN
562,,X3401_0100_0032,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,32,Healthy Volunteers,50mg oral single dose,50mg oral single dose,6,VISIT 6,0,0,08-08-2015,10:08,0,168,168,Hours,Concentration,Plasma concentration HS02,2.29,,ng/ml,NaN,1,,NaN,NaN,NaN
563,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,1,VISIT 1 - Screening,0,1,27-08-2015,09:21,0,-168,-168.5996667,Hours,Demographics,Age,35,,Years,NaN,NaN,,NaN,NaN,NaN
564,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,1,VISIT 1 - Screening,0,1,27-08-2015,09:21,0,-168,-168.5996667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
565,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,03-09-2015,08:56,0,-1,-1,Hours,Body,BMI,25.1,,kg/m2,NaN,NaN,,NaN,NaN,NaN
566,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,03-09-2015,08:56,0,-1,-1,Hours,Body,Bodyweight,76,,kg,NaN,NaN,,NaN,NaN,NaN
567,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,03-09-2015,08:56,0,-1,-1,Hours,Body,Height,174,,cm,NaN,NaN,,NaN,NaN,NaN
568,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-09-2015,09:52,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
569,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-09-2015,09:56,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
570,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-09-2015,10:01,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,26.7,,ng/ml,NaN,1,,NaN,NaN,NaN
571,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-09-2015,10:11,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,64.8,,ng/ml,NaN,1,,NaN,NaN,NaN
572,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-09-2015,10:26,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,110,,ng/ml,NaN,1,,NaN,NaN,NaN
573,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-09-2015,10:56,0,1,1,Hours,Concentration,Plasma concentration HS02,125,,ng/ml,NaN,1,,NaN,NaN,NaN
574,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-09-2015,11:56,0,2,2,Hours,Concentration,Plasma concentration HS02,143,,ng/ml,NaN,1,,NaN,NaN,NaN
575,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-09-2015,13:56,0,4,4,Hours,Concentration,Plasma concentration HS02,69.5,,ng/ml,NaN,1,,NaN,NaN,NaN
576,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-09-2015,21:56,0,12,12,Hours,Concentration,Plasma concentration HS02,16.4,,ng/ml,NaN,1,,NaN,NaN,NaN
577,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,3,VISIT 3,0,0,04-09-2015,09:56,0,24,24,Hours,Concentration,Plasma concentration HS02,4.47,,ng/ml,NaN,1,,NaN,NaN,NaN
578,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,4,VISIT 4,0,0,05-09-2015,09:56,0,48,48,Hours,Concentration,Plasma concentration HS02,3.13,,ng/ml,NaN,1,,NaN,NaN,NaN
579,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,5,VISIT 5,0,0,07-09-2015,09:56,0,96,96,Hours,Concentration,Plasma concentration HS02,2.99,,ng/ml,NaN,1,,NaN,NaN,NaN
580,,X3401_0100_0033,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,33,Healthy Volunteers,50mg oral single dose,50mg oral single dose,6,VISIT 6,0,0,10-09-2015,09:56,0,168,168,Hours,Concentration,Plasma concentration HS02,2.01,,ng/ml,NaN,1,,NaN,NaN,NaN
581,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,1,VISIT 1 - Screening,0,1,20-08-2015,09:47,0,-168,-167.9496667,Hours,Demographics,Age,27,,Years,NaN,NaN,,NaN,NaN,NaN
582,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,1,VISIT 1 - Screening,0,1,20-08-2015,09:47,0,-168,-167.9496667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
583,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,27-08-2015,08:43,0,-1,-1,Hours,Body,BMI,25.64,,kg/m2,NaN,NaN,,NaN,NaN,NaN
584,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,27-08-2015,08:43,0,-1,-1,Hours,Body,Bodyweight,84,,kg,NaN,NaN,,NaN,NaN,NaN
585,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,27-08-2015,08:43,0,-1,-1,Hours,Body,Height,181,,cm,NaN,NaN,,NaN,NaN,NaN
586,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,09:39,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
587,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,09:43,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
588,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,09:48,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,17.3,,ng/ml,NaN,1,,NaN,NaN,NaN
589,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,09:58,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,43.7,,ng/ml,NaN,1,,NaN,NaN,NaN
590,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,10:13,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,79.3,,ng/ml,NaN,1,,NaN,NaN,NaN
591,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,10:43,0,1,1,Hours,Concentration,Plasma concentration HS02,89.4,,ng/ml,NaN,1,,NaN,NaN,NaN
592,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,11:43,0,2,2,Hours,Concentration,Plasma concentration HS02,96.1,,ng/ml,NaN,1,,NaN,NaN,NaN
593,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,13:43,0,4,4,Hours,Concentration,Plasma concentration HS02,75.9,,ng/ml,NaN,1,,NaN,NaN,NaN
594,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,21:43,0,12,12,Hours,Concentration,Plasma concentration HS02,13.5,,ng/ml,NaN,1,,NaN,NaN,NaN
595,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,3,VISIT 3,0,0,28-08-2015,09:43,0,24,24,Hours,Concentration,Plasma concentration HS02,3.4,,ng/ml,NaN,1,,NaN,NaN,NaN
596,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,4,VISIT 4,0,0,29-08-2015,09:43,0,48,48,Hours,Concentration,Plasma concentration HS02,2.08,,ng/ml,NaN,1,,NaN,NaN,NaN
597,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,5,VISIT 5,0,0,31-08-2015,09:43,0,96,96,Hours,Concentration,Plasma concentration HS02,1.12,,ng/ml,NaN,1,,NaN,NaN,NaN
598,,X3401_0100_0034,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,34,Healthy Volunteers,50mg oral single dose,50mg oral single dose,6,VISIT 6,0,0,03-09-2015,09:43,0,168,168,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
599,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,1,VISIT 1 - Screening,0,1,25-08-2015,09:05,0,-168,-168.3663333,Hours,Demographics,Age,34,,Years,NaN,NaN,,NaN,NaN,NaN
600,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,1,VISIT 1 - Screening,0,1,25-08-2015,09:05,0,-168,-168.3663333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
601,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,01-09-2015,08:26,0,-1,-1,Hours,Body,BMI,28.69,,kg/m2,NaN,NaN,,NaN,NaN,NaN
602,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,01-09-2015,08:26,0,-1,-1,Hours,Body,Bodyweight,94,,kg,NaN,NaN,,NaN,NaN,NaN
603,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,01-09-2015,08:26,0,-1,-1,Hours,Body,Height,181,,cm,NaN,NaN,,NaN,NaN,NaN
604,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,09:22,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
605,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,09:26,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
606,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,09:31,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,47.2,,ng/ml,NaN,1,,NaN,NaN,NaN
607,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,09:41,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,106,,ng/ml,NaN,1,,NaN,NaN,NaN
608,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,09:56,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,137,,ng/ml,NaN,1,,NaN,NaN,NaN
609,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,10:26,0,1,1,Hours,Concentration,Plasma concentration HS02,182,,ng/ml,NaN,1,,NaN,NaN,NaN
610,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,11:26,0,2,2,Hours,Concentration,Plasma concentration HS02,167,,ng/ml,NaN,1,,NaN,NaN,NaN
611,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,13:26,0,4,4,Hours,Concentration,Plasma concentration HS02,91,,ng/ml,NaN,1,,NaN,NaN,NaN
612,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,21:26,0,12,12,Hours,Concentration,Plasma concentration HS02,12.2,,ng/ml,NaN,1,,NaN,NaN,NaN
613,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,3,VISIT 3,0,0,02-09-2015,09:26,0,24,24,Hours,Concentration,Plasma concentration HS02,5.54,,ng/ml,NaN,1,,NaN,NaN,NaN
614,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,4,VISIT 4,0,0,03-09-2015,09:26,0,48,48,Hours,Concentration,Plasma concentration HS02,4.04,,ng/ml,NaN,1,,NaN,NaN,NaN
615,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,5,VISIT 5,0,0,05-09-2015,09:26,0,96,96,Hours,Concentration,Plasma concentration HS02,4.15,,ng/ml,NaN,1,,NaN,NaN,NaN
616,,X3401_0100_0035,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,35,Healthy Volunteers,50mg oral single dose,50mg oral single dose,6,VISIT 6,0,0,08-09-2015,09:26,0,168,168,Hours,Concentration,Plasma concentration HS02,2.04,,ng/ml,NaN,1,,NaN,NaN,NaN
617,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,1,VISIT 1 - Screening,0,1,29-07-2015,09:25,0,-168,-168.6663333,Hours,Demographics,Age,34,,Years,NaN,NaN,,NaN,NaN,NaN
618,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,1,VISIT 1 - Screening,0,1,29-07-2015,09:25,0,-168,-168.6663333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
619,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,05-08-2015,09:04,0,-1,-1,Hours,Body,BMI,22.64,,kg/m2,NaN,NaN,,NaN,NaN,NaN
620,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,05-08-2015,09:04,0,-1,-1,Hours,Body,Bodyweight,75,,kg,NaN,NaN,,NaN,NaN,NaN
621,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,05-08-2015,09:04,0,-1,-1,Hours,Body,Height,182,,cm,NaN,NaN,,NaN,NaN,NaN
622,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,10:00,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
623,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,10:04,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
624,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,10:09,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,37.5,,ng/ml,NaN,1,,NaN,NaN,NaN
625,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,10:19,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,84.3,,ng/ml,NaN,1,,NaN,NaN,NaN
626,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,10:34,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,130,,ng/ml,NaN,1,,NaN,NaN,NaN
627,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,11:04,0,1,1,Hours,Concentration,Plasma concentration HS02,223,,ng/ml,NaN,1,,NaN,NaN,NaN
628,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,12:04,0,2,2,Hours,Concentration,Plasma concentration HS02,195,,ng/ml,NaN,1,,NaN,NaN,NaN
629,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,14:04,0,4,4,Hours,Concentration,Plasma concentration HS02,149,,ng/ml,NaN,1,,NaN,NaN,NaN
630,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,05-08-2015,22:04,0,12,12,Hours,Concentration,Plasma concentration HS02,29.5,,ng/ml,NaN,1,,NaN,NaN,NaN
631,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,3,VISIT 3,0,0,06-08-2015,10:04,0,24,24,Hours,Concentration,Plasma concentration HS02,7.83,,ng/ml,NaN,1,,NaN,NaN,NaN
632,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,4,VISIT 4,0,0,07-08-2015,10:04,0,48,48,Hours,Concentration,Plasma concentration HS02,4.47,,ng/ml,NaN,1,,NaN,NaN,NaN
633,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,5,VISIT 5,0,0,09-08-2015,10:04,0,96,96,Hours,Concentration,Plasma concentration HS02,4.39,,ng/ml,NaN,1,,NaN,NaN,NaN
634,,X3401_0100_0036,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,36,Healthy Volunteers,50mg oral single dose,50mg oral single dose,6,VISIT 6,0,0,12-08-2015,10:04,0,168,168,Hours,Concentration,Plasma concentration HS02,1.91,,ng/ml,NaN,1,,NaN,NaN,NaN
635,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,1,VISIT 1 - Screening,0,1,30-07-2015,09:53,0,-168,-167.983,Hours,Demographics,Age,22,,Years,NaN,NaN,,NaN,NaN,NaN
636,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,1,VISIT 1 - Screening,0,1,30-07-2015,09:53,0,-168,-167.983,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
637,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,06-08-2015,08:51,0,-1,-1,Hours,Body,BMI,24.62,,kg/m2,NaN,NaN,,NaN,NaN,NaN
638,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,06-08-2015,08:51,0,-1,-1,Hours,Body,Bodyweight,78,,kg,NaN,NaN,,NaN,NaN,NaN
639,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,06-08-2015,08:51,0,-1,-1,Hours,Body,Height,178,,cm,NaN,NaN,,NaN,NaN,NaN
640,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,09:47,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
641,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,09:51,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
642,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,09:56,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,38,,ng/ml,NaN,1,,NaN,NaN,NaN
643,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,10:06,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,118,,ng/ml,NaN,1,,NaN,NaN,NaN
644,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,10:21,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,156,,ng/ml,NaN,1,,NaN,NaN,NaN
645,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,10:51,0,1,1,Hours,Concentration,Plasma concentration HS02,268,,ng/ml,NaN,1,,NaN,NaN,NaN
646,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,11:51,0,2,2,Hours,Concentration,Plasma concentration HS02,226,,ng/ml,NaN,1,,NaN,NaN,NaN
647,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,13:51,0,4,4,Hours,Concentration,Plasma concentration HS02,187,,ng/ml,NaN,1,,NaN,NaN,NaN
648,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,21:51,0,12,12,Hours,Concentration,Plasma concentration HS02,72.2,,ng/ml,NaN,1,,NaN,NaN,NaN
649,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,3,VISIT 3,0,0,07-08-2015,09:51,0,24,24,Hours,Concentration,Plasma concentration HS02,19.8,,ng/ml,NaN,1,,NaN,NaN,NaN
650,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,4,VISIT 4,0,0,08-08-2015,09:51,0,48,48,Hours,Concentration,Plasma concentration HS02,5.57,,ng/ml,NaN,1,,NaN,NaN,NaN
651,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,5,VISIT 5,0,0,10-08-2015,09:51,0,96,96,Hours,Concentration,Plasma concentration HS02,6.25,,ng/ml,NaN,1,,NaN,NaN,NaN
652,,X3401_0100_0037,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,37,Healthy Volunteers,100mg oral single dose,100mg oral single dose,6,VISIT 6,0,0,13-08-2015,09:51,0,168,168,Hours,Concentration,Plasma concentration HS02,4.89,,ng/ml,NaN,1,,NaN,NaN,NaN
653,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,1,VISIT 1 - Screening,0,1,21-07-2015,10:04,0,-168,-167.2663333,Hours,Demographics,Age,21,,Years,NaN,NaN,,NaN,NaN,NaN
654,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,1,VISIT 1 - Screening,0,1,21-07-2015,10:04,0,-168,-167.2663333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
655,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-07-2015,08:19,0,-1,-1,Hours,Body,BMI,23.63,,kg/m2,NaN,NaN,,NaN,NaN,NaN
656,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-07-2015,08:19,0,-1,-1,Hours,Body,Bodyweight,80,,kg,NaN,NaN,,NaN,NaN,NaN
657,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-07-2015,08:19,0,-1,-1,Hours,Body,Height,184,,cm,NaN,NaN,,NaN,NaN,NaN
658,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,09:15,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
659,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,09:19,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
660,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,09:24,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,54.5,,ng/ml,NaN,1,,NaN,NaN,NaN
661,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,09:34,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,171,,ng/ml,NaN,1,,NaN,NaN,NaN
662,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,09:49,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,254,,ng/ml,NaN,1,,NaN,NaN,NaN
663,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,10:19,0,1,1,Hours,Concentration,Plasma concentration HS02,256,,ng/ml,NaN,1,,NaN,NaN,NaN
664,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,11:19,0,2,2,Hours,Concentration,Plasma concentration HS02,253,,ng/ml,NaN,1,,NaN,NaN,NaN
665,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,13:19,0,4,4,Hours,Concentration,Plasma concentration HS02,202,,ng/ml,NaN,1,,NaN,NaN,NaN
666,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,21:19,0,12,12,Hours,Concentration,Plasma concentration HS02,94.8,,ng/ml,NaN,1,,NaN,NaN,NaN
667,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,3,VISIT 3,0,0,29-07-2015,09:19,0,24,24,Hours,Concentration,Plasma concentration HS02,25.1,,ng/ml,NaN,1,,NaN,NaN,NaN
668,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,4,VISIT 4,0,0,30-07-2015,09:19,0,48,48,Hours,Concentration,Plasma concentration HS02,7.26,,ng/ml,NaN,1,,NaN,NaN,NaN
669,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,5,VISIT 5,0,0,01-08-2015,09:19,0,96,96,Hours,Concentration,Plasma concentration HS02,5.5,,ng/ml,NaN,1,,NaN,NaN,NaN
670,,X3401_0100_0038,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,38,Healthy Volunteers,100mg oral single dose,100mg oral single dose,6,VISIT 6,0,0,04-08-2015,09:19,0,168,168,Hours,Concentration,Plasma concentration HS02,5.84,,ng/ml,NaN,1,,NaN,NaN,NaN
671,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,1,VISIT 1 - Screening,0,1,26-08-2015,09:31,0,-168,-167.983,Hours,Demographics,Age,32,,Years,NaN,NaN,,NaN,NaN,NaN
672,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,1,VISIT 1 - Screening,0,1,26-08-2015,09:31,0,-168,-167.983,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
673,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:29,0,-1,-1,Hours,Body,BMI,26.53,,kg/m2,NaN,NaN,,NaN,NaN,NaN
674,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:29,0,-1,-1,Hours,Body,Bodyweight,85,,kg,NaN,NaN,,NaN,NaN,NaN
675,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:29,0,-1,-1,Hours,Body,Height,179,,cm,NaN,NaN,,NaN,NaN,NaN
676,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:25,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
677,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:29,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
678,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:34,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,73,,ng/ml,NaN,1,,NaN,NaN,NaN
679,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:44,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,194,,ng/ml,NaN,1,,NaN,NaN,NaN
680,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:59,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,257,,ng/ml,NaN,1,,NaN,NaN,NaN
681,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,10:29,0,1,1,Hours,Concentration,Plasma concentration HS02,419,,ng/ml,NaN,1,,NaN,NaN,NaN
682,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,11:29,0,2,2,Hours,Concentration,Plasma concentration HS02,439,,ng/ml,NaN,1,,NaN,NaN,NaN
683,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,13:29,0,4,4,Hours,Concentration,Plasma concentration HS02,320,,ng/ml,NaN,1,,NaN,NaN,NaN
684,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,21:29,0,12,12,Hours,Concentration,Plasma concentration HS02,56.4,,ng/ml,NaN,1,,NaN,NaN,NaN
685,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,3,VISIT 3,0,0,03-09-2015,09:29,0,24,24,Hours,Concentration,Plasma concentration HS02,16.9,,ng/ml,NaN,1,,NaN,NaN,NaN
686,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,4,VISIT 4,0,0,04-09-2015,09:29,0,48,48,Hours,Concentration,Plasma concentration HS02,11.8,,ng/ml,NaN,1,,NaN,NaN,NaN
687,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,5,VISIT 5,0,0,06-09-2015,09:29,0,96,96,Hours,Concentration,Plasma concentration HS02,8.34,,ng/ml,NaN,1,,NaN,NaN,NaN
688,,X3401_0100_0039,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,39,Healthy Volunteers,100mg oral single dose,100mg oral single dose,6,VISIT 6,0,0,09-09-2015,09:29,0,168,168,Hours,Concentration,Plasma concentration HS02,6.85,,ng/ml,NaN,1,,NaN,NaN,NaN
689,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,1,VISIT 1 - Screening,0,1,21-08-2015,09:25,0,-168,-168.283,Hours,Demographics,Age,33,,Years,NaN,NaN,,NaN,NaN,NaN
690,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,1,VISIT 1 - Screening,0,1,21-08-2015,09:25,0,-168,-168.283,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
691,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-08-2015,08:41,0,-1,-1,Hours,Body,BMI,28.71,,kg/m2,NaN,NaN,,NaN,NaN,NaN
692,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-08-2015,08:41,0,-1,-1,Hours,Body,Bodyweight,92,,kg,NaN,NaN,,NaN,NaN,NaN
693,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-08-2015,08:41,0,-1,-1,Hours,Body,Height,179,,cm,NaN,NaN,,NaN,NaN,NaN
694,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,09:37,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
695,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,09:41,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
696,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,09:46,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,86.7,,ng/ml,NaN,1,,NaN,NaN,NaN
697,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,09:56,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,203,,ng/ml,NaN,1,,NaN,NaN,NaN
698,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,10:11,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,293,,ng/ml,NaN,1,,NaN,NaN,NaN
699,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,10:41,0,1,1,Hours,Concentration,Plasma concentration HS02,334,,ng/ml,NaN,1,,NaN,NaN,NaN
700,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,11:41,0,2,2,Hours,Concentration,Plasma concentration HS02,291,,ng/ml,NaN,1,,NaN,NaN,NaN
701,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,13:41,0,4,4,Hours,Concentration,Plasma concentration HS02,243,,ng/ml,NaN,1,,NaN,NaN,NaN
702,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,21:41,0,12,12,Hours,Concentration,Plasma concentration HS02,56.8,,ng/ml,NaN,1,,NaN,NaN,NaN
703,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,3,VISIT 3,0,0,29-08-2015,09:41,0,24,24,Hours,Concentration,Plasma concentration HS02,11.5,,ng/ml,NaN,1,,NaN,NaN,NaN
704,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,4,VISIT 4,0,0,30-08-2015,09:41,0,48,48,Hours,Concentration,Plasma concentration HS02,5.03,,ng/ml,NaN,1,,NaN,NaN,NaN
705,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,5,VISIT 5,0,0,01-09-2015,09:41,0,96,96,Hours,Concentration,Plasma concentration HS02,2.78,,ng/ml,NaN,1,,NaN,NaN,NaN
706,,X3401_0100_0040,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,40,Healthy Volunteers,100mg oral single dose,100mg oral single dose,6,VISIT 6,0,0,04-09-2015,09:41,0,168,168,Hours,Concentration,Plasma concentration HS02,2.16,,ng/ml,NaN,1,,NaN,NaN,NaN
707,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,1,VISIT 1 - Screening,0,1,28-08-2015,09:47,0,-168,-168.3163333,Hours,Demographics,Age,34,,Years,NaN,NaN,,NaN,NaN,NaN
708,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,1,VISIT 1 - Screening,0,1,28-08-2015,09:47,0,-168,-168.3163333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
709,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,09:05,0,-1,-1,Hours,Body,BMI,27.77,,kg/m2,NaN,NaN,,NaN,NaN,NaN
710,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,09:05,0,-1,-1,Hours,Body,Bodyweight,88,,kg,NaN,NaN,,NaN,NaN,NaN
711,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,09:05,0,-1,-1,Hours,Body,Height,178,,cm,NaN,NaN,,NaN,NaN,NaN
712,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:01,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
713,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:05,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
714,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:10,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,62.9,,ng/ml,NaN,1,,NaN,NaN,NaN
715,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:20,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,142,,ng/ml,NaN,1,,NaN,NaN,NaN
716,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:35,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,215,,ng/ml,NaN,1,,NaN,NaN,NaN
717,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,11:05,0,1,1,Hours,Concentration,Plasma concentration HS02,318,,ng/ml,NaN,1,,NaN,NaN,NaN
718,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,12:05,0,2,2,Hours,Concentration,Plasma concentration HS02,254,,ng/ml,NaN,1,,NaN,NaN,NaN
719,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,14:05,0,4,4,Hours,Concentration,Plasma concentration HS02,169,,ng/ml,NaN,1,,NaN,NaN,NaN
720,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,22:05,0,12,12,Hours,Concentration,Plasma concentration HS02,28.7,,ng/ml,NaN,1,,NaN,NaN,NaN
721,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,3,VISIT 3,0,0,05-09-2015,10:05,0,24,24,Hours,Concentration,Plasma concentration HS02,9.77,,ng/ml,NaN,1,,NaN,NaN,NaN
722,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,4,VISIT 4,0,0,06-09-2015,10:05,0,48,48,Hours,Concentration,Plasma concentration HS02,5.55,,ng/ml,NaN,1,,NaN,NaN,NaN
723,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,5,VISIT 5,0,0,08-09-2015,10:05,0,96,96,Hours,Concentration,Plasma concentration HS02,4.13,,ng/ml,NaN,1,,NaN,NaN,NaN
724,,X3401_0100_0041,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,41,Healthy Volunteers,100mg oral single dose,100mg oral single dose,6,VISIT 6,0,0,11-09-2015,10:05,0,168,168,Hours,Concentration,Plasma concentration HS02,1.96,,ng/ml,NaN,1,,NaN,NaN,NaN
725,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,1,VISIT 1 - Screening,0,1,28-07-2015,09:02,0,-168,-168.983,Hours,Demographics,Age,31,,Years,NaN,NaN,,NaN,NaN,NaN
726,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,1,VISIT 1 - Screening,0,1,28-07-2015,09:02,0,-168,-168.983,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
727,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-08-2015,09:00,0,-1,-1,Hours,Body,BMI,25.46,,kg/m2,NaN,NaN,,NaN,NaN,NaN
728,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-08-2015,09:00,0,-1,-1,Hours,Body,Bodyweight,90,,kg,NaN,NaN,,NaN,NaN,NaN
729,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-08-2015,09:00,0,-1,-1,Hours,Body,Height,188,,cm,NaN,NaN,,NaN,NaN,NaN
730,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,09:56,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
731,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,10:00,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
732,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,10:05,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,82.7,,ng/ml,NaN,1,,NaN,NaN,NaN
733,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,10:15,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,202,,ng/ml,NaN,1,,NaN,NaN,NaN
734,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,10:30,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,284,,ng/ml,NaN,1,,NaN,NaN,NaN
735,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,11:00,0,1,1,Hours,Concentration,Plasma concentration HS02,310,,ng/ml,NaN,1,,NaN,NaN,NaN
736,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,12:00,0,2,2,Hours,Concentration,Plasma concentration HS02,256,,ng/ml,NaN,1,,NaN,NaN,NaN
737,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,14:00,0,4,4,Hours,Concentration,Plasma concentration HS02,182,,ng/ml,NaN,1,,NaN,NaN,NaN
738,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,22:00,0,12,12,Hours,Concentration,Plasma concentration HS02,27.2,,ng/ml,NaN,1,,NaN,NaN,NaN
739,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,3,VISIT 3,0,0,05-08-2015,10:00,0,24,24,Hours,Concentration,Plasma concentration HS02,14,,ng/ml,NaN,1,,NaN,NaN,NaN
740,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,4,VISIT 4,0,0,06-08-2015,10:00,0,48,48,Hours,Concentration,Plasma concentration HS02,11.3,,ng/ml,NaN,1,,NaN,NaN,NaN
741,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,5,VISIT 5,0,0,08-08-2015,10:00,0,96,96,Hours,Concentration,Plasma concentration HS02,5.37,,ng/ml,NaN,1,,NaN,NaN,NaN
742,,X3401_0100_0042,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,42,Healthy Volunteers,100mg oral single dose,100mg oral single dose,6,VISIT 6,0,0,11-08-2015,10:00,0,168,168,Hours,Concentration,Plasma concentration HS02,2.58,,ng/ml,NaN,1,,NaN,NaN,NaN
743,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,1,VISIT 1 - Screening,0,1,30-07-2015,09:09,0,-168,-168.7663333,Hours,Demographics,Age,31,,Years,NaN,NaN,,NaN,NaN,NaN
744,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,1,VISIT 1 - Screening,0,1,30-07-2015,09:09,0,-168,-168.7663333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
745,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,06-08-2015,08:54,0,-1,-1,Hours,Body,BMI,23.57,,kg/m2,NaN,NaN,,NaN,NaN,NaN
746,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,06-08-2015,08:54,0,-1,-1,Hours,Body,Bodyweight,73,,kg,NaN,NaN,,NaN,NaN,NaN
747,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,06-08-2015,08:54,0,-1,-1,Hours,Body,Height,176,,cm,NaN,NaN,,NaN,NaN,NaN
748,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,09:50,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
749,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,09:54,0,0,0,Hours,Dose,Dose HS02,200000,,ug,NaN,NaN,oral,NaN,NaN,NaN
750,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,09:59,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,166,,ng/ml,NaN,1,,NaN,NaN,NaN
751,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,10:09,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,374,,ng/ml,NaN,1,,NaN,NaN,NaN
752,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,10:24,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,504,,ng/ml,NaN,1,,NaN,NaN,NaN
753,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,10:54,0,1,1,Hours,Concentration,Plasma concentration HS02,862,,ng/ml,NaN,1,,NaN,NaN,NaN
754,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,11:54,0,2,2,Hours,Concentration,Plasma concentration HS02,788,,ng/ml,NaN,1,,NaN,NaN,NaN
755,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,13:54,0,4,4,Hours,Concentration,Plasma concentration HS02,490,,ng/ml,NaN,1,,NaN,NaN,NaN
756,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,06-08-2015,21:54,0,12,12,Hours,Concentration,Plasma concentration HS02,143,,ng/ml,NaN,1,,NaN,NaN,NaN
757,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,3,VISIT 3,0,0,07-08-2015,09:54,0,24,24,Hours,Concentration,Plasma concentration HS02,21.1,,ng/ml,NaN,1,,NaN,NaN,NaN
758,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,4,VISIT 4,0,0,08-08-2015,09:54,0,48,48,Hours,Concentration,Plasma concentration HS02,5.75,,ng/ml,NaN,1,,NaN,NaN,NaN
759,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,5,VISIT 5,0,0,10-08-2015,09:54,0,96,96,Hours,Concentration,Plasma concentration HS02,6.67,,ng/ml,NaN,1,,NaN,NaN,NaN
760,,X3401_0100_0043,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,43,Healthy Volunteers,200mg oral single dose,200mg oral single dose,6,VISIT 6,0,0,13-08-2015,09:54,0,168,168,Hours,Concentration,Plasma concentration HS02,5.93,,ng/ml,NaN,1,,NaN,NaN,NaN
761,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,1,VISIT 1 - Screening,0,1,06-08-2015,09:50,0,-168,-168.3663333,Hours,Demographics,Age,28,,Years,NaN,NaN,,NaN,NaN,NaN
762,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,1,VISIT 1 - Screening,0,1,06-08-2015,09:50,0,-168,-168.3663333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
763,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,13-08-2015,09:11,0,-1,-1,Hours,Body,BMI,23.29,,kg/m2,NaN,NaN,,NaN,NaN,NaN
764,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,13-08-2015,09:11,0,-1,-1,Hours,Body,Bodyweight,78,,kg,NaN,NaN,,NaN,NaN,NaN
765,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,13-08-2015,09:11,0,-1,-1,Hours,Body,Height,183,,cm,NaN,NaN,,NaN,NaN,NaN
766,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,10:07,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
767,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,10:11,0,0,0,Hours,Dose,Dose HS02,200000,,ug,NaN,NaN,oral,NaN,NaN,NaN
768,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,10:16,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,85.5,,ng/ml,NaN,1,,NaN,NaN,NaN
769,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,10:26,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,182,,ng/ml,NaN,1,,NaN,NaN,NaN
770,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,10:41,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,323,,ng/ml,NaN,1,,NaN,NaN,NaN
771,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,11:11,0,1,1,Hours,Concentration,Plasma concentration HS02,434,,ng/ml,NaN,1,,NaN,NaN,NaN
772,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,12:11,0,2,2,Hours,Concentration,Plasma concentration HS02,417,,ng/ml,NaN,1,,NaN,NaN,NaN
773,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,14:11,0,4,4,Hours,Concentration,Plasma concentration HS02,232,,ng/ml,NaN,1,,NaN,NaN,NaN
774,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,13-08-2015,22:11,0,12,12,Hours,Concentration,Plasma concentration HS02,39.6,,ng/ml,NaN,1,,NaN,NaN,NaN
775,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,3,VISIT 3,0,0,14-08-2015,10:11,0,24,24,Hours,Concentration,Plasma concentration HS02,8.77,,ng/ml,NaN,1,,NaN,NaN,NaN
776,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,4,VISIT 4,0,0,15-08-2015,10:11,0,48,48,Hours,Concentration,Plasma concentration HS02,7.78,,ng/ml,NaN,1,,NaN,NaN,NaN
777,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,5,VISIT 5,0,0,17-08-2015,10:11,0,96,96,Hours,Concentration,Plasma concentration HS02,4.19,,ng/ml,NaN,1,,NaN,NaN,NaN
778,,X3401_0100_0044,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,44,Healthy Volunteers,200mg oral single dose,200mg oral single dose,6,VISIT 6,0,0,20-08-2015,10:11,0,168,168,Hours,Concentration,Plasma concentration HS02,4.1,,ng/ml,NaN,1,,NaN,NaN,NaN
779,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,1,VISIT 1 - Screening,0,1,17-08-2015,09:25,0,-168,-168.5496667,Hours,Demographics,Age,31,,Years,NaN,NaN,,NaN,NaN,NaN
780,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,1,VISIT 1 - Screening,0,1,17-08-2015,09:25,0,-168,-168.5496667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
781,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,24-08-2015,08:57,0,-1,-1,Hours,Body,BMI,22.65,,kg/m2,NaN,NaN,,NaN,NaN,NaN
782,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,24-08-2015,08:57,0,-1,-1,Hours,Body,Bodyweight,67,,kg,NaN,NaN,,NaN,NaN,NaN
783,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,24-08-2015,08:57,0,-1,-1,Hours,Body,Height,172,,cm,NaN,NaN,,NaN,NaN,NaN
784,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,09:53,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
785,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,09:57,0,0,0,Hours,Dose,Dose HS02,200000,,ug,NaN,NaN,oral,NaN,NaN,NaN
786,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:02,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,175,,ng/ml,NaN,1,,NaN,NaN,NaN
787,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:12,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,376,,ng/ml,NaN,1,,NaN,NaN,NaN
788,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:27,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,593,,ng/ml,NaN,1,,NaN,NaN,NaN
789,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:57,0,1,1,Hours,Concentration,Plasma concentration HS02,635,,ng/ml,NaN,1,,NaN,NaN,NaN
790,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,11:57,0,2,2,Hours,Concentration,Plasma concentration HS02,517,,ng/ml,NaN,1,,NaN,NaN,NaN
791,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,13:57,0,4,4,Hours,Concentration,Plasma concentration HS02,429,,ng/ml,NaN,1,,NaN,NaN,NaN
792,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,21:57,0,12,12,Hours,Concentration,Plasma concentration HS02,92.4,,ng/ml,NaN,1,,NaN,NaN,NaN
793,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,3,VISIT 3,0,0,25-08-2015,09:57,0,24,24,Hours,Concentration,Plasma concentration HS02,19.3,,ng/ml,NaN,1,,NaN,NaN,NaN
794,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,4,VISIT 4,0,0,26-08-2015,09:57,0,48,48,Hours,Concentration,Plasma concentration HS02,12.2,,ng/ml,NaN,1,,NaN,NaN,NaN
795,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,5,VISIT 5,0,0,28-08-2015,09:57,0,96,96,Hours,Concentration,Plasma concentration HS02,6.61,,ng/ml,NaN,1,,NaN,NaN,NaN
796,,X3401_0100_0045,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,45,Healthy Volunteers,200mg oral single dose,200mg oral single dose,6,VISIT 6,0,0,31-08-2015,09:57,0,168,168,Hours,Concentration,Plasma concentration HS02,6.25,,ng/ml,NaN,1,,NaN,NaN,NaN
797,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,1,VISIT 1 - Screening,0,1,26-07-2015,09:12,0,-168,-167.983,Hours,Demographics,Age,32,,Years,NaN,NaN,,NaN,NaN,NaN
798,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,1,VISIT 1 - Screening,0,1,26-07-2015,09:12,0,-168,-167.983,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
799,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-08-2015,08:10,0,-1,-1,Hours,Body,BMI,24.3,,kg/m2,NaN,NaN,,NaN,NaN,NaN
800,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-08-2015,08:10,0,-1,-1,Hours,Body,Bodyweight,77,,kg,NaN,NaN,,NaN,NaN,NaN
801,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-08-2015,08:10,0,-1,-1,Hours,Body,Height,178,,cm,NaN,NaN,,NaN,NaN,NaN
802,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,09:06,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
803,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,09:10,0,0,0,Hours,Dose,Dose HS02,200000,,ug,NaN,NaN,oral,NaN,NaN,NaN
804,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,09:15,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,80.5,,ng/ml,NaN,1,,NaN,NaN,NaN
805,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,09:25,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,193,,ng/ml,NaN,1,,NaN,NaN,NaN
806,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,09:40,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,324,,ng/ml,NaN,1,,NaN,NaN,NaN
807,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,10:10,0,1,1,Hours,Concentration,Plasma concentration HS02,545,,ng/ml,NaN,1,,NaN,NaN,NaN
808,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,11:10,0,2,2,Hours,Concentration,Plasma concentration HS02,487,,ng/ml,NaN,1,,NaN,NaN,NaN
809,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,13:10,0,4,4,Hours,Concentration,Plasma concentration HS02,321,,ng/ml,NaN,1,,NaN,NaN,NaN
810,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,21:10,0,12,12,Hours,Concentration,Plasma concentration HS02,59.4,,ng/ml,NaN,1,,NaN,NaN,NaN
811,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,3,VISIT 3,0,0,03-08-2015,09:10,0,24,24,Hours,Concentration,Plasma concentration HS02,10.7,,ng/ml,NaN,1,,NaN,NaN,NaN
812,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,4,VISIT 4,0,0,04-08-2015,09:10,0,48,48,Hours,Concentration,Plasma concentration HS02,3.19,,ng/ml,NaN,1,,NaN,NaN,NaN
813,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,5,VISIT 5,0,0,06-08-2015,09:10,0,96,96,Hours,Concentration,Plasma concentration HS02,3.24,,ng/ml,NaN,1,,NaN,NaN,NaN
814,,X3401_0100_0046,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,46,Healthy Volunteers,200mg oral single dose,200mg oral single dose,6,VISIT 6,0,0,09-08-2015,09:10,0,168,168,Hours,Concentration,Plasma concentration HS02,2.77,,ng/ml,NaN,1,,NaN,NaN,NaN
815,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,1,VISIT 1 - Screening,0,1,26-08-2015,09:33,0,-168,-168.2163333,Hours,Demographics,Age,38,,Years,NaN,NaN,,NaN,NaN,NaN
816,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,1,VISIT 1 - Screening,0,1,26-08-2015,09:33,0,-168,-168.2163333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
817,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:45,0,-1,-1,Hours,Body,BMI,30.06,,kg/m2,NaN,NaN,,NaN,NaN,NaN
818,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:45,0,-1,-1,Hours,Body,Bodyweight,91,,kg,NaN,NaN,,NaN,NaN,NaN
819,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:45,0,-1,-1,Hours,Body,Height,174,,cm,NaN,NaN,,NaN,NaN,NaN
820,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:41,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
821,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:45,0,0,0,Hours,Dose,Dose HS02,200000,,ug,NaN,NaN,oral,NaN,NaN,NaN
822,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:50,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,110,,ng/ml,NaN,1,,NaN,NaN,NaN
823,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,10:00,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,265,,ng/ml,NaN,1,,NaN,NaN,NaN
824,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,10:15,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,427,,ng/ml,NaN,1,,NaN,NaN,NaN
825,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,10:45,0,1,1,Hours,Concentration,Plasma concentration HS02,552,,ng/ml,NaN,1,,NaN,NaN,NaN
826,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,11:45,0,2,2,Hours,Concentration,Plasma concentration HS02,432,,ng/ml,NaN,1,,NaN,NaN,NaN
827,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,13:45,0,4,4,Hours,Concentration,Plasma concentration HS02,354,,ng/ml,NaN,1,,NaN,NaN,NaN
828,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,21:45,0,12,12,Hours,Concentration,Plasma concentration HS02,97.5,,ng/ml,NaN,1,,NaN,NaN,NaN
829,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,3,VISIT 3,0,0,03-09-2015,09:45,0,24,24,Hours,Concentration,Plasma concentration HS02,25.2,,ng/ml,NaN,1,,NaN,NaN,NaN
830,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,4,VISIT 4,0,0,04-09-2015,09:45,0,48,48,Hours,Concentration,Plasma concentration HS02,12.4,,ng/ml,NaN,1,,NaN,NaN,NaN
831,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,5,VISIT 5,0,0,06-09-2015,09:45,0,96,96,Hours,Concentration,Plasma concentration HS02,11.4,,ng/ml,NaN,1,,NaN,NaN,NaN
832,,X3401_0100_0047,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,47,Healthy Volunteers,200mg oral single dose,200mg oral single dose,6,VISIT 6,0,0,09-09-2015,09:45,0,168,168,Hours,Concentration,Plasma concentration HS02,8.55,,ng/ml,NaN,1,,NaN,NaN,NaN
833,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,1,VISIT 1 - Screening,0,1,21-07-2015,09:42,0,-168,-167.683,Hours,Demographics,Age,22,,Years,NaN,NaN,,NaN,NaN,NaN
834,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,1,VISIT 1 - Screening,0,1,21-07-2015,09:42,0,-168,-167.683,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
835,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-07-2015,08:22,0,-1,-1,Hours,Body,BMI,24.86,,kg/m2,NaN,NaN,,NaN,NaN,NaN
836,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-07-2015,08:22,0,-1,-1,Hours,Body,Bodyweight,77,,kg,NaN,NaN,,NaN,NaN,NaN
837,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-07-2015,08:22,0,-1,-1,Hours,Body,Height,176,,cm,NaN,NaN,,NaN,NaN,NaN
838,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,09:18,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,1,,NaN,NaN,NaN
839,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,09:22,0,0,0,Hours,Dose,Dose HS02,200000,,ug,NaN,NaN,oral,NaN,NaN,NaN
840,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,09:27,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,183,,ng/ml,NaN,1,,NaN,NaN,NaN
841,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,09:37,0,0.25,0.25,Hours,Concentration,Plasma concentration HS02,500,,ng/ml,NaN,1,,NaN,NaN,NaN
842,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,09:52,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,706,,ng/ml,NaN,1,,NaN,NaN,NaN
843,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,10:22,0,1,1,Hours,Concentration,Plasma concentration HS02,984,,ng/ml,NaN,1,,NaN,NaN,NaN
844,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,11:22,0,2,2,Hours,Concentration,Plasma concentration HS02,830,,ng/ml,NaN,1,,NaN,NaN,NaN
845,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,13:22,0,4,4,Hours,Concentration,Plasma concentration HS02,593,,ng/ml,NaN,1,,NaN,NaN,NaN
846,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-07-2015,21:22,0,12,12,Hours,Concentration,Plasma concentration HS02,196,,ng/ml,NaN,1,,NaN,NaN,NaN
847,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,3,VISIT 3,0,0,29-07-2015,09:22,0,24,24,Hours,Concentration,Plasma concentration HS02,56.7,,ng/ml,NaN,1,,NaN,NaN,NaN
848,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,4,VISIT 4,0,0,30-07-2015,09:22,0,48,48,Hours,Concentration,Plasma concentration HS02,18.8,,ng/ml,NaN,1,,NaN,NaN,NaN
849,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,5,VISIT 5,0,0,01-08-2015,09:22,0,96,96,Hours,Concentration,Plasma concentration HS02,19.3,,ng/ml,NaN,1,,NaN,NaN,NaN
850,,X3401_0100_0048,HS02,X3401,FIH SAD Study in Male HVs,1,0,100,48,Healthy Volunteers,200mg oral single dose,200mg oral single dose,6,VISIT 6,0,0,04-08-2015,09:22,0,168,168,Hours,Concentration,Plasma concentration HS02,15.1,,ng/ml,NaN,1,,NaN,NaN,NaN
851,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,25-08-2015,09:10,0,-168,-168.7163333,Hours,Demographics,Age,34,,Years,NaN,NaN,,NaN,NaN,NaN
852,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,25-08-2015,09:10,0,-168,-168.7163333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
853,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,01-09-2015,08:52,0,-1,-1,Hours,Body,BMI,23.29,,kg/m2,NaN,NaN,,NaN,NaN,NaN
854,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,01-09-2015,08:52,0,-1,-1,Hours,Body,Bodyweight,78,,kg,NaN,NaN,,NaN,NaN,NaN
855,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,01-09-2015,08:52,0,-1,-1,Hours,Body,Height,183,,cm,NaN,NaN,,NaN,NaN,NaN
856,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,09:48,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
857,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,09:52,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
858,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,09:57,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,3.51,,ng/ml,NaN,0.5,,NaN,NaN,NaN
859,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,10:22,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,17.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
860,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,10:52,0,1,1,Hours,Concentration,Plasma concentration HS02,21.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
861,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,11:52,0,2,2,Hours,Concentration,Plasma concentration HS02,22.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
862,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,13:52,0,4,4,Hours,Concentration,Plasma concentration HS02,16.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
863,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,17:52,0,8,8,Hours,Concentration,Plasma concentration HS02,8.43,,ng/ml,NaN,0.5,,NaN,NaN,NaN
864,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,02-09-2015,09:48,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,1.41,,ng/ml,NaN,0.5,,NaN,NaN,NaN
865,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,02-09-2015,09:52,0,24,24,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
866,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,4,VISIT 4,0,0,03-09-2015,09:52,0,48,48,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
867,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,5,VISIT 5,0,0,04-09-2015,09:52,0,72,72,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
868,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,05-09-2015,09:48,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,3.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
869,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,05-09-2015,09:52,0,96,96,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
870,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,7,VISIT 7,0,0,06-09-2015,09:52,0,120,120,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
871,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,8,VISIT 8,0,0,07-09-2015,09:52,0,144,144,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
872,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,9,VISIT 9,0,0,08-09-2015,09:52,0,168,168,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
873,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,09-09-2015,09:48,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,3.97,,ng/ml,NaN,0.5,,NaN,NaN,NaN
874,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,09-09-2015,09:52,0,192,192,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
875,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,11,VISIT 11,0,0,10-09-2015,09:52,0,216,216,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
876,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,12,VISIT 12,0,0,11-09-2015,09:52,0,240,240,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
877,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,13,VISIT 13,0,0,12-09-2015,09:52,0,264,264,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
878,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,13-09-2015,09:48,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,4.77,,ng/ml,NaN,0.5,,NaN,NaN,NaN
879,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,13-09-2015,09:52,0,288,288,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
880,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,15,VISIT 15,0,0,14-09-2015,09:52,0,312,312,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
881,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,16,VISIT 16,0,0,15-09-2015,09:52,0,336,336,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
882,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,17,VISIT 17,0,0,16-09-2015,09:52,0,360,360,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
883,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,17-09-2015,09:48,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,4.86,,ng/ml,NaN,0.5,,NaN,NaN,NaN
884,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,17-09-2015,09:52,0,384,384,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
885,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,19,VISIT 19,0,0,18-09-2015,09:52,0,408,408,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
886,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,20,VISIT 20,0,0,19-09-2015,09:52,0,432,432,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
887,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,21,VISIT 21,0,0,20-09-2015,09:52,0,456,456,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
888,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,09:48,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,5.03,,ng/ml,NaN,0.5,,NaN,NaN,NaN
889,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,09:52,0,480,480,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
890,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,09:57,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,8.99,,ng/ml,NaN,0.5,,NaN,NaN,NaN
891,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,10:22,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,26.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
892,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,10:52,0,481,481,Hours,Concentration,Plasma concentration HS02,29.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
893,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,11:52,0,482,482,Hours,Concentration,Plasma concentration HS02,26.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
894,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,13:52,0,484,484,Hours,Concentration,Plasma concentration HS02,26.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
895,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,17:52,0,488,488,Hours,Concentration,Plasma concentration HS02,10.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
896,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,22-09-2015,09:48,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,4.88,,ng/ml,NaN,0.5,,NaN,NaN,NaN
897,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,22-09-2015,09:52,0,504,504,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
898,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,24,VISIT 24,0,0,23-09-2015,09:52,0,528,528,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
899,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,25,VISIT 25,0,0,24-09-2015,09:52,0,552,552,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
900,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,26,VISIT 26,0,0,25-09-2015,09:52,0,576,576,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
901,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,26-09-2015,09:48,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,5.98,,ng/ml,NaN,0.5,,NaN,NaN,NaN
902,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,26-09-2015,09:52,0,600,600,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
903,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,28,VISIT 28,0,0,27-09-2015,09:52,0,624,624,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
904,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,29,VISIT 29,0,0,28-09-2015,09:52,0,648,648,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
905,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,30,VISIT 30,0,0,30-09-2015,09:52,0,696,696,Hours,Concentration,Plasma concentration HS02,5.28,,ng/ml,NaN,0.5,,NaN,NaN,NaN
906,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,31,VISIT 31,0,0,04-Oct-2015,09:52,0,792,792,Hours,Concentration,Plasma concentration HS02,2.98,,ng/ml,NaN,0.5,,NaN,NaN,NaN
907,,X3402_0105_0201,HS02,X3402,MAD Study in Male HVs,1,0,105,201,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,32,VISIT 32,0,0,11-Oct-2015,09:52,0,960,960,Hours,Concentration,Plasma concentration HS02,1.51,,ng/ml,NaN,0.5,,NaN,NaN,NaN
908,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,28-08-2015,09:13,0,-168,-168.5496667,Hours,Demographics,Age,27,,Years,NaN,NaN,,NaN,NaN,NaN
909,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,28-08-2015,09:13,0,-168,-168.5496667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
910,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:45,0,-1,-1,Hours,Body,BMI,24.86,,kg/m2,NaN,NaN,,NaN,NaN,NaN
911,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:45,0,-1,-1,Hours,Body,Bodyweight,77,,kg,NaN,NaN,,NaN,NaN,NaN
912,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:45,0,-1,-1,Hours,Body,Height,176,,cm,NaN,NaN,,NaN,NaN,NaN
913,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:41,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
914,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:45,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
915,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:50,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,8.74,,ng/ml,NaN,0.5,,NaN,NaN,NaN
916,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:15,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,33.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
917,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:45,0,1,1,Hours,Concentration,Plasma concentration HS02,36.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
918,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,11:45,0,2,2,Hours,Concentration,Plasma concentration HS02,27.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
919,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,13:45,0,4,4,Hours,Concentration,Plasma concentration HS02,23.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
920,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,17:45,0,8,8,Hours,Concentration,Plasma concentration HS02,9.94,,ng/ml,NaN,0.5,,NaN,NaN,NaN
921,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,05-09-2015,09:41,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
922,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,05-09-2015,09:45,0,24,24,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
923,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,4,VISIT 4,0,0,06-09-2015,09:45,0,48,48,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
924,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,5,VISIT 5,0,0,07-09-2015,09:45,0,72,72,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
925,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,08-09-2015,09:41,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,3.38,,ng/ml,NaN,0.5,,NaN,NaN,NaN
926,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,08-09-2015,09:45,0,96,96,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
927,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,7,VISIT 7,0,0,09-09-2015,09:45,0,120,120,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
928,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,8,VISIT 8,0,0,10-09-2015,09:45,0,144,144,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
929,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,9,VISIT 9,0,0,11-09-2015,09:45,0,168,168,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
930,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,12-09-2015,09:41,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,6.28,,ng/ml,NaN,0.5,,NaN,NaN,NaN
931,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,12-09-2015,09:45,0,192,192,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
932,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,11,VISIT 11,0,0,13-09-2015,09:45,0,216,216,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
933,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,12,VISIT 12,0,0,14-09-2015,09:45,0,240,240,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
934,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,13,VISIT 13,0,0,15-09-2015,09:45,0,264,264,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
935,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,16-09-2015,09:41,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,6.76,,ng/ml,NaN,0.5,,NaN,NaN,NaN
936,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,16-09-2015,09:45,0,288,288,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
937,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,15,VISIT 15,0,0,17-09-2015,09:45,0,312,312,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
938,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,16,VISIT 16,0,0,18-09-2015,09:45,0,336,336,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
939,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,17,VISIT 17,0,0,19-09-2015,09:45,0,360,360,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
940,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,20-09-2015,09:41,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,9.43,,ng/ml,NaN,0.5,,NaN,NaN,NaN
941,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,20-09-2015,09:45,0,384,384,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
942,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,19,VISIT 19,0,0,21-09-2015,09:45,0,408,408,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
943,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,20,VISIT 20,0,0,22-09-2015,09:45,0,432,432,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
944,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,21,VISIT 21,0,0,23-09-2015,09:45,0,456,456,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
945,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,09:41,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,10.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
946,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,09:45,0,480,480,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
947,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,09:50,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,17.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
948,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,10:15,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,34.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
949,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,10:45,0,481,481,Hours,Concentration,Plasma concentration HS02,46.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
950,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,11:45,0,482,482,Hours,Concentration,Plasma concentration HS02,38,,ng/ml,NaN,0.5,,NaN,NaN,NaN
951,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,13:45,0,484,484,Hours,Concentration,Plasma concentration HS02,32.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
952,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,17:45,0,488,488,Hours,Concentration,Plasma concentration HS02,16.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
953,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,25-09-2015,09:41,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,9.04,,ng/ml,NaN,0.5,,NaN,NaN,NaN
954,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,25-09-2015,09:45,0,504,504,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
955,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,24,VISIT 24,0,0,26-09-2015,09:45,0,528,528,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
956,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,25,VISIT 25,0,0,27-09-2015,09:45,0,552,552,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
957,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,26,VISIT 26,0,0,28-09-2015,09:45,0,576,576,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
958,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,29-09-2015,09:41,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,11.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
959,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,29-09-2015,09:45,0,600,600,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
960,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,28,VISIT 28,0,0,30-09-2015,09:45,0,624,624,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
961,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,29,VISIT 29,0,0,01-Oct-2015,09:45,0,648,648,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
962,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,30,VISIT 30,0,0,03-Oct-2015,09:45,0,696,696,Hours,Concentration,Plasma concentration HS02,8.53,,ng/ml,NaN,0.5,,NaN,NaN,NaN
963,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,31,VISIT 31,0,0,07-Oct-2015,09:45,0,792,792,Hours,Concentration,Plasma concentration HS02,6.05,,ng/ml,NaN,0.5,,NaN,NaN,NaN
964,,X3402_0105_0202,HS02,X3402,MAD Study in Male HVs,1,0,105,202,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,32,VISIT 32,0,0,14-Oct-2015,09:45,0,960,960,Hours,Concentration,Plasma concentration HS02,2.23,,ng/ml,NaN,0.5,,NaN,NaN,NaN
965,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,08-08-2015,09:55,0,-168,-167.783,Hours,Demographics,Age,22,,Years,NaN,NaN,,NaN,NaN,NaN
966,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,08-08-2015,09:55,0,-168,-167.783,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
967,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,15-08-2015,08:41,0,-1,-1,Hours,Body,BMI,24.09,,kg/m2,NaN,NaN,,NaN,NaN,NaN
968,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,15-08-2015,08:41,0,-1,-1,Hours,Body,Bodyweight,68,,kg,NaN,NaN,,NaN,NaN,NaN
969,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,15-08-2015,08:41,0,-1,-1,Hours,Body,Height,168,,cm,NaN,NaN,,NaN,NaN,NaN
970,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:37,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
971,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:41,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
972,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:46,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,10.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
973,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,10:11,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,34.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
974,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,10:41,0,1,1,Hours,Concentration,Plasma concentration HS02,49.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
975,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,11:41,0,2,2,Hours,Concentration,Plasma concentration HS02,42.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
976,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,13:41,0,4,4,Hours,Concentration,Plasma concentration HS02,32.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
977,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,17:41,0,8,8,Hours,Concentration,Plasma concentration HS02,13.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
978,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,16-08-2015,09:37,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,1.89,,ng/ml,NaN,0.5,,NaN,NaN,NaN
979,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,16-08-2015,09:41,0,24,24,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
980,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,4,VISIT 4,0,0,17-08-2015,09:41,0,48,48,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
981,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,5,VISIT 5,0,0,18-08-2015,09:41,0,72,72,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
982,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,19-08-2015,09:37,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,5.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
983,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,19-08-2015,09:41,0,96,96,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
984,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,7,VISIT 7,0,0,20-08-2015,09:41,0,120,120,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
985,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,8,VISIT 8,0,0,21-08-2015,09:41,0,144,144,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
986,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,9,VISIT 9,0,0,22-08-2015,09:41,0,168,168,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
987,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,23-08-2015,09:37,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,7.59,,ng/ml,NaN,0.5,,NaN,NaN,NaN
988,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,23-08-2015,09:41,0,192,192,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
989,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,11,VISIT 11,0,0,24-08-2015,09:41,0,216,216,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
990,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,12,VISIT 12,0,0,25-08-2015,09:41,0,240,240,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
991,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,13,VISIT 13,0,0,26-08-2015,09:41,0,264,264,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
992,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,27-08-2015,09:37,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,13.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
993,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,27-08-2015,09:41,0,288,288,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
994,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,15,VISIT 15,0,0,28-08-2015,09:41,0,312,312,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
995,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,16,VISIT 16,0,0,29-08-2015,09:41,0,336,336,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
996,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,17,VISIT 17,0,0,30-08-2015,09:41,0,360,360,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
997,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,31-08-2015,09:37,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,9.68,,ng/ml,NaN,0.5,,NaN,NaN,NaN
998,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,31-08-2015,09:41,0,384,384,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
999,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,19,VISIT 19,0,0,01-09-2015,09:41,0,408,408,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1000,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,20,VISIT 20,0,0,02-09-2015,09:41,0,432,432,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1001,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,21,VISIT 21,0,0,03-09-2015,09:41,0,456,456,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1002,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,09:37,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,15.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1003,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,09:41,0,480,480,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1004,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,09:46,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,23.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1005,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,10:11,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,44.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1006,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,10:41,0,481,481,Hours,Concentration,Plasma concentration HS02,55.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1007,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,11:41,0,482,482,Hours,Concentration,Plasma concentration HS02,61.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1008,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,13:41,0,484,484,Hours,Concentration,Plasma concentration HS02,42.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1009,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,17:41,0,488,488,Hours,Concentration,Plasma concentration HS02,30.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1010,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,05-09-2015,09:37,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,13.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1011,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,05-09-2015,09:41,0,504,504,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1012,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,24,VISIT 24,0,0,06-09-2015,09:41,0,528,528,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1013,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,25,VISIT 25,0,0,07-09-2015,09:41,0,552,552,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1014,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,26,VISIT 26,0,0,08-09-2015,09:41,0,576,576,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1015,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,09-09-2015,09:37,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,15.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1016,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,09-09-2015,09:41,0,600,600,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1017,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,28,VISIT 28,0,0,10-09-2015,09:41,0,624,624,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1018,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,29,VISIT 29,0,0,11-09-2015,09:41,0,648,648,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1019,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,30,VISIT 30,0,0,13-09-2015,09:41,0,696,696,Hours,Concentration,Plasma concentration HS02,14.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1020,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,31,VISIT 31,0,0,17-09-2015,09:41,0,792,792,Hours,Concentration,Plasma concentration HS02,10.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1021,,X3402_0105_0203,HS02,X3402,MAD Study in Male HVs,1,0,105,203,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,32,VISIT 32,0,0,24-09-2015,09:41,0,960,960,Hours,Concentration,Plasma concentration HS02,9.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1022,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,26-07-2015,10:02,0,-168,-167.8663333,Hours,Demographics,Age,28,,Years,NaN,NaN,,NaN,NaN,NaN
1023,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,26-07-2015,10:02,0,-168,-167.8663333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1024,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-08-2015,08:53,0,-1,-1,Hours,Body,BMI,23.63,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1025,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-08-2015,08:53,0,-1,-1,Hours,Body,Bodyweight,80,,kg,NaN,NaN,,NaN,NaN,NaN
1026,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-08-2015,08:53,0,-1,-1,Hours,Body,Height,184,,cm,NaN,NaN,,NaN,NaN,NaN
1027,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,09:49,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1028,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,09:53,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1029,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,09:58,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,4.15,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1030,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,10:23,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,25.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1031,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,10:53,0,1,1,Hours,Concentration,Plasma concentration HS02,38.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1032,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,11:53,0,2,2,Hours,Concentration,Plasma concentration HS02,32.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1033,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,13:53,0,4,4,Hours,Concentration,Plasma concentration HS02,23.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1034,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-08-2015,17:53,0,8,8,Hours,Concentration,Plasma concentration HS02,6.38,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1035,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,03-08-2015,09:49,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,1.01,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1036,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,03-08-2015,09:53,0,24,24,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1037,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,4,VISIT 4,0,0,04-08-2015,09:53,0,48,48,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1038,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,5,VISIT 5,0,0,05-08-2015,09:53,0,72,72,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1039,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,06-08-2015,09:49,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,3.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1040,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,06-08-2015,09:53,0,96,96,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1041,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,7,VISIT 7,0,0,07-08-2015,09:53,0,120,120,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1042,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,8,VISIT 8,0,0,08-08-2015,09:53,0,144,144,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1043,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,9,VISIT 9,0,0,09-08-2015,09:53,0,168,168,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1044,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,10-08-2015,09:49,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,3.16,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1045,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,10-08-2015,09:53,0,192,192,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1046,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,11,VISIT 11,0,0,11-08-2015,09:53,0,216,216,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1047,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,12,VISIT 12,0,0,12-08-2015,09:53,0,240,240,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1048,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,13,VISIT 13,0,0,13-08-2015,09:53,0,264,264,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1049,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,14-08-2015,09:49,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,3.84,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1050,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,14-08-2015,09:53,0,288,288,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1051,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,15,VISIT 15,0,0,15-08-2015,09:53,0,312,312,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1052,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,16,VISIT 16,0,0,16-08-2015,09:53,0,336,336,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1053,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,17,VISIT 17,0,0,17-08-2015,09:53,0,360,360,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1054,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,18-08-2015,09:49,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,3.78,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1055,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,18-08-2015,09:53,0,384,384,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1056,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,19,VISIT 19,0,0,19-08-2015,09:53,0,408,408,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1057,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,20,VISIT 20,0,0,20-08-2015,09:53,0,432,432,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1058,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,21,VISIT 21,0,0,21-08-2015,09:53,0,456,456,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1059,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-08-2015,09:49,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,3.73,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1060,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-08-2015,09:53,0,480,480,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1061,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-08-2015,09:58,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,12.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1062,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-08-2015,10:23,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,34.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1063,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-08-2015,10:53,0,481,481,Hours,Concentration,Plasma concentration HS02,44.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1064,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-08-2015,11:53,0,482,482,Hours,Concentration,Plasma concentration HS02,37.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1065,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-08-2015,13:53,0,484,484,Hours,Concentration,Plasma concentration HS02,23.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1066,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-08-2015,17:53,0,488,488,Hours,Concentration,Plasma concentration HS02,10.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1067,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,23-08-2015,09:49,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,3.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1068,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,23-08-2015,09:53,0,504,504,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1069,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,24,VISIT 24,0,0,24-08-2015,09:53,0,528,528,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1070,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,25,VISIT 25,0,0,25-08-2015,09:53,0,552,552,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1071,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,26,VISIT 26,0,0,26-08-2015,09:53,0,576,576,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1072,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,27-08-2015,09:49,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,4.52,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1073,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,27-08-2015,09:53,0,600,600,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1074,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,28,VISIT 28,0,0,28-08-2015,09:53,0,624,624,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1075,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,29,VISIT 29,0,0,29-08-2015,09:53,0,648,648,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1076,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,30,VISIT 30,0,0,31-08-2015,09:53,0,696,696,Hours,Concentration,Plasma concentration HS02,2.72,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1077,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,31,VISIT 31,0,0,04-09-2015,09:53,0,792,792,Hours,Concentration,Plasma concentration HS02,1.12,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1078,,X3402_0105_0204,HS02,X3402,MAD Study in Male HVs,1,0,105,204,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,32,VISIT 32,0,0,11-09-2015,09:53,0,960,960,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1079,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,10-08-2015,09:16,0,-168,-168.483,Hours,Demographics,Age,33,,Years,NaN,NaN,,NaN,NaN,NaN
1080,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,10-08-2015,09:16,0,-168,-168.483,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1081,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,17-08-2015,08:44,0,-1,-1,Hours,Body,BMI,22.13,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1082,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,17-08-2015,08:44,0,-1,-1,Hours,Body,Bodyweight,67,,kg,NaN,NaN,,NaN,NaN,NaN
1083,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,17-08-2015,08:44,0,-1,-1,Hours,Body,Height,174,,cm,NaN,NaN,,NaN,NaN,NaN
1084,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,09:40,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1085,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,09:44,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1086,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,09:49,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,6.77,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1087,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,10:14,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,27.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1088,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,10:44,0,1,1,Hours,Concentration,Plasma concentration HS02,33.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1089,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,11:44,0,2,2,Hours,Concentration,Plasma concentration HS02,32.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1090,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,13:44,0,4,4,Hours,Concentration,Plasma concentration HS02,17,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1091,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,17:44,0,8,8,Hours,Concentration,Plasma concentration HS02,5.83,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1092,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,18-08-2015,09:40,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1093,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,18-08-2015,09:44,0,24,24,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1094,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,4,VISIT 4,0,0,19-08-2015,09:44,0,48,48,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1095,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,5,VISIT 5,0,0,20-08-2015,09:44,0,72,72,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1096,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,21-08-2015,09:40,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,3.99,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1097,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,21-08-2015,09:44,0,96,96,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1098,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,7,VISIT 7,0,0,22-08-2015,09:44,0,120,120,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1099,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,8,VISIT 8,0,0,23-08-2015,09:44,0,144,144,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1100,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,9,VISIT 9,0,0,24-08-2015,09:44,0,168,168,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1101,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,25-08-2015,09:40,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,5.34,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1102,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,25-08-2015,09:44,0,192,192,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1103,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,11,VISIT 11,0,0,26-08-2015,09:44,0,216,216,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1104,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,12,VISIT 12,0,0,27-08-2015,09:44,0,240,240,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1105,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,13,VISIT 13,0,0,28-08-2015,09:44,0,264,264,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1106,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,29-08-2015,09:40,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,4.49,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1107,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,29-08-2015,09:44,0,288,288,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1108,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,15,VISIT 15,0,0,30-08-2015,09:44,0,312,312,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1109,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,16,VISIT 16,0,0,31-08-2015,09:44,0,336,336,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1110,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,17,VISIT 17,0,0,01-09-2015,09:44,0,360,360,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1111,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,02-09-2015,09:40,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,5.33,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1112,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,02-09-2015,09:44,0,384,384,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1113,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,19,VISIT 19,0,0,03-09-2015,09:44,0,408,408,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1114,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,20,VISIT 20,0,0,04-09-2015,09:44,0,432,432,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1115,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,21,VISIT 21,0,0,05-09-2015,09:44,0,456,456,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1116,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,09:40,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,6.12,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1117,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,09:44,0,480,480,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1118,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,09:49,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,13.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1119,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,10:14,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,39.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1120,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,10:44,0,481,481,Hours,Concentration,Plasma concentration HS02,33.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1121,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,11:44,0,482,482,Hours,Concentration,Plasma concentration HS02,33.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1122,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,13:44,0,484,484,Hours,Concentration,Plasma concentration HS02,24.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1123,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,17:44,0,488,488,Hours,Concentration,Plasma concentration HS02,12.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1124,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,07-09-2015,09:40,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,6.71,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1125,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,07-09-2015,09:44,0,504,504,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1126,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,24,VISIT 24,0,0,08-09-2015,09:44,0,528,528,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1127,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,25,VISIT 25,0,0,09-09-2015,09:44,0,552,552,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1128,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,26,VISIT 26,0,0,10-09-2015,09:44,0,576,576,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1129,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,11-09-2015,09:40,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,6.06,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1130,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,11-09-2015,09:44,0,600,600,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1131,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,28,VISIT 28,0,0,12-09-2015,09:44,0,624,624,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1132,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,29,VISIT 29,0,0,13-09-2015,09:44,0,648,648,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1133,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,30,VISIT 30,0,0,15-09-2015,09:44,0,696,696,Hours,Concentration,Plasma concentration HS02,4.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1134,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,31,VISIT 31,0,0,19-09-2015,09:44,0,792,792,Hours,Concentration,Plasma concentration HS02,1.72,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1135,,X3402_0105_0205,HS02,X3402,MAD Study in Male HVs,1,0,105,205,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,32,VISIT 32,0,0,26-09-2015,09:44,0,960,960,Hours,Concentration,Plasma concentration HS02,0.62,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1136,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,28-08-2015,10:03,0,-168,-167.9663333,Hours,Demographics,Age,31,,Years,NaN,NaN,,NaN,NaN,NaN
1137,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,28-08-2015,10:03,0,-168,-167.9663333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1138,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,09:00,0,-1,-1,Hours,Body,BMI,20.53,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1139,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,09:00,0,-1,-1,Hours,Body,Bodyweight,68,,kg,NaN,NaN,,NaN,NaN,NaN
1140,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,09:00,0,-1,-1,Hours,Body,Height,182,,cm,NaN,NaN,,NaN,NaN,NaN
1141,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:56,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1142,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:00,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1143,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:05,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,11,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1144,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:30,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,45.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1145,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,11:00,0,1,1,Hours,Concentration,Plasma concentration HS02,66.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1146,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,12:00,0,2,2,Hours,Concentration,Plasma concentration HS02,65,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1147,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,14:00,0,4,4,Hours,Concentration,Plasma concentration HS02,34.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1148,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,18:00,0,8,8,Hours,Concentration,Plasma concentration HS02,16.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1149,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,05-09-2015,09:56,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,2.39,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1150,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,05-09-2015,10:00,0,24,24,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1151,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,4,VISIT 4,0,0,06-09-2015,10:00,0,48,48,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1152,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,5,VISIT 5,0,0,07-09-2015,10:00,0,72,72,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1153,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,08-09-2015,09:56,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,8.21,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1154,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,08-09-2015,10:00,0,96,96,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1155,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,7,VISIT 7,0,0,09-09-2015,10:00,0,120,120,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1156,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,8,VISIT 8,0,0,10-09-2015,10:00,0,144,144,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1157,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,9,VISIT 9,0,0,11-09-2015,10:00,0,168,168,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1158,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,12-09-2015,09:56,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,16.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1159,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,12-09-2015,10:00,0,192,192,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1160,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,11,VISIT 11,0,0,13-09-2015,10:00,0,216,216,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1161,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,12,VISIT 12,0,0,14-09-2015,10:00,0,240,240,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1162,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,13,VISIT 13,0,0,15-09-2015,10:00,0,264,264,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1163,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,16-09-2015,09:56,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,19.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1164,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,16-09-2015,10:00,0,288,288,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1165,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,15,VISIT 15,0,0,17-09-2015,10:00,0,312,312,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1166,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,16,VISIT 16,0,0,18-09-2015,10:00,0,336,336,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1167,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,17,VISIT 17,0,0,19-09-2015,10:00,0,360,360,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1168,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,20-09-2015,09:56,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,18.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1169,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,20-09-2015,10:00,0,384,384,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1170,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,19,VISIT 19,0,0,21-09-2015,10:00,0,408,408,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1171,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,20,VISIT 20,0,0,22-09-2015,10:00,0,432,432,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1172,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,21,VISIT 21,0,0,23-09-2015,10:00,0,456,456,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1173,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,09:56,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,20.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1174,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,10:00,0,480,480,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1175,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,10:05,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,29.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1176,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,10:30,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,69.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1177,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,11:00,0,481,481,Hours,Concentration,Plasma concentration HS02,74.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1178,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,12:00,0,482,482,Hours,Concentration,Plasma concentration HS02,84.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1179,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,14:00,0,484,484,Hours,Concentration,Plasma concentration HS02,62.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1180,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,18:00,0,488,488,Hours,Concentration,Plasma concentration HS02,33.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1181,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,25-09-2015,09:56,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,17.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1182,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,25-09-2015,10:00,0,504,504,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1183,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,24,VISIT 24,0,0,26-09-2015,10:00,0,528,528,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1184,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,25,VISIT 25,0,0,27-09-2015,10:00,0,552,552,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1185,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,26,VISIT 26,0,0,28-09-2015,10:00,0,576,576,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1186,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,29-09-2015,09:56,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,20.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1187,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,29-09-2015,10:00,0,600,600,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1188,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,28,VISIT 28,0,0,30-09-2015,10:00,0,624,624,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1189,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,29,VISIT 29,0,0,01-Oct-2015,10:00,0,648,648,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1190,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,30,VISIT 30,0,0,03-Oct-2015,10:00,0,696,696,Hours,Concentration,Plasma concentration HS02,18.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1191,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,31,VISIT 31,0,0,07-Oct-2015,10:00,0,792,792,Hours,Concentration,Plasma concentration HS02,8.01,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1192,,X3402_0105_0206,HS02,X3402,MAD Study in Male HVs,1,0,105,206,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,32,VISIT 32,0,0,14-Oct-2015,10:00,0,960,960,Hours,Concentration,Plasma concentration HS02,2.39,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1193,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,22-08-2015,09:32,0,-168,-168.2163333,Hours,Demographics,Age,34,,Years,NaN,NaN,,NaN,NaN,NaN
1194,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,22-08-2015,09:32,0,-168,-168.2163333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1195,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,29-08-2015,08:44,0,-1,-1,Hours,Body,BMI,25.44,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1196,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,29-08-2015,08:44,0,-1,-1,Hours,Body,Bodyweight,88,,kg,NaN,NaN,,NaN,NaN,NaN
1197,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,29-08-2015,08:44,0,-1,-1,Hours,Body,Height,186,,cm,NaN,NaN,,NaN,NaN,NaN
1198,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,09:40,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1199,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,09:44,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1200,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,09:49,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,15.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1201,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,10:14,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,54.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1202,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,10:44,0,1,1,Hours,Concentration,Plasma concentration HS02,67.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1203,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,11:44,0,2,2,Hours,Concentration,Plasma concentration HS02,57,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1204,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,13:44,0,4,4,Hours,Concentration,Plasma concentration HS02,42.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1205,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,29-08-2015,17:44,0,8,8,Hours,Concentration,Plasma concentration HS02,22.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1206,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,30-08-2015,09:40,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,2.67,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1207,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,30-08-2015,09:44,0,24,24,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1208,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,4,VISIT 4,0,0,31-08-2015,09:44,0,48,48,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1209,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,5,VISIT 5,0,0,01-09-2015,09:44,0,72,72,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1210,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,02-09-2015,09:40,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,4.76,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1211,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,02-09-2015,09:44,0,96,96,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1212,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,7,VISIT 7,0,0,03-09-2015,09:44,0,120,120,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1213,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,8,VISIT 8,0,0,04-09-2015,09:44,0,144,144,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1214,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,9,VISIT 9,0,0,05-09-2015,09:44,0,168,168,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1215,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,06-09-2015,09:40,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,7.62,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1216,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,06-09-2015,09:44,0,192,192,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1217,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,11,VISIT 11,0,0,07-09-2015,09:44,0,216,216,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1218,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,12,VISIT 12,0,0,08-09-2015,09:44,0,240,240,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1219,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,13,VISIT 13,0,0,09-09-2015,09:44,0,264,264,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1220,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,10-09-2015,09:40,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,9.22,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1221,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,10-09-2015,09:44,0,288,288,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1222,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,15,VISIT 15,0,0,11-09-2015,09:44,0,312,312,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1223,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,16,VISIT 16,0,0,12-09-2015,09:44,0,336,336,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1224,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,17,VISIT 17,0,0,13-09-2015,09:44,0,360,360,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1225,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,14-09-2015,09:40,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,10,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1226,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,14-09-2015,09:44,0,384,384,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1227,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,19,VISIT 19,0,0,15-09-2015,09:44,0,408,408,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1228,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,20,VISIT 20,0,0,16-09-2015,09:44,0,432,432,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1229,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,21,VISIT 21,0,0,17-09-2015,09:44,0,456,456,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1230,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,18-09-2015,09:40,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,11.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1231,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,18-09-2015,09:44,0,480,480,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1232,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,18-09-2015,09:49,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,26.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1233,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,18-09-2015,10:14,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,72,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1234,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,18-09-2015,10:44,0,481,481,Hours,Concentration,Plasma concentration HS02,80.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1235,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,18-09-2015,11:44,0,482,482,Hours,Concentration,Plasma concentration HS02,76.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1236,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,18-09-2015,13:44,0,484,484,Hours,Concentration,Plasma concentration HS02,62.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1237,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,18-09-2015,17:44,0,488,488,Hours,Concentration,Plasma concentration HS02,41.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1238,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,19-09-2015,09:40,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,13.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1239,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,19-09-2015,09:44,0,504,504,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1240,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,24,VISIT 24,0,0,20-09-2015,09:44,0,528,528,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1241,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,25,VISIT 25,0,0,21-09-2015,09:44,0,552,552,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1242,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,26,VISIT 26,0,0,22-09-2015,09:44,0,576,576,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1243,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,23-09-2015,09:40,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,10.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1244,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,23-09-2015,09:44,0,600,600,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1245,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,28,VISIT 28,0,0,24-09-2015,09:44,0,624,624,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1246,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,29,VISIT 29,0,0,25-09-2015,09:44,0,648,648,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1247,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,30,VISIT 30,0,0,27-09-2015,09:44,0,696,696,Hours,Concentration,Plasma concentration HS02,10.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1248,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,31,VISIT 31,0,0,01-Oct-2015,09:44,0,792,792,Hours,Concentration,Plasma concentration HS02,8.22,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1249,,X3402_0105_0207,HS02,X3402,MAD Study in Male HVs,1,0,105,207,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,32,VISIT 32,0,0,08-Oct-2015,09:44,0,960,960,Hours,Concentration,Plasma concentration HS02,3.85,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1250,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,26-08-2015,10:08,0,-168,-167.333,Hours,Demographics,Age,25,,Years,NaN,NaN,,NaN,NaN,NaN
1251,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,26-08-2015,10:08,0,-168,-167.333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1252,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:27,0,-1,-1,Hours,Body,BMI,25.1,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1253,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:27,0,-1,-1,Hours,Body,Bodyweight,76,,kg,NaN,NaN,,NaN,NaN,NaN
1254,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,02-09-2015,08:27,0,-1,-1,Hours,Body,Height,174,,cm,NaN,NaN,,NaN,NaN,NaN
1255,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:23,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1256,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:27,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1257,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:32,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,13.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1258,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,09:57,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,49.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1259,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,10:27,0,1,1,Hours,Concentration,Plasma concentration HS02,57.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1260,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,11:27,0,2,2,Hours,Concentration,Plasma concentration HS02,71.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1261,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,13:27,0,4,4,Hours,Concentration,Plasma concentration HS02,34.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1262,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,02-09-2015,17:27,0,8,8,Hours,Concentration,Plasma concentration HS02,23,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1263,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,03-09-2015,09:23,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,3.61,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1264,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,03-09-2015,09:27,0,24,24,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1265,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,4,VISIT 4,0,0,04-09-2015,09:27,0,48,48,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1266,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,5,VISIT 5,0,0,05-09-2015,09:27,0,72,72,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1267,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,06-09-2015,09:23,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,11.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1268,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,06-09-2015,09:27,0,96,96,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1269,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,7,VISIT 7,0,0,07-09-2015,09:27,0,120,120,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1270,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,8,VISIT 8,0,0,08-09-2015,09:27,0,144,144,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1271,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,9,VISIT 9,0,0,09-09-2015,09:27,0,168,168,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1272,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,10-09-2015,09:23,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,17.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1273,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,10-09-2015,09:27,0,192,192,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1274,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,11,VISIT 11,0,0,11-09-2015,09:27,0,216,216,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1275,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,12,VISIT 12,0,0,12-09-2015,09:27,0,240,240,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1276,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,13,VISIT 13,0,0,13-09-2015,09:27,0,264,264,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1277,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,14-09-2015,09:23,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,19.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1278,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,14-09-2015,09:27,0,288,288,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1279,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,15,VISIT 15,0,0,15-09-2015,09:27,0,312,312,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1280,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,16,VISIT 16,0,0,16-09-2015,09:27,0,336,336,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1281,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,17,VISIT 17,0,0,17-09-2015,09:27,0,360,360,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1282,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,18-09-2015,09:23,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,21.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1283,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,18-09-2015,09:27,0,384,384,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1284,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,19,VISIT 19,0,0,19-09-2015,09:27,0,408,408,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1285,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,20,VISIT 20,0,0,20-09-2015,09:27,0,432,432,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1286,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,21,VISIT 21,0,0,21-09-2015,09:27,0,456,456,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1287,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-09-2015,09:23,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,20.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1288,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-09-2015,09:27,0,480,480,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1289,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-09-2015,09:32,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,26.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1290,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-09-2015,09:57,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,77.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1291,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-09-2015,10:27,0,481,481,Hours,Concentration,Plasma concentration HS02,86.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1292,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-09-2015,11:27,0,482,482,Hours,Concentration,Plasma concentration HS02,74.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1293,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-09-2015,13:27,0,484,484,Hours,Concentration,Plasma concentration HS02,58.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1294,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,22-09-2015,17:27,0,488,488,Hours,Concentration,Plasma concentration HS02,43.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1295,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,23-09-2015,09:23,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,20.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1296,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,23-09-2015,09:27,0,504,504,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1297,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,24,VISIT 24,0,0,24-09-2015,09:27,0,528,528,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1298,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,25,VISIT 25,0,0,25-09-2015,09:27,0,552,552,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1299,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,26,VISIT 26,0,0,26-09-2015,09:27,0,576,576,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1300,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,27-09-2015,09:23,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,23.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1301,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,27-09-2015,09:27,0,600,600,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1302,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,28,VISIT 28,0,0,28-09-2015,09:27,0,624,624,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1303,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,29,VISIT 29,0,0,29-09-2015,09:27,0,648,648,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1304,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,30,VISIT 30,0,0,01-Oct-2015,09:27,0,696,696,Hours,Concentration,Plasma concentration HS02,18.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1305,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,31,VISIT 31,0,0,05-Oct-2015,09:27,0,792,792,Hours,Concentration,Plasma concentration HS02,9.69,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1306,,X3402_0105_0208,HS02,X3402,MAD Study in Male HVs,1,0,105,208,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,32,VISIT 32,0,0,12-Oct-2015,09:27,0,960,960,Hours,Concentration,Plasma concentration HS02,5.71,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1307,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,18-08-2015,09:53,0,-168,-167.3663333,Hours,Demographics,Age,36,,Years,NaN,NaN,,NaN,NaN,NaN
1308,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,18-08-2015,09:53,0,-168,-167.3663333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1309,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,25-08-2015,08:14,0,-1,-1,Hours,Body,BMI,26.56,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1310,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,25-08-2015,08:14,0,-1,-1,Hours,Body,Bodyweight,87,,kg,NaN,NaN,,NaN,NaN,NaN
1311,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,25-08-2015,08:14,0,-1,-1,Hours,Body,Height,181,,cm,NaN,NaN,,NaN,NaN,NaN
1312,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,25-08-2015,09:10,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1313,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,25-08-2015,09:14,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1314,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,25-08-2015,09:19,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,14.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1315,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,25-08-2015,09:44,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,56.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1316,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,25-08-2015,10:14,0,1,1,Hours,Concentration,Plasma concentration HS02,65.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1317,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,25-08-2015,11:14,0,2,2,Hours,Concentration,Plasma concentration HS02,73.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1318,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,25-08-2015,13:14,0,4,4,Hours,Concentration,Plasma concentration HS02,45.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1319,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,25-08-2015,17:14,0,8,8,Hours,Concentration,Plasma concentration HS02,27.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1320,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,26-08-2015,09:10,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,2.43,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1321,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,26-08-2015,09:14,0,24,24,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1322,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,4,VISIT 4,0,0,27-08-2015,09:14,0,48,48,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1323,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,5,VISIT 5,0,0,28-08-2015,09:14,0,72,72,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1324,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,29-08-2015,09:10,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,5.36,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1325,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,29-08-2015,09:14,0,96,96,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1326,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,7,VISIT 7,0,0,30-08-2015,09:14,0,120,120,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1327,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,8,VISIT 8,0,0,31-08-2015,09:14,0,144,144,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1328,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,9,VISIT 9,0,0,01-09-2015,09:14,0,168,168,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1329,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,02-09-2015,09:10,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,9.36,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1330,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,02-09-2015,09:14,0,192,192,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1331,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,11,VISIT 11,0,0,03-09-2015,09:14,0,216,216,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1332,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,12,VISIT 12,0,0,04-09-2015,09:14,0,240,240,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1333,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,13,VISIT 13,0,0,05-09-2015,09:14,0,264,264,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1334,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,06-09-2015,09:10,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,10.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1335,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,06-09-2015,09:14,0,288,288,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1336,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,15,VISIT 15,0,0,07-09-2015,09:14,0,312,312,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1337,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,16,VISIT 16,0,0,08-09-2015,09:14,0,336,336,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1338,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,17,VISIT 17,0,0,09-09-2015,09:14,0,360,360,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1339,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,10-09-2015,09:10,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,11.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1340,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,10-09-2015,09:14,0,384,384,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1341,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,19,VISIT 19,0,0,11-09-2015,09:14,0,408,408,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1342,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,20,VISIT 20,0,0,12-09-2015,09:14,0,432,432,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1343,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,21,VISIT 21,0,0,13-09-2015,09:14,0,456,456,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1344,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,14-09-2015,09:10,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,12.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1345,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,14-09-2015,09:14,0,480,480,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1346,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,14-09-2015,09:19,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,28.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1347,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,14-09-2015,09:44,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,70.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1348,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,14-09-2015,10:14,0,481,481,Hours,Concentration,Plasma concentration HS02,84,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1349,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,14-09-2015,11:14,0,482,482,Hours,Concentration,Plasma concentration HS02,84.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1350,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,14-09-2015,13:14,0,484,484,Hours,Concentration,Plasma concentration HS02,67.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1351,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,14-09-2015,17:14,0,488,488,Hours,Concentration,Plasma concentration HS02,44.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1352,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,15-09-2015,09:10,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,16.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1353,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,15-09-2015,09:14,0,504,504,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1354,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,24,VISIT 24,0,0,16-09-2015,09:14,0,528,528,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1355,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,25,VISIT 25,0,0,17-09-2015,09:14,0,552,552,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1356,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,26,VISIT 26,0,0,18-09-2015,09:14,0,576,576,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1357,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,19-09-2015,09:10,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,14.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1358,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,19-09-2015,09:14,0,600,600,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1359,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,28,VISIT 28,0,0,20-09-2015,09:14,0,624,624,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1360,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,29,VISIT 29,0,0,21-09-2015,09:14,0,648,648,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1361,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,30,VISIT 30,0,0,23-09-2015,09:14,0,696,696,Hours,Concentration,Plasma concentration HS02,10.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1362,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,31,VISIT 31,0,0,27-09-2015,09:14,0,792,792,Hours,Concentration,Plasma concentration HS02,10.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1363,,X3402_0105_0209,HS02,X3402,MAD Study in Male HVs,1,0,105,209,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,32,VISIT 32,0,0,04-Oct-2015,09:14,0,960,960,Hours,Concentration,Plasma concentration HS02,5.93,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1364,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,25-08-2015,09:53,0,-168,-168.1996667,Hours,Demographics,Age,33,,Years,NaN,NaN,,NaN,NaN,NaN
1365,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,25-08-2015,09:53,0,-168,-168.1996667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1366,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,01-09-2015,09:04,0,-1,-1,Hours,Body,BMI,18.62,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1367,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,01-09-2015,09:04,0,-1,-1,Hours,Body,Bodyweight,59,,kg,NaN,NaN,,NaN,NaN,NaN
1368,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,01-09-2015,09:04,0,-1,-1,Hours,Body,Height,178,,cm,NaN,NaN,,NaN,NaN,NaN
1369,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,10:00,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1370,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,10:04,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1371,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,10:09,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,19.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1372,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,10:34,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,67,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1373,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,11:04,0,1,1,Hours,Concentration,Plasma concentration HS02,78.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1374,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,12:04,0,2,2,Hours,Concentration,Plasma concentration HS02,96.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1375,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,14:04,0,4,4,Hours,Concentration,Plasma concentration HS02,64.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1376,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,01-09-2015,18:04,0,8,8,Hours,Concentration,Plasma concentration HS02,25.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1377,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,02-09-2015,10:00,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,4.94,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1378,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,02-09-2015,10:04,0,24,24,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1379,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,4,VISIT 4,0,0,03-09-2015,10:04,0,48,48,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1380,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,5,VISIT 5,0,0,04-09-2015,10:04,0,72,72,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1381,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,05-09-2015,10:00,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,12.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1382,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,05-09-2015,10:04,0,96,96,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1383,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,7,VISIT 7,0,0,06-09-2015,10:04,0,120,120,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1384,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,8,VISIT 8,0,0,07-09-2015,10:04,0,144,144,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1385,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,9,VISIT 9,0,0,08-09-2015,10:04,0,168,168,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1386,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,09-09-2015,10:00,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,18.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1387,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,09-09-2015,10:04,0,192,192,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1388,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,11,VISIT 11,0,0,10-09-2015,10:04,0,216,216,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1389,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,12,VISIT 12,0,0,11-09-2015,10:04,0,240,240,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1390,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,13,VISIT 13,0,0,12-09-2015,10:04,0,264,264,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1391,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,13-09-2015,10:00,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,30.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1392,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,13-09-2015,10:04,0,288,288,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1393,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,15,VISIT 15,0,0,14-09-2015,10:04,0,312,312,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1394,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,16,VISIT 16,0,0,15-09-2015,10:04,0,336,336,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1395,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,17,VISIT 17,0,0,16-09-2015,10:04,0,360,360,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1396,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,17-09-2015,10:00,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,29.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1397,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,17-09-2015,10:04,0,384,384,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1398,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,19,VISIT 19,0,0,18-09-2015,10:04,0,408,408,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1399,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,20,VISIT 20,0,0,19-09-2015,10:04,0,432,432,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1400,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,21,VISIT 21,0,0,20-09-2015,10:04,0,456,456,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1401,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,10:00,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,27.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1402,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,10:04,0,480,480,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1403,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,10:09,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,41,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1404,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,10:34,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,100,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1405,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,11:04,0,481,481,Hours,Concentration,Plasma concentration HS02,124,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1406,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,12:04,0,482,482,Hours,Concentration,Plasma concentration HS02,111,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1407,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,14:04,0,484,484,Hours,Concentration,Plasma concentration HS02,96.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1408,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,21-09-2015,18:04,0,488,488,Hours,Concentration,Plasma concentration HS02,56.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1409,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,22-09-2015,10:00,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,33.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1410,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,22-09-2015,10:04,0,504,504,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1411,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,24,VISIT 24,0,0,23-09-2015,10:04,0,528,528,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1412,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,25,VISIT 25,0,0,24-09-2015,10:04,0,552,552,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1413,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,26,VISIT 26,0,0,25-09-2015,10:04,0,576,576,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1414,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,26-09-2015,10:00,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,25.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1415,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,26-09-2015,10:04,0,600,600,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1416,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,28,VISIT 28,0,0,27-09-2015,10:04,0,624,624,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1417,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,29,VISIT 29,0,0,28-09-2015,10:04,0,648,648,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1418,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,30,VISIT 30,0,0,30-09-2015,10:04,0,696,696,Hours,Concentration,Plasma concentration HS02,25.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1419,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,31,VISIT 31,0,0,04-Oct-2015,10:04,0,792,792,Hours,Concentration,Plasma concentration HS02,16.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1420,,X3402_0105_0210,HS02,X3402,MAD Study in Male HVs,1,0,105,210,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,32,VISIT 32,0,0,11-Oct-2015,10:04,0,960,960,Hours,Concentration,Plasma concentration HS02,6.51,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1421,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,02-08-2015,09:42,0,-168,-167.6496667,Hours,Demographics,Age,36,,Years,NaN,NaN,,NaN,NaN,NaN
1422,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,02-08-2015,09:42,0,-168,-167.6496667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1423,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,09-08-2015,08:20,0,-1,-1,Hours,Body,BMI,24.34,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1424,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,09-08-2015,08:20,0,-1,-1,Hours,Body,Bodyweight,78,,kg,NaN,NaN,,NaN,NaN,NaN
1425,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,09-08-2015,08:20,0,-1,-1,Hours,Body,Height,179,,cm,NaN,NaN,,NaN,NaN,NaN
1426,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,09:16,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1427,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,09:20,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1428,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,09:25,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,30.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1429,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,09:50,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,109,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1430,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,10:20,0,1,1,Hours,Concentration,Plasma concentration HS02,149,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1431,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,11:20,0,2,2,Hours,Concentration,Plasma concentration HS02,184,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1432,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,13:20,0,4,4,Hours,Concentration,Plasma concentration HS02,99.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1433,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,17:20,0,8,8,Hours,Concentration,Plasma concentration HS02,32.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1434,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,10-08-2015,09:16,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,8.99,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1435,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,10-08-2015,09:20,0,24,24,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1436,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,4,VISIT 4,0,0,11-08-2015,09:20,0,48,48,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1437,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,5,VISIT 5,0,0,12-08-2015,09:20,0,72,72,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1438,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,13-08-2015,09:16,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,27.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1439,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,13-08-2015,09:20,0,96,96,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1440,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,7,VISIT 7,0,0,14-08-2015,09:20,0,120,120,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1441,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,8,VISIT 8,0,0,15-08-2015,09:20,0,144,144,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1442,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,9,VISIT 9,0,0,16-08-2015,09:20,0,168,168,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1443,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,17-08-2015,09:16,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,34.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1444,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,17-08-2015,09:20,0,192,192,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1445,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,11,VISIT 11,0,0,18-08-2015,09:20,0,216,216,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1446,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,12,VISIT 12,0,0,19-08-2015,09:20,0,240,240,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1447,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,13,VISIT 13,0,0,20-08-2015,09:20,0,264,264,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1448,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,21-08-2015,09:16,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,42.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1449,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,21-08-2015,09:20,0,288,288,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1450,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,15,VISIT 15,0,0,22-08-2015,09:20,0,312,312,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1451,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,16,VISIT 16,0,0,23-08-2015,09:20,0,336,336,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1452,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,17,VISIT 17,0,0,24-08-2015,09:20,0,360,360,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1453,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,25-08-2015,09:16,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,55.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1454,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,25-08-2015,09:20,0,384,384,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1455,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,19,VISIT 19,0,0,26-08-2015,09:20,0,408,408,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1456,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,20,VISIT 20,0,0,27-08-2015,09:20,0,432,432,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1457,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,21,VISIT 21,0,0,28-08-2015,09:20,0,456,456,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1458,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,09:16,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,42.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1459,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,09:20,0,480,480,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1460,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,09:25,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,74.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1461,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,09:50,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,175,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1462,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,10:20,0,481,481,Hours,Concentration,Plasma concentration HS02,207,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1463,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,11:20,0,482,482,Hours,Concentration,Plasma concentration HS02,225,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1464,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,13:20,0,484,484,Hours,Concentration,Plasma concentration HS02,136,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1465,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,17:20,0,488,488,Hours,Concentration,Plasma concentration HS02,75.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1466,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,30-08-2015,09:16,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,47.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1467,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,30-08-2015,09:20,0,504,504,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1468,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,24,VISIT 24,0,0,31-08-2015,09:20,0,528,528,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1469,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,25,VISIT 25,0,0,01-09-2015,09:20,0,552,552,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1470,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,26,VISIT 26,0,0,02-09-2015,09:20,0,576,576,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1471,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,03-09-2015,09:16,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,35.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1472,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,03-09-2015,09:20,0,600,600,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1473,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,28,VISIT 28,0,0,04-09-2015,09:20,0,624,624,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1474,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,29,VISIT 29,0,0,05-09-2015,09:20,0,648,648,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1475,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,30,VISIT 30,0,0,07-09-2015,09:20,0,696,696,Hours,Concentration,Plasma concentration HS02,40.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1476,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,31,VISIT 31,0,0,11-09-2015,09:20,0,792,792,Hours,Concentration,Plasma concentration HS02,18.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1477,,X3402_0105_0211,HS02,X3402,MAD Study in Male HVs,1,0,105,211,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,32,VISIT 32,0,0,18-09-2015,09:20,0,960,960,Hours,Concentration,Plasma concentration HS02,4.04,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1478,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,21-08-2015,09:11,0,-168,-168.9996667,Hours,Demographics,Age,29,,Years,NaN,NaN,,NaN,NaN,NaN
1479,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,21-08-2015,09:11,0,-168,-168.9996667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1480,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-08-2015,09:10,0,-1,-1,Hours,Body,BMI,24.42,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1481,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-08-2015,09:10,0,-1,-1,Hours,Body,Bodyweight,80,,kg,NaN,NaN,,NaN,NaN,NaN
1482,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-08-2015,09:10,0,-1,-1,Hours,Body,Height,181,,cm,NaN,NaN,,NaN,NaN,NaN
1483,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,10:06,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1484,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,10:10,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1485,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,10:15,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,14.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1486,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,10:40,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,59.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1487,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,11:10,0,1,1,Hours,Concentration,Plasma concentration HS02,99.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1488,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,12:10,0,2,2,Hours,Concentration,Plasma concentration HS02,107,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1489,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,14:10,0,4,4,Hours,Concentration,Plasma concentration HS02,85.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1490,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,18:10,0,8,8,Hours,Concentration,Plasma concentration HS02,44.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1491,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,29-08-2015,10:06,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,6.22,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1492,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,29-08-2015,10:10,0,24,24,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1493,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,4,VISIT 4,0,0,30-08-2015,10:10,0,48,48,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1494,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,5,VISIT 5,0,0,31-08-2015,10:10,0,72,72,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1495,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,01-09-2015,10:06,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,14.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1496,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,01-09-2015,10:10,0,96,96,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1497,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,7,VISIT 7,0,0,02-09-2015,10:10,0,120,120,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1498,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,8,VISIT 8,0,0,03-09-2015,10:10,0,144,144,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1499,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,9,VISIT 9,0,0,04-09-2015,10:10,0,168,168,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1500,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,05-09-2015,10:06,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,16.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1501,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,05-09-2015,10:10,0,192,192,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1502,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,11,VISIT 11,0,0,06-09-2015,10:10,0,216,216,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1503,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,12,VISIT 12,0,0,07-09-2015,10:10,0,240,240,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1504,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,13,VISIT 13,0,0,08-09-2015,10:10,0,264,264,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1505,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,09-09-2015,10:06,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,25,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1506,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,09-09-2015,10:10,0,288,288,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1507,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,15,VISIT 15,0,0,10-09-2015,10:10,0,312,312,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1508,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,16,VISIT 16,0,0,11-09-2015,10:10,0,336,336,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1509,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,17,VISIT 17,0,0,12-09-2015,10:10,0,360,360,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1510,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,13-09-2015,10:06,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,23.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1511,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,13-09-2015,10:10,0,384,384,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1512,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,19,VISIT 19,0,0,14-09-2015,10:10,0,408,408,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1513,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,20,VISIT 20,0,0,15-09-2015,10:10,0,432,432,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1514,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,21,VISIT 21,0,0,16-09-2015,10:10,0,456,456,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1515,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,10:06,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,27.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1516,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,10:10,0,480,480,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1517,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,10:15,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,37.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1518,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,10:40,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,81.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1519,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,11:10,0,481,481,Hours,Concentration,Plasma concentration HS02,125,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1520,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,12:10,0,482,482,Hours,Concentration,Plasma concentration HS02,122,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1521,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,14:10,0,484,484,Hours,Concentration,Plasma concentration HS02,99.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1522,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,18:10,0,488,488,Hours,Concentration,Plasma concentration HS02,67.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1523,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,18-09-2015,10:06,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,28.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1524,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,18-09-2015,10:10,0,504,504,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1525,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,24,VISIT 24,0,0,19-09-2015,10:10,0,528,528,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1526,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,25,VISIT 25,0,0,20-09-2015,10:10,0,552,552,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1527,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,26,VISIT 26,0,0,21-09-2015,10:10,0,576,576,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1528,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,22-09-2015,10:06,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,21.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1529,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,22-09-2015,10:10,0,600,600,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1530,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,28,VISIT 28,0,0,23-09-2015,10:10,0,624,624,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1531,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,29,VISIT 29,0,0,24-09-2015,10:10,0,648,648,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1532,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,30,VISIT 30,0,0,26-09-2015,10:10,0,696,696,Hours,Concentration,Plasma concentration HS02,21,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1533,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,31,VISIT 31,0,0,30-09-2015,10:10,0,792,792,Hours,Concentration,Plasma concentration HS02,10,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1534,,X3402_0105_0212,HS02,X3402,MAD Study in Male HVs,1,0,105,212,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,32,VISIT 32,0,0,07-Oct-2015,10:10,0,960,960,Hours,Concentration,Plasma concentration HS02,7.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1535,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,02-08-2015,09:43,0,-168,-167.533,Hours,Demographics,Age,26,,Years,NaN,NaN,,NaN,NaN,NaN
1536,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,02-08-2015,09:43,0,-168,-167.533,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1537,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,09-08-2015,08:14,0,-1,-1,Hours,Body,Height,178,,cm,NaN,NaN,,NaN,NaN,NaN
1538,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,09:10,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1539,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,09:14,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1540,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,09:19,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,27.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1541,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,09:44,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,102,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1542,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,10:14,0,1,1,Hours,Concentration,Plasma concentration HS02,137,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1543,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,11:14,0,2,2,Hours,Concentration,Plasma concentration HS02,101,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1544,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,13:14,0,4,4,Hours,Concentration,Plasma concentration HS02,99.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1545,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,09-08-2015,17:14,0,8,8,Hours,Concentration,Plasma concentration HS02,52.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1546,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,10-08-2015,09:10,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,9.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1547,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,10-08-2015,09:14,0,24,24,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1548,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,4,VISIT 4,0,0,11-08-2015,09:14,0,48,48,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1549,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,5,VISIT 5,0,0,12-08-2015,09:14,0,72,72,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1550,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,13-08-2015,09:10,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,21.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1551,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,13-08-2015,09:14,0,96,96,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1552,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,7,VISIT 7,0,0,14-08-2015,09:14,0,120,120,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1553,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,8,VISIT 8,0,0,15-08-2015,09:14,0,144,144,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1554,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,9,VISIT 9,0,0,16-08-2015,09:14,0,168,168,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1555,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,17-08-2015,09:10,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,29.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1556,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,17-08-2015,09:14,0,192,192,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1557,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,11,VISIT 11,0,0,18-08-2015,09:14,0,216,216,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1558,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,12,VISIT 12,0,0,19-08-2015,09:14,0,240,240,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1559,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,13,VISIT 13,0,0,20-08-2015,09:14,0,264,264,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1560,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,21-08-2015,09:10,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,47.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1561,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,21-08-2015,09:14,0,288,288,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1562,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,15,VISIT 15,0,0,22-08-2015,09:14,0,312,312,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1563,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,16,VISIT 16,0,0,23-08-2015,09:14,0,336,336,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1564,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,17,VISIT 17,0,0,24-08-2015,09:14,0,360,360,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1565,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,25-08-2015,09:10,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,43.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1566,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,25-08-2015,09:14,0,384,384,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1567,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,19,VISIT 19,0,0,26-08-2015,09:14,0,408,408,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1568,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,20,VISIT 20,0,0,27-08-2015,09:14,0,432,432,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1569,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,21,VISIT 21,0,0,28-08-2015,09:14,0,456,456,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1570,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,09:10,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,50.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1571,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,09:14,0,480,480,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1572,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,09:19,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,95,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1573,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,09:44,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,131,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1574,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,10:14,0,481,481,Hours,Concentration,Plasma concentration HS02,166,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1575,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,11:14,0,482,482,Hours,Concentration,Plasma concentration HS02,177,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1576,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,13:14,0,484,484,Hours,Concentration,Plasma concentration HS02,108,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1577,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,29-08-2015,17:14,0,488,488,Hours,Concentration,Plasma concentration HS02,92.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1578,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,30-08-2015,09:10,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,53.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1579,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,30-08-2015,09:14,0,504,504,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1580,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,24,VISIT 24,0,0,31-08-2015,09:14,0,528,528,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1581,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,25,VISIT 25,0,0,01-09-2015,09:14,0,552,552,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1582,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,26,VISIT 26,0,0,02-09-2015,09:14,0,576,576,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1583,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,03-09-2015,09:10,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,56.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1584,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,03-09-2015,09:14,0,600,600,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1585,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,28,VISIT 28,0,0,04-09-2015,09:14,0,624,624,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1586,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,29,VISIT 29,0,0,05-09-2015,09:14,0,648,648,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1587,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,30,VISIT 30,0,0,07-09-2015,09:14,0,696,696,Hours,Concentration,Plasma concentration HS02,45.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1588,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,31,VISIT 31,0,0,11-09-2015,09:14,0,792,792,Hours,Concentration,Plasma concentration HS02,45.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1589,,X3402_0105_0213,HS02,X3402,MAD Study in Male HVs,1,0,105,213,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,32,VISIT 32,0,0,18-09-2015,09:14,0,960,960,Hours,Concentration,Plasma concentration HS02,23,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1590,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,13-08-2015,10:04,0,-168,-167.283,Hours,Demographics,Age,18,,Years,NaN,NaN,,NaN,NaN,NaN
1591,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,13-08-2015,10:04,0,-168,-167.283,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1592,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,20-08-2015,08:20,0,-1,-1,Hours,Body,BMI,23.08,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1593,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,20-08-2015,08:20,0,-1,-1,Hours,Body,Bodyweight,79,,kg,NaN,NaN,,NaN,NaN,NaN
1594,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,20-08-2015,08:20,0,-1,-1,Hours,Body,Height,185,,cm,NaN,NaN,,NaN,NaN,NaN
1595,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,20-08-2015,09:16,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1596,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,20-08-2015,09:20,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1597,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,20-08-2015,09:25,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,41,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1598,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,20-08-2015,09:50,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,157,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1599,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,20-08-2015,10:20,0,1,1,Hours,Concentration,Plasma concentration HS02,198,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1600,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,20-08-2015,11:20,0,2,2,Hours,Concentration,Plasma concentration HS02,175,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1601,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,20-08-2015,13:20,0,4,4,Hours,Concentration,Plasma concentration HS02,99.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1602,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,20-08-2015,17:20,0,8,8,Hours,Concentration,Plasma concentration HS02,43,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1603,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,21-08-2015,09:16,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,10.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1604,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,21-08-2015,09:20,0,24,24,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1605,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,4,VISIT 4,0,0,22-08-2015,09:20,0,48,48,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1606,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,5,VISIT 5,0,0,23-08-2015,09:20,0,72,72,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1607,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,24-08-2015,09:16,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,27.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1608,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,24-08-2015,09:20,0,96,96,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1609,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,7,VISIT 7,0,0,25-08-2015,09:20,0,120,120,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1610,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,8,VISIT 8,0,0,26-08-2015,09:20,0,144,144,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1611,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,9,VISIT 9,0,0,27-08-2015,09:20,0,168,168,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1612,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,28-08-2015,09:16,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,38,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1613,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,28-08-2015,09:20,0,192,192,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1614,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,11,VISIT 11,0,0,29-08-2015,09:20,0,216,216,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1615,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,12,VISIT 12,0,0,30-08-2015,09:20,0,240,240,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1616,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,13,VISIT 13,0,0,31-08-2015,09:20,0,264,264,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1617,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,01-09-2015,09:16,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,40,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1618,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,01-09-2015,09:20,0,288,288,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1619,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,15,VISIT 15,0,0,02-09-2015,09:20,0,312,312,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1620,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,16,VISIT 16,0,0,03-09-2015,09:20,0,336,336,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1621,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,17,VISIT 17,0,0,04-09-2015,09:20,0,360,360,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1622,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,05-09-2015,09:16,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,54.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1623,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,05-09-2015,09:20,0,384,384,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1624,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,19,VISIT 19,0,0,06-09-2015,09:20,0,408,408,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1625,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,20,VISIT 20,0,0,07-09-2015,09:20,0,432,432,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1626,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,21,VISIT 21,0,0,08-09-2015,09:20,0,456,456,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1627,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,09-09-2015,09:16,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,45.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1628,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,09-09-2015,09:20,0,480,480,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1629,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,09-09-2015,09:25,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,84.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1630,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,09-09-2015,09:50,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,189,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1631,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,09-09-2015,10:20,0,481,481,Hours,Concentration,Plasma concentration HS02,236,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1632,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,09-09-2015,11:20,0,482,482,Hours,Concentration,Plasma concentration HS02,212,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1633,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,09-09-2015,13:20,0,484,484,Hours,Concentration,Plasma concentration HS02,170,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1634,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,09-09-2015,17:20,0,488,488,Hours,Concentration,Plasma concentration HS02,76.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1635,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,10-09-2015,09:16,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,44.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1636,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,10-09-2015,09:20,0,504,504,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1637,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,24,VISIT 24,0,0,11-09-2015,09:20,0,528,528,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1638,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,25,VISIT 25,0,0,12-09-2015,09:20,0,552,552,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1639,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,26,VISIT 26,0,0,13-09-2015,09:20,0,576,576,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1640,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,14-09-2015,09:16,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,49.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1641,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,14-09-2015,09:20,0,600,600,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1642,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,28,VISIT 28,0,0,15-09-2015,09:20,0,624,624,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1643,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,29,VISIT 29,0,0,16-09-2015,09:20,0,648,648,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1644,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,30,VISIT 30,0,0,18-09-2015,09:20,0,696,696,Hours,Concentration,Plasma concentration HS02,32.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1645,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,31,VISIT 31,0,0,22-09-2015,09:20,0,792,792,Hours,Concentration,Plasma concentration HS02,14.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1646,,X3402_0105_0214,HS02,X3402,MAD Study in Male HVs,1,0,105,214,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,32,VISIT 32,0,0,29-09-2015,09:20,0,960,960,Hours,Concentration,Plasma concentration HS02,2.32,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1647,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,28-07-2015,09:39,0,-168,-167.683,Hours,Demographics,Age,26,,Years,NaN,NaN,,NaN,NaN,NaN
1648,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,28-07-2015,09:39,0,-168,-167.683,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1649,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-08-2015,08:19,0,-1,-1,Hours,Body,BMI,23.16,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1650,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-08-2015,08:19,0,-1,-1,Hours,Body,Bodyweight,81,,kg,NaN,NaN,,NaN,NaN,NaN
1651,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-08-2015,08:19,0,-1,-1,Hours,Body,Height,187,,cm,NaN,NaN,,NaN,NaN,NaN
1652,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,09:15,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1653,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,09:19,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1654,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,09:24,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,40.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1655,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,09:49,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,169,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1656,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,10:19,0,1,1,Hours,Concentration,Plasma concentration HS02,148,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1657,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,11:19,0,2,2,Hours,Concentration,Plasma concentration HS02,146,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1658,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,13:19,0,4,4,Hours,Concentration,Plasma concentration HS02,116,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1659,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-08-2015,17:19,0,8,8,Hours,Concentration,Plasma concentration HS02,63.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1660,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,05-08-2015,09:15,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,7.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1661,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,05-08-2015,09:19,0,24,24,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1662,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,4,VISIT 4,0,0,06-08-2015,09:19,0,48,48,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1663,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,5,VISIT 5,0,0,07-08-2015,09:19,0,72,72,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1664,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,08-08-2015,09:15,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,17.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1665,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,08-08-2015,09:19,0,96,96,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1666,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,7,VISIT 7,0,0,09-08-2015,09:19,0,120,120,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1667,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,8,VISIT 8,0,0,10-08-2015,09:19,0,144,144,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1668,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,9,VISIT 9,0,0,11-08-2015,09:19,0,168,168,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1669,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,12-08-2015,09:15,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,31,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1670,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,12-08-2015,09:19,0,192,192,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1671,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,11,VISIT 11,0,0,13-08-2015,09:19,0,216,216,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1672,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,12,VISIT 12,0,0,14-08-2015,09:19,0,240,240,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1673,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,13,VISIT 13,0,0,15-08-2015,09:19,0,264,264,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1674,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,16-08-2015,09:15,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,33.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1675,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,16-08-2015,09:19,0,288,288,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1676,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,15,VISIT 15,0,0,17-08-2015,09:19,0,312,312,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1677,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,16,VISIT 16,0,0,18-08-2015,09:19,0,336,336,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1678,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,17,VISIT 17,0,0,19-08-2015,09:19,0,360,360,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1679,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,20-08-2015,09:15,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,40,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1680,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,20-08-2015,09:19,0,384,384,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1681,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,19,VISIT 19,0,0,21-08-2015,09:19,0,408,408,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1682,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,20,VISIT 20,0,0,22-08-2015,09:19,0,432,432,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1683,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,21,VISIT 21,0,0,23-08-2015,09:19,0,456,456,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1684,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-08-2015,09:15,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,43.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1685,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-08-2015,09:19,0,480,480,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1686,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-08-2015,09:24,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,99.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1687,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-08-2015,09:49,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,223,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1688,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-08-2015,10:19,0,481,481,Hours,Concentration,Plasma concentration HS02,184,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1689,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-08-2015,11:19,0,482,482,Hours,Concentration,Plasma concentration HS02,144,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1690,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-08-2015,13:19,0,484,484,Hours,Concentration,Plasma concentration HS02,168,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1691,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-08-2015,17:19,0,488,488,Hours,Concentration,Plasma concentration HS02,76.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1692,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,25-08-2015,09:15,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,39.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1693,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,25-08-2015,09:19,0,504,504,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1694,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,24,VISIT 24,0,0,26-08-2015,09:19,0,528,528,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1695,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,25,VISIT 25,0,0,27-08-2015,09:19,0,552,552,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1696,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,26,VISIT 26,0,0,28-08-2015,09:19,0,576,576,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1697,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,29-08-2015,09:15,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,47.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1698,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,29-08-2015,09:19,0,600,600,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1699,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,28,VISIT 28,0,0,30-08-2015,09:19,0,624,624,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1700,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,29,VISIT 29,0,0,31-08-2015,09:19,0,648,648,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1701,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,30,VISIT 30,0,0,02-09-2015,09:19,0,696,696,Hours,Concentration,Plasma concentration HS02,30.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1702,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,31,VISIT 31,0,0,06-09-2015,09:19,0,792,792,Hours,Concentration,Plasma concentration HS02,27.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1703,,X3402_0105_0215,HS02,X3402,MAD Study in Male HVs,1,0,105,215,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,32,VISIT 32,0,0,13-09-2015,09:19,0,960,960,Hours,Concentration,Plasma concentration HS02,9.83,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1704,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,17-08-2015,09:33,0,-168,-168.5663333,Hours,Demographics,Age,31,,Years,NaN,NaN,,NaN,NaN,NaN
1705,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,17-08-2015,09:33,0,-168,-168.5663333,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1706,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,24-08-2015,09:06,0,-1,-1,Hours,Body,BMI,28.41,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1707,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,24-08-2015,09:06,0,-1,-1,Hours,Body,Bodyweight,88,,kg,NaN,NaN,,NaN,NaN,NaN
1708,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,24-08-2015,09:06,0,-1,-1,Hours,Body,Height,176,,cm,NaN,NaN,,NaN,NaN,NaN
1709,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:02,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1710,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:06,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1711,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:11,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,63.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1712,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:36,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,211,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1713,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,11:06,0,1,1,Hours,Concentration,Plasma concentration HS02,170,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1714,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,12:06,0,2,2,Hours,Concentration,Plasma concentration HS02,187,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1715,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,14:06,0,4,4,Hours,Concentration,Plasma concentration HS02,151,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1716,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,18:06,0,8,8,Hours,Concentration,Plasma concentration HS02,115,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1717,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,25-08-2015,10:02,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,28.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1718,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,25-08-2015,10:06,0,24,24,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1719,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,4,VISIT 4,0,0,26-08-2015,10:06,0,48,48,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1720,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,5,VISIT 5,0,0,27-08-2015,10:06,0,72,72,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1721,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,28-08-2015,10:02,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,49.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1722,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,28-08-2015,10:06,0,96,96,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1723,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,7,VISIT 7,0,0,29-08-2015,10:06,0,120,120,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1724,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,8,VISIT 8,0,0,30-08-2015,10:06,0,144,144,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1725,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,9,VISIT 9,0,0,31-08-2015,10:06,0,168,168,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1726,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,01-09-2015,10:02,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,78.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1727,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,01-09-2015,10:06,0,192,192,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1728,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,11,VISIT 11,0,0,02-09-2015,10:06,0,216,216,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1729,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,12,VISIT 12,0,0,03-09-2015,10:06,0,240,240,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1730,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,13,VISIT 13,0,0,04-09-2015,10:06,0,264,264,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1731,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,05-09-2015,10:02,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,78.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1732,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,05-09-2015,10:06,0,288,288,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1733,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,15,VISIT 15,0,0,06-09-2015,10:06,0,312,312,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1734,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,16,VISIT 16,0,0,07-09-2015,10:06,0,336,336,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1735,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,17,VISIT 17,0,0,08-09-2015,10:06,0,360,360,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1736,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,09-09-2015,10:02,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,103,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1737,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,09-09-2015,10:06,0,384,384,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1738,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,19,VISIT 19,0,0,10-09-2015,10:06,0,408,408,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1739,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,20,VISIT 20,0,0,11-09-2015,10:06,0,432,432,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1740,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,21,VISIT 21,0,0,12-09-2015,10:06,0,456,456,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1741,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,10:02,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,122,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1742,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,10:06,0,480,480,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1743,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,10:11,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,196,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1744,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,10:36,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,305,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1745,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,11:06,0,481,481,Hours,Concentration,Plasma concentration HS02,390,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1746,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,12:06,0,482,482,Hours,Concentration,Plasma concentration HS02,310,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1747,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,14:06,0,484,484,Hours,Concentration,Plasma concentration HS02,303,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1748,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,18:06,0,488,488,Hours,Concentration,Plasma concentration HS02,221,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1749,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,14-09-2015,10:02,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,114,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1750,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,14-09-2015,10:06,0,504,504,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1751,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,24,VISIT 24,0,0,15-09-2015,10:06,0,528,528,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1752,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,25,VISIT 25,0,0,16-09-2015,10:06,0,552,552,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1753,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,26,VISIT 26,0,0,17-09-2015,10:06,0,576,576,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1754,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,18-09-2015,10:02,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,131,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1755,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,18-09-2015,10:06,0,600,600,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1756,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,28,VISIT 28,0,0,19-09-2015,10:06,0,624,624,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1757,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,29,VISIT 29,0,0,20-09-2015,10:06,0,648,648,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1758,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,30,VISIT 30,0,0,22-09-2015,10:06,0,696,696,Hours,Concentration,Plasma concentration HS02,98.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1759,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,31,VISIT 31,0,0,26-09-2015,10:06,0,792,792,Hours,Concentration,Plasma concentration HS02,72,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1760,,X3402_0105_0216,HS02,X3402,MAD Study in Male HVs,1,0,105,216,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,32,VISIT 32,0,0,03-Oct-2015,10:06,0,960,960,Hours,Concentration,Plasma concentration HS02,40.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1761,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,01-08-2015,09:56,0,-168,-167.3496667,Hours,Demographics,Age,21,,Years,NaN,NaN,,NaN,NaN,NaN
1762,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,01-08-2015,09:56,0,-168,-167.3496667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1763,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,08-08-2015,08:16,0,-1,-1,Hours,Body,BMI,22.64,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1764,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,08-08-2015,08:16,0,-1,-1,Hours,Body,Bodyweight,75,,kg,NaN,NaN,,NaN,NaN,NaN
1765,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,08-08-2015,08:16,0,-1,-1,Hours,Body,Height,182,,cm,NaN,NaN,,NaN,NaN,NaN
1766,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,09:12,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1767,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,09:16,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1768,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,09:21,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,27.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1769,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,09:46,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,160,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1770,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,10:16,0,1,1,Hours,Concentration,Plasma concentration HS02,180,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1771,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,11:16,0,2,2,Hours,Concentration,Plasma concentration HS02,189,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1772,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,13:16,0,4,4,Hours,Concentration,Plasma concentration HS02,143,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1773,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,17:16,0,8,8,Hours,Concentration,Plasma concentration HS02,99.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1774,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,09-08-2015,09:12,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,29.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1775,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,09-08-2015,09:16,0,24,24,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1776,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,4,VISIT 4,0,0,10-08-2015,09:16,0,48,48,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1777,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,5,VISIT 5,0,0,11-08-2015,09:16,0,72,72,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1778,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,12-08-2015,09:12,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,51,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1779,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,12-08-2015,09:16,0,96,96,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1780,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,7,VISIT 7,0,0,13-08-2015,09:16,0,120,120,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1781,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,8,VISIT 8,0,0,14-08-2015,09:16,0,144,144,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1782,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,9,VISIT 9,0,0,15-08-2015,09:16,0,168,168,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1783,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,16-08-2015,09:12,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,75.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1784,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,16-08-2015,09:16,0,192,192,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1785,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,11,VISIT 11,0,0,17-08-2015,09:16,0,216,216,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1786,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,12,VISIT 12,0,0,18-08-2015,09:16,0,240,240,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1787,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,13,VISIT 13,0,0,19-08-2015,09:16,0,264,264,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1788,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,20-08-2015,09:12,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,93.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1789,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,20-08-2015,09:16,0,288,288,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1790,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,15,VISIT 15,0,0,21-08-2015,09:16,0,312,312,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1791,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,16,VISIT 16,0,0,22-08-2015,09:16,0,336,336,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1792,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,17,VISIT 17,0,0,23-08-2015,09:16,0,360,360,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1793,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,24-08-2015,09:12,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,78.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1794,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,24-08-2015,09:16,0,384,384,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1795,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,19,VISIT 19,0,0,25-08-2015,09:16,0,408,408,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1796,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,20,VISIT 20,0,0,26-08-2015,09:16,0,432,432,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1797,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,21,VISIT 21,0,0,27-08-2015,09:16,0,456,456,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1798,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,09:12,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,121,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1799,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,09:16,0,480,480,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1800,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,09:21,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,152,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1801,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,09:46,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,218,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1802,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,10:16,0,481,481,Hours,Concentration,Plasma concentration HS02,209,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1803,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,11:16,0,482,482,Hours,Concentration,Plasma concentration HS02,310,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1804,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,13:16,0,484,484,Hours,Concentration,Plasma concentration HS02,230,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1805,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,17:16,0,488,488,Hours,Concentration,Plasma concentration HS02,193,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1806,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,29-08-2015,09:12,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,105,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1807,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,29-08-2015,09:16,0,504,504,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1808,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,24,VISIT 24,0,0,30-08-2015,09:16,0,528,528,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1809,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,25,VISIT 25,0,0,31-08-2015,09:16,0,552,552,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1810,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,26,VISIT 26,0,0,01-09-2015,09:16,0,576,576,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1811,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,02-09-2015,09:12,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,90.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1812,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,02-09-2015,09:16,0,600,600,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1813,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,28,VISIT 28,0,0,03-09-2015,09:16,0,624,624,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1814,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,29,VISIT 29,0,0,04-09-2015,09:16,0,648,648,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1815,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,30,VISIT 30,0,0,06-09-2015,09:16,0,696,696,Hours,Concentration,Plasma concentration HS02,87.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1816,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,31,VISIT 31,0,0,10-09-2015,09:16,0,792,792,Hours,Concentration,Plasma concentration HS02,54.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1817,,X3402_0105_0217,HS02,X3402,MAD Study in Male HVs,1,0,105,217,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,32,VISIT 32,0,0,17-09-2015,09:16,0,960,960,Hours,Concentration,Plasma concentration HS02,28.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1818,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,27-07-2015,09:37,0,-168,-168.2996667,Hours,Demographics,Age,38,,Years,NaN,NaN,,NaN,NaN,NaN
1819,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,27-07-2015,09:37,0,-168,-168.2996667,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1820,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,03-08-2015,08:54,0,-1,-1,Hours,Body,BMI,25.22,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1821,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,03-08-2015,08:54,0,-1,-1,Hours,Body,Bodyweight,79,,kg,NaN,NaN,,NaN,NaN,NaN
1822,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,03-08-2015,08:54,0,-1,-1,Hours,Body,Height,177,,cm,NaN,NaN,,NaN,NaN,NaN
1823,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,09:50,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1824,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,09:54,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1825,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,09:59,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,25.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1826,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,10:24,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,113,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1827,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,10:54,0,1,1,Hours,Concentration,Plasma concentration HS02,161,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1828,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,11:54,0,2,2,Hours,Concentration,Plasma concentration HS02,167,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1829,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,13:54,0,4,4,Hours,Concentration,Plasma concentration HS02,141,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1830,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,17:54,0,8,8,Hours,Concentration,Plasma concentration HS02,67.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1831,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,04-08-2015,09:50,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1832,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,04-08-2015,09:54,0,24,24,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1833,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,4,VISIT 4,0,0,05-08-2015,09:54,0,48,48,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1834,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,5,VISIT 5,0,0,06-08-2015,09:54,0,72,72,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1835,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,07-08-2015,09:50,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,22,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1836,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,07-08-2015,09:54,0,96,96,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1837,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,7,VISIT 7,0,0,08-08-2015,09:54,0,120,120,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1838,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,8,VISIT 8,0,0,09-08-2015,09:54,0,144,144,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1839,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,9,VISIT 9,0,0,10-08-2015,09:54,0,168,168,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1840,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,11-08-2015,09:50,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,25.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1841,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,11-08-2015,09:54,0,192,192,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1842,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,11,VISIT 11,0,0,12-08-2015,09:54,0,216,216,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1843,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,12,VISIT 12,0,0,13-08-2015,09:54,0,240,240,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1844,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,13,VISIT 13,0,0,14-08-2015,09:54,0,264,264,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1845,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,15-08-2015,09:50,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,28.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1846,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,15-08-2015,09:54,0,288,288,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1847,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,15,VISIT 15,0,0,16-08-2015,09:54,0,312,312,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1848,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,16,VISIT 16,0,0,17-08-2015,09:54,0,336,336,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1849,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,17,VISIT 17,0,0,18-08-2015,09:54,0,360,360,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1850,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,19-08-2015,09:50,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,32.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1851,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,19-08-2015,09:54,0,384,384,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1852,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,19,VISIT 19,0,0,20-08-2015,09:54,0,408,408,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1853,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,20,VISIT 20,0,0,21-08-2015,09:54,0,432,432,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1854,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,21,VISIT 21,0,0,22-08-2015,09:54,0,456,456,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1855,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,09:50,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,37.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1856,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,09:54,0,480,480,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1857,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,09:59,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,52,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1858,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,10:24,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,121,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1859,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,10:54,0,481,481,Hours,Concentration,Plasma concentration HS02,213,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1860,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,11:54,0,482,482,Hours,Concentration,Plasma concentration HS02,198,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1861,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,13:54,0,484,484,Hours,Concentration,Plasma concentration HS02,185,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1862,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,17:54,0,488,488,Hours,Concentration,Plasma concentration HS02,80.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1863,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,24-08-2015,09:50,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,30.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1864,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,24-08-2015,09:54,0,504,504,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1865,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,24,VISIT 24,0,0,25-08-2015,09:54,0,528,528,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1866,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,25,VISIT 25,0,0,26-08-2015,09:54,0,552,552,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1867,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,26,VISIT 26,0,0,27-08-2015,09:54,0,576,576,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1868,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,28-08-2015,09:50,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,36.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1869,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,28-08-2015,09:54,0,600,600,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1870,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,28,VISIT 28,0,0,29-08-2015,09:54,0,624,624,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1871,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,29,VISIT 29,0,0,30-08-2015,09:54,0,648,648,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1872,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,30,VISIT 30,0,0,01-09-2015,09:54,0,696,696,Hours,Concentration,Plasma concentration HS02,24.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1873,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,31,VISIT 31,0,0,05-09-2015,09:54,0,792,792,Hours,Concentration,Plasma concentration HS02,13,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1874,,X3402_0105_0218,HS02,X3402,MAD Study in Male HVs,1,0,105,218,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,32,VISIT 32,0,0,12-09-2015,09:54,0,960,960,Hours,Concentration,Plasma concentration HS02,4.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1875,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,03-08-2015,09:16,0,-168,-168.833,Hours,Demographics,Age,26,,Years,NaN,NaN,,NaN,NaN,NaN
1876,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,03-08-2015,09:16,0,-168,-168.833,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1877,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,10-08-2015,09:05,0,-1,-1,Hours,Body,BMI,23.63,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1878,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,10-08-2015,09:05,0,-1,-1,Hours,Body,Bodyweight,80,,kg,NaN,NaN,,NaN,NaN,NaN
1879,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,10-08-2015,09:05,0,-1,-1,Hours,Body,Height,184,,cm,NaN,NaN,,NaN,NaN,NaN
1880,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,10-08-2015,10:01,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1881,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,10-08-2015,10:05,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1882,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,10-08-2015,10:10,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,73.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1883,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,10-08-2015,10:35,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,256,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1884,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,10-08-2015,11:05,0,1,1,Hours,Concentration,Plasma concentration HS02,328,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1885,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,10-08-2015,12:05,0,2,2,Hours,Concentration,Plasma concentration HS02,338,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1886,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,10-08-2015,14:05,0,4,4,Hours,Concentration,Plasma concentration HS02,247,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1887,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,10-08-2015,18:05,0,8,8,Hours,Concentration,Plasma concentration HS02,113,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1888,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,11-08-2015,10:01,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,13,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1889,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,11-08-2015,10:05,0,24,24,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1890,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,4,VISIT 4,0,0,12-08-2015,10:05,0,48,48,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1891,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,5,VISIT 5,0,0,13-08-2015,10:05,0,72,72,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1892,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,14-08-2015,10:01,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,28.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1893,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,14-08-2015,10:05,0,96,96,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1894,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,7,VISIT 7,0,0,15-08-2015,10:05,0,120,120,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1895,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,8,VISIT 8,0,0,16-08-2015,10:05,0,144,144,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1896,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,9,VISIT 9,0,0,17-08-2015,10:05,0,168,168,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1897,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,18-08-2015,10:01,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,46.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1898,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,18-08-2015,10:05,0,192,192,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1899,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,11,VISIT 11,0,0,19-08-2015,10:05,0,216,216,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1900,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,12,VISIT 12,0,0,20-08-2015,10:05,0,240,240,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1901,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,13,VISIT 13,0,0,21-08-2015,10:05,0,264,264,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1902,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,22-08-2015,10:01,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,53.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1903,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,22-08-2015,10:05,0,288,288,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1904,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,15,VISIT 15,0,0,23-08-2015,10:05,0,312,312,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1905,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,16,VISIT 16,0,0,24-08-2015,10:05,0,336,336,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1906,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,17,VISIT 17,0,0,25-08-2015,10:05,0,360,360,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1907,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,26-08-2015,10:01,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,69,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1908,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,26-08-2015,10:05,0,384,384,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1909,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,19,VISIT 19,0,0,27-08-2015,10:05,0,408,408,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1910,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,20,VISIT 20,0,0,28-08-2015,10:05,0,432,432,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1911,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,21,VISIT 21,0,0,29-08-2015,10:05,0,456,456,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1912,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,30-08-2015,10:01,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,73.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1913,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,30-08-2015,10:05,0,480,480,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1914,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,30-08-2015,10:10,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,150,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1915,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,30-08-2015,10:35,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,320,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1916,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,30-08-2015,11:05,0,481,481,Hours,Concentration,Plasma concentration HS02,405,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1917,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,30-08-2015,12:05,0,482,482,Hours,Concentration,Plasma concentration HS02,501,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1918,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,30-08-2015,14:05,0,484,484,Hours,Concentration,Plasma concentration HS02,286,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1919,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,30-08-2015,18:05,0,488,488,Hours,Concentration,Plasma concentration HS02,151,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1920,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,31-08-2015,10:01,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,64.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1921,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,31-08-2015,10:05,0,504,504,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1922,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,24,VISIT 24,0,0,01-09-2015,10:05,0,528,528,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1923,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,25,VISIT 25,0,0,02-09-2015,10:05,0,552,552,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1924,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,26,VISIT 26,0,0,03-09-2015,10:05,0,576,576,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1925,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,04-09-2015,10:01,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,75.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1926,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,04-09-2015,10:05,0,600,600,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1927,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,28,VISIT 28,0,0,05-09-2015,10:05,0,624,624,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1928,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,29,VISIT 29,0,0,06-09-2015,10:05,0,648,648,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1929,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,30,VISIT 30,0,0,08-09-2015,10:05,0,696,696,Hours,Concentration,Plasma concentration HS02,49.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1930,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,31,VISIT 31,0,0,12-09-2015,10:05,0,792,792,Hours,Concentration,Plasma concentration HS02,37.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1931,,X3402_0105_0219,HS02,X3402,MAD Study in Male HVs,1,0,105,219,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,32,VISIT 32,0,0,19-09-2015,10:05,0,960,960,Hours,Concentration,Plasma concentration HS02,15.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1932,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,09-08-2015,09:41,0,-168,-168.233,Hours,Demographics,Age,27,,Years,NaN,NaN,,NaN,NaN,NaN
1933,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,09-08-2015,09:41,0,-168,-168.233,Hours,Demographics,Gender,1,male,.,NaN,NaN,,NaN,NaN,NaN
1934,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,16-08-2015,08:54,0,-1,-1,Hours,Body,BMI,25.56,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1935,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,16-08-2015,08:54,0,-1,-1,Hours,Body,Bodyweight,81,,kg,NaN,NaN,,NaN,NaN,NaN
1936,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,16-08-2015,08:54,0,-1,-1,Hours,Body,Height,178,,cm,NaN,NaN,,NaN,NaN,NaN
1937,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,09:50,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1938,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,09:54,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1939,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,09:59,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,70.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1940,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,10:24,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,198,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1941,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,10:54,0,1,1,Hours,Concentration,Plasma concentration HS02,204,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1942,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,11:54,0,2,2,Hours,Concentration,Plasma concentration HS02,230,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1943,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,13:54,0,4,4,Hours,Concentration,Plasma concentration HS02,171,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1944,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,17:54,0,8,8,Hours,Concentration,Plasma concentration HS02,65.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1945,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,17-08-2015,09:50,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,14.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1946,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,17-08-2015,09:54,0,24,24,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1947,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,4,VISIT 4,0,0,18-08-2015,09:54,0,48,48,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1948,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,5,VISIT 5,0,0,19-08-2015,09:54,0,72,72,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1949,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,20-08-2015,09:50,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,57.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1950,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,20-08-2015,09:54,0,96,96,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1951,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,7,VISIT 7,0,0,21-08-2015,09:54,0,120,120,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1952,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,8,VISIT 8,0,0,22-08-2015,09:54,0,144,144,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1953,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,9,VISIT 9,0,0,23-08-2015,09:54,0,168,168,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1954,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,24-08-2015,09:50,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,65,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1955,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,24-08-2015,09:54,0,192,192,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1956,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,11,VISIT 11,0,0,25-08-2015,09:54,0,216,216,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1957,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,12,VISIT 12,0,0,26-08-2015,09:54,0,240,240,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1958,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,13,VISIT 13,0,0,27-08-2015,09:54,0,264,264,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1959,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,28-08-2015,09:50,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,102,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1960,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,28-08-2015,09:54,0,288,288,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1961,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,15,VISIT 15,0,0,29-08-2015,09:54,0,312,312,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1962,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,16,VISIT 16,0,0,30-08-2015,09:54,0,336,336,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1963,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,17,VISIT 17,0,0,31-08-2015,09:54,0,360,360,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1964,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,01-09-2015,09:50,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,87.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1965,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,01-09-2015,09:54,0,384,384,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1966,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,19,VISIT 19,0,0,02-09-2015,09:54,0,408,408,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1967,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,20,VISIT 20,0,0,03-09-2015,09:54,0,432,432,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1968,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,21,VISIT 21,0,0,04-09-2015,09:54,0,456,456,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1969,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,09:50,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,131,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1970,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,09:54,0,480,480,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1971,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,09:59,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,140,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1972,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,10:24,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,323,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1973,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,10:54,0,481,481,Hours,Concentration,Plasma concentration HS02,338,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1974,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,11:54,0,482,482,Hours,Concentration,Plasma concentration HS02,298,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1975,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,13:54,0,484,484,Hours,Concentration,Plasma concentration HS02,237,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1976,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,17:54,0,488,488,Hours,Concentration,Plasma concentration HS02,182,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1977,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,06-09-2015,09:50,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,99.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1978,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,06-09-2015,09:54,0,504,504,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1979,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,24,VISIT 24,0,0,07-09-2015,09:54,0,528,528,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1980,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,25,VISIT 25,0,0,08-09-2015,09:54,0,552,552,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1981,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,26,VISIT 26,0,0,09-09-2015,09:54,0,576,576,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1982,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,10-09-2015,09:50,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,115,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1983,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,10-09-2015,09:54,0,600,600,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1984,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,28,VISIT 28,0,0,11-09-2015,09:54,0,624,624,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1985,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,29,VISIT 29,0,0,12-09-2015,09:54,0,648,648,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1986,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,30,VISIT 30,0,0,14-09-2015,09:54,0,696,696,Hours,Concentration,Plasma concentration HS02,104,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1987,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,31,VISIT 31,0,0,18-09-2015,09:54,0,792,792,Hours,Concentration,Plasma concentration HS02,51.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1988,,X3402_0105_0220,HS02,X3402,MAD Study in Male HVs,1,0,105,220,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,32,VISIT 32,0,0,25-09-2015,09:54,0,960,960,Hours,Concentration,Plasma concentration HS02,18.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1989,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,08-08-2015,09:07,0,-168,-168.2496667,Hours,Demographics,Age,46,,Years,NaN,NaN,,NaN,NaN,NaN
1990,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,08-08-2015,09:07,0,-168,-168.2496667,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
1991,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,15-08-2015,08:21,0,-1,-1,Hours,Body,BMI,25.1,,kg/m2,NaN,NaN,,NaN,NaN,NaN
1992,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,15-08-2015,08:21,0,-1,-1,Hours,Body,Bodyweight,70,,kg,NaN,NaN,,NaN,NaN,NaN
1993,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,15-08-2015,08:21,0,-1,-1,Hours,Body,Height,167,,cm,NaN,NaN,,NaN,NaN,NaN
1994,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:17,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1995,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:21,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
1996,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:26,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,5.24,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1997,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,09:51,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,22.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1998,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,10:21,0,1,1,Hours,Concentration,Plasma concentration HS02,22.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
1999,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,11:21,0,2,2,Hours,Concentration,Plasma concentration HS02,22.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2000,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,13:21,0,4,4,Hours,Concentration,Plasma concentration HS02,7.75,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2001,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,15-08-2015,17:21,0,8,8,Hours,Concentration,Plasma concentration HS02,1.34,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2002,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,16-08-2015,09:17,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2003,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,16-08-2015,09:21,0,24,24,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2004,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,4,VISIT 4,0,0,17-08-2015,09:21,0,48,48,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2005,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,5,VISIT 5,0,0,18-08-2015,09:21,0,72,72,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2006,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,19-08-2015,09:17,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,0.54,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2007,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,19-08-2015,09:21,0,96,96,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2008,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,7,VISIT 7,0,0,20-08-2015,09:21,0,120,120,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2009,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,8,VISIT 8,0,0,21-08-2015,09:21,0,144,144,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2010,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,9,VISIT 9,0,0,22-08-2015,09:21,0,168,168,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2011,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,23-08-2015,09:17,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,0.71,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2012,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,23-08-2015,09:21,0,192,192,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2013,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,11,VISIT 11,0,0,24-08-2015,09:21,0,216,216,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2014,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,12,VISIT 12,0,0,25-08-2015,09:21,0,240,240,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2015,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,13,VISIT 13,0,0,26-08-2015,09:21,0,264,264,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2016,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,27-08-2015,09:17,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,0.96,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2017,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,27-08-2015,09:21,0,288,288,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2018,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,15,VISIT 15,0,0,28-08-2015,09:21,0,312,312,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2019,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,16,VISIT 16,0,0,29-08-2015,09:21,0,336,336,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2020,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,17,VISIT 17,0,0,30-08-2015,09:21,0,360,360,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2021,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,31-08-2015,09:17,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,0.94,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2022,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,31-08-2015,09:21,0,384,384,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2023,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,19,VISIT 19,0,0,01-09-2015,09:21,0,408,408,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2024,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,20,VISIT 20,0,0,02-09-2015,09:21,0,432,432,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2025,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,21,VISIT 21,0,0,03-09-2015,09:21,0,456,456,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2026,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,09:17,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,0.51,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2027,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,09:21,0,480,480,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2028,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,09:26,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,8.18,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2029,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,09:51,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,19,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2030,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,10:21,0,481,481,Hours,Concentration,Plasma concentration HS02,28.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2031,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,11:21,0,482,482,Hours,Concentration,Plasma concentration HS02,22.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2032,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,13:21,0,484,484,Hours,Concentration,Plasma concentration HS02,9.66,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2033,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,04-09-2015,17:21,0,488,488,Hours,Concentration,Plasma concentration HS02,2.37,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2034,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,05-09-2015,09:17,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,0.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2035,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,05-09-2015,09:21,0,504,504,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2036,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,24,VISIT 24,0,0,06-09-2015,09:21,0,528,528,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2037,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,25,VISIT 25,0,0,07-09-2015,09:21,0,552,552,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2038,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,26,VISIT 26,0,0,08-09-2015,09:21,0,576,576,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2039,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,09-09-2015,09:17,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2040,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,09-09-2015,09:21,0,600,600,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2041,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,28,VISIT 28,0,0,10-09-2015,09:21,0,624,624,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2042,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,29,VISIT 29,0,0,11-09-2015,09:21,0,648,648,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2043,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,30,VISIT 30,0,0,13-09-2015,09:21,0,696,696,Hours,Concentration,Plasma concentration HS02,1.23,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2044,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,31,VISIT 31,0,0,17-09-2015,09:21,0,792,792,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2045,,X3402_0105_0221,HS02,X3402,MAD Study in Male HVs,1,0,105,221,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,32,VISIT 32,0,0,24-09-2015,09:21,0,960,960,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2046,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,21-08-2015,09:43,0,-168,-167.483,Hours,Demographics,Age,49,,Years,NaN,NaN,,NaN,NaN,NaN
2047,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,21-08-2015,09:43,0,-168,-167.483,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2048,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-08-2015,08:11,0,-1,-1,Hours,Body,BMI,16.16,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2049,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-08-2015,08:11,0,-1,-1,Hours,Body,Bodyweight,44,,kg,NaN,NaN,,NaN,NaN,NaN
2050,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,28-08-2015,08:11,0,-1,-1,Hours,Body,Height,165,,cm,NaN,NaN,,NaN,NaN,NaN
2051,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,09:07,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2052,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,09:11,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2053,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,09:16,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,13.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2054,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,09:41,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,63.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2055,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,10:11,0,1,1,Hours,Concentration,Plasma concentration HS02,63.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2056,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,11:11,0,2,2,Hours,Concentration,Plasma concentration HS02,40.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2057,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,13:11,0,4,4,Hours,Concentration,Plasma concentration HS02,9.83,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2058,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,28-08-2015,17:11,0,8,8,Hours,Concentration,Plasma concentration HS02,0.88,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2059,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,29-08-2015,09:07,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2060,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,29-08-2015,09:11,0,24,24,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2061,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,4,VISIT 4,0,0,30-08-2015,09:11,0,48,48,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2062,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,5,VISIT 5,0,0,31-08-2015,09:11,0,72,72,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2063,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,01-09-2015,09:07,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,0.72,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2064,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,01-09-2015,09:11,0,96,96,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2065,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,7,VISIT 7,0,0,02-09-2015,09:11,0,120,120,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2066,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,8,VISIT 8,0,0,03-09-2015,09:11,0,144,144,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2067,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,9,VISIT 9,0,0,04-09-2015,09:11,0,168,168,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2068,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,05-09-2015,09:07,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,1.28,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2069,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,05-09-2015,09:11,0,192,192,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2070,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,11,VISIT 11,0,0,06-09-2015,09:11,0,216,216,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2071,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,12,VISIT 12,0,0,07-09-2015,09:11,0,240,240,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2072,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,13,VISIT 13,0,0,08-09-2015,09:11,0,264,264,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2073,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,09-09-2015,09:07,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,1.24,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2074,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,09-09-2015,09:11,0,288,288,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2075,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,15,VISIT 15,0,0,10-09-2015,09:11,0,312,312,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2076,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,16,VISIT 16,0,0,11-09-2015,09:11,0,336,336,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2077,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,17,VISIT 17,0,0,12-09-2015,09:11,0,360,360,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2078,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,13-09-2015,09:07,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,1.31,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2079,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,13-09-2015,09:11,0,384,384,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2080,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,19,VISIT 19,0,0,14-09-2015,09:11,0,408,408,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2081,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,20,VISIT 20,0,0,15-09-2015,09:11,0,432,432,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2082,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,21,VISIT 21,0,0,16-09-2015,09:11,0,456,456,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2083,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,09:07,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,1.44,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2084,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,09:11,0,480,480,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2085,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,09:16,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,17.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2086,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,09:41,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,59.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2087,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,10:11,0,481,481,Hours,Concentration,Plasma concentration HS02,61,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2088,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,11:11,0,482,482,Hours,Concentration,Plasma concentration HS02,39.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2089,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,13:11,0,484,484,Hours,Concentration,Plasma concentration HS02,9.84,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2090,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,17-09-2015,17:11,0,488,488,Hours,Concentration,Plasma concentration HS02,2.93,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2091,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,18-09-2015,09:07,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,1.88,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2092,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,18-09-2015,09:11,0,504,504,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2093,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,24,VISIT 24,0,0,19-09-2015,09:11,0,528,528,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2094,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,25,VISIT 25,0,0,20-09-2015,09:11,0,552,552,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2095,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,26,VISIT 26,0,0,21-09-2015,09:11,0,576,576,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2096,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,22-09-2015,09:07,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,2.44,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2097,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,22-09-2015,09:11,0,600,600,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2098,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,28,VISIT 28,0,0,23-09-2015,09:11,0,624,624,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2099,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,29,VISIT 29,0,0,24-09-2015,09:11,0,648,648,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2100,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,30,VISIT 30,0,0,26-09-2015,09:11,0,696,696,Hours,Concentration,Plasma concentration HS02,1.37,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2101,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,31,VISIT 31,0,0,30-09-2015,09:11,0,792,792,Hours,Concentration,Plasma concentration HS02,1.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2102,,X3402_0105_0222,HS02,X3402,MAD Study in Male HVs,1,0,105,222,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,32,VISIT 32,0,0,07-Oct-2015,09:11,0,960,960,Hours,Concentration,Plasma concentration HS02,0.81,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2103,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,23-08-2015,09:17,0,-168,-168.433,Hours,Demographics,Age,43,,Years,NaN,NaN,,NaN,NaN,NaN
2104,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,23-08-2015,09:17,0,-168,-168.433,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2105,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,30-08-2015,08:42,0,-1,-1,Hours,Body,BMI,24,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2106,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,30-08-2015,08:42,0,-1,-1,Hours,Body,Bodyweight,71,,kg,NaN,NaN,,NaN,NaN,NaN
2107,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,30-08-2015,08:42,0,-1,-1,Hours,Body,Height,172,,cm,NaN,NaN,,NaN,NaN,NaN
2108,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,09:38,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2109,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,09:42,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2110,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,09:47,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,6.79,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2111,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,10:12,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,24,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2112,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,10:42,0,1,1,Hours,Concentration,Plasma concentration HS02,33.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2113,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,11:42,0,2,2,Hours,Concentration,Plasma concentration HS02,25.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2114,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,13:42,0,4,4,Hours,Concentration,Plasma concentration HS02,8.57,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2115,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,17:42,0,8,8,Hours,Concentration,Plasma concentration HS02,1.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2116,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,31-08-2015,09:38,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2117,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,31-08-2015,09:42,0,24,24,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2118,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,4,VISIT 4,0,0,01-09-2015,09:42,0,48,48,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2119,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,5,VISIT 5,0,0,02-09-2015,09:42,0,72,72,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2120,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,03-09-2015,09:38,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2121,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,03-09-2015,09:42,0,96,96,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2122,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,7,VISIT 7,0,0,04-09-2015,09:42,0,120,120,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2123,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,8,VISIT 8,0,0,05-09-2015,09:42,0,144,144,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2124,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,9,VISIT 9,0,0,06-09-2015,09:42,0,168,168,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2125,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,07-09-2015,09:38,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,0.92,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2126,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,07-09-2015,09:42,0,192,192,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2127,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,11,VISIT 11,0,0,08-09-2015,09:42,0,216,216,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2128,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,12,VISIT 12,0,0,09-09-2015,09:42,0,240,240,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2129,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,13,VISIT 13,0,0,10-09-2015,09:42,0,264,264,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2130,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,11-09-2015,09:38,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,0.79,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2131,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,11-09-2015,09:42,0,288,288,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2132,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,15,VISIT 15,0,0,12-09-2015,09:42,0,312,312,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2133,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,16,VISIT 16,0,0,13-09-2015,09:42,0,336,336,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2134,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,17,VISIT 17,0,0,14-09-2015,09:42,0,360,360,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2135,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,15-09-2015,09:38,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,1.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2136,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,15-09-2015,09:42,0,384,384,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2137,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,19,VISIT 19,0,0,16-09-2015,09:42,0,408,408,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2138,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,20,VISIT 20,0,0,17-09-2015,09:42,0,432,432,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2139,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,21,VISIT 21,0,0,18-09-2015,09:42,0,456,456,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2140,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,09:38,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,0.52,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2141,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,09:42,0,480,480,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2142,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,09:47,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,8.09,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2143,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,10:12,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,26.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2144,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,10:42,0,481,481,Hours,Concentration,Plasma concentration HS02,23.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2145,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,11:42,0,482,482,Hours,Concentration,Plasma concentration HS02,25.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2146,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,13:42,0,484,484,Hours,Concentration,Plasma concentration HS02,11.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2147,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,17:42,0,488,488,Hours,Concentration,Plasma concentration HS02,2.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2148,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,20-09-2015,09:38,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,0.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2149,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,20-09-2015,09:42,0,504,504,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2150,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,24,VISIT 24,0,0,21-09-2015,09:42,0,528,528,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2151,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,25,VISIT 25,0,0,22-09-2015,09:42,0,552,552,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2152,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,26,VISIT 26,0,0,23-09-2015,09:42,0,576,576,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2153,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,24-09-2015,09:38,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,0.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2154,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,24-09-2015,09:42,0,600,600,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2155,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,28,VISIT 28,0,0,25-09-2015,09:42,0,624,624,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2156,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,29,VISIT 29,0,0,26-09-2015,09:42,0,648,648,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2157,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,30,VISIT 30,0,0,28-09-2015,09:42,0,696,696,Hours,Concentration,Plasma concentration HS02,0.61,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2158,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,31,VISIT 31,0,0,02-Oct-2015,09:42,0,792,792,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2159,,X3402_0105_0223,HS02,X3402,MAD Study in Male HVs,1,0,105,223,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,32,VISIT 32,0,0,09-Oct-2015,09:42,0,960,960,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2160,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,19-08-2015,09:40,0,-168,-167.433,Hours,Demographics,Age,38,,Years,NaN,NaN,,NaN,NaN,NaN
2161,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,19-08-2015,09:40,0,-168,-167.433,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2162,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,26-08-2015,08:05,0,-1,-1,Hours,Body,BMI,25.46,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2163,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,26-08-2015,08:05,0,-1,-1,Hours,Body,Bodyweight,71,,kg,NaN,NaN,,NaN,NaN,NaN
2164,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,26-08-2015,08:05,0,-1,-1,Hours,Body,Height,167,,cm,NaN,NaN,,NaN,NaN,NaN
2165,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,26-08-2015,09:01,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2166,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,26-08-2015,09:05,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2167,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,26-08-2015,09:10,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,5.77,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2168,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,26-08-2015,09:35,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,21.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2169,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,26-08-2015,10:05,0,1,1,Hours,Concentration,Plasma concentration HS02,31.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2170,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,26-08-2015,11:05,0,2,2,Hours,Concentration,Plasma concentration HS02,32.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2171,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,26-08-2015,13:05,0,4,4,Hours,Concentration,Plasma concentration HS02,15.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2172,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,26-08-2015,17:05,0,8,8,Hours,Concentration,Plasma concentration HS02,4.77,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2173,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,27-08-2015,09:01,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2174,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,27-08-2015,09:05,0,24,24,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2175,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,4,VISIT 4,0,0,28-08-2015,09:05,0,48,48,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2176,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,5,VISIT 5,0,0,29-08-2015,09:05,0,72,72,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2177,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,30-08-2015,09:01,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,0.89,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2178,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,30-08-2015,09:05,0,96,96,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2179,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,7,VISIT 7,0,0,31-08-2015,09:05,0,120,120,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2180,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,8,VISIT 8,0,0,01-09-2015,09:05,0,144,144,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2181,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,9,VISIT 9,0,0,02-09-2015,09:05,0,168,168,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2182,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,03-09-2015,09:01,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,1.26,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2183,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,03-09-2015,09:05,0,192,192,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2184,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,11,VISIT 11,0,0,04-09-2015,09:05,0,216,216,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2185,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,12,VISIT 12,0,0,05-09-2015,09:05,0,240,240,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2186,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,13,VISIT 13,0,0,06-09-2015,09:05,0,264,264,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2187,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,07-09-2015,09:01,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,1.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2188,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,07-09-2015,09:05,0,288,288,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2189,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,15,VISIT 15,0,0,08-09-2015,09:05,0,312,312,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2190,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,16,VISIT 16,0,0,09-09-2015,09:05,0,336,336,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2191,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,17,VISIT 17,0,0,10-09-2015,09:05,0,360,360,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2192,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,11-09-2015,09:01,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,1.54,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2193,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,11-09-2015,09:05,0,384,384,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2194,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,19,VISIT 19,0,0,12-09-2015,09:05,0,408,408,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2195,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,20,VISIT 20,0,0,13-09-2015,09:05,0,432,432,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2196,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,21,VISIT 21,0,0,14-09-2015,09:05,0,456,456,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2197,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,15-09-2015,09:01,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,1.72,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2198,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,15-09-2015,09:05,0,480,480,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2199,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,15-09-2015,09:10,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,6.64,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2200,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,15-09-2015,09:35,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,24.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2201,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,15-09-2015,10:05,0,481,481,Hours,Concentration,Plasma concentration HS02,39.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2202,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,15-09-2015,11:05,0,482,482,Hours,Concentration,Plasma concentration HS02,30.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2203,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,15-09-2015,13:05,0,484,484,Hours,Concentration,Plasma concentration HS02,21.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2204,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,15-09-2015,17:05,0,488,488,Hours,Concentration,Plasma concentration HS02,5.48,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2205,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,16-09-2015,09:01,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,2.38,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2206,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,16-09-2015,09:05,0,504,504,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2207,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,24,VISIT 24,0,0,17-09-2015,09:05,0,528,528,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2208,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,25,VISIT 25,0,0,18-09-2015,09:05,0,552,552,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2209,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,26,VISIT 26,0,0,19-09-2015,09:05,0,576,576,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2210,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,20-09-2015,09:01,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,1.37,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2211,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,20-09-2015,09:05,0,600,600,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2212,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,28,VISIT 28,0,0,21-09-2015,09:05,0,624,624,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2213,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,29,VISIT 29,0,0,22-09-2015,09:05,0,648,648,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2214,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,30,VISIT 30,0,0,24-09-2015,09:05,0,696,696,Hours,Concentration,Plasma concentration HS02,1.88,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2215,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,31,VISIT 31,0,0,28-09-2015,09:05,0,792,792,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2216,,X3402_0105_0224,HS02,X3402,MAD Study in Male HVs,1,0,105,224,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,32,VISIT 32,0,0,05-Oct-2015,09:05,0,960,960,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2217,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,17-08-2015,10:02,0,-168,-168.233,Hours,Demographics,Age,38,,Years,NaN,NaN,,NaN,NaN,NaN
2218,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,17-08-2015,10:02,0,-168,-168.233,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2219,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,24-08-2015,09:15,0,-1,-1,Hours,Body,BMI,29.05,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2220,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,24-08-2015,09:15,0,-1,-1,Hours,Body,Bodyweight,82,,kg,NaN,NaN,,NaN,NaN,NaN
2221,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,24-08-2015,09:15,0,-1,-1,Hours,Body,Height,168,,cm,NaN,NaN,,NaN,NaN,NaN
2222,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:11,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2223,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:15,0,0,0,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2224,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:20,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,7.68,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2225,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:45,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,25.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2226,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,11:15,0,1,1,Hours,Concentration,Plasma concentration HS02,21.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2227,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,12:15,0,2,2,Hours,Concentration,Plasma concentration HS02,17.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2228,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,14:15,0,4,4,Hours,Concentration,Plasma concentration HS02,5.93,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2229,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,18:15,0,8,8,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2230,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,25-08-2015,10:11,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2231,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,3,VISIT 3,0,0,25-08-2015,10:15,0,24,24,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2232,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,4,VISIT 4,0,0,26-08-2015,10:15,0,48,48,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2233,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,5,VISIT 5,0,0,27-08-2015,10:15,0,72,72,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2234,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,28-08-2015,10:11,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,0.82,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2235,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,6,VISIT 6,0,0,28-08-2015,10:15,0,96,96,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2236,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,7,VISIT 7,0,0,29-08-2015,10:15,0,120,120,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2237,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,8,VISIT 8,0,0,30-08-2015,10:15,0,144,144,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2238,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,9,VISIT 9,0,0,31-08-2015,10:15,0,168,168,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2239,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,01-09-2015,10:11,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,0.96,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2240,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,10,VISIT 10,0,0,01-09-2015,10:15,0,192,192,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2241,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,11,VISIT 11,0,0,02-09-2015,10:15,0,216,216,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2242,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,12,VISIT 12,0,0,03-09-2015,10:15,0,240,240,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2243,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,13,VISIT 13,0,0,04-09-2015,10:15,0,264,264,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2244,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,05-09-2015,10:11,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,0.83,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2245,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,14,VISIT 14,0,0,05-09-2015,10:15,0,288,288,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2246,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,15,VISIT 15,0,0,06-09-2015,10:15,0,312,312,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2247,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,16,VISIT 16,0,0,07-09-2015,10:15,0,336,336,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2248,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,17,VISIT 17,0,0,08-09-2015,10:15,0,360,360,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2249,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,09-09-2015,10:11,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,0.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2250,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,18,VISIT 18,0,0,09-09-2015,10:15,0,384,384,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2251,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,19,VISIT 19,0,0,10-09-2015,10:15,0,408,408,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2252,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,20,VISIT 20,0,0,11-09-2015,10:15,0,432,432,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2253,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,21,VISIT 21,0,0,12-09-2015,10:15,0,456,456,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2254,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,10:11,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,1.58,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2255,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,10:15,0,480,480,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2256,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,10:20,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,7.85,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2257,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,10:45,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,26.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2258,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,11:15,0,481,481,Hours,Concentration,Plasma concentration HS02,27.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2259,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,12:15,0,482,482,Hours,Concentration,Plasma concentration HS02,18.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2260,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,14:15,0,484,484,Hours,Concentration,Plasma concentration HS02,7.29,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2261,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,18:15,0,488,488,Hours,Concentration,Plasma concentration HS02,1.34,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2262,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,14-09-2015,10:11,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,0.75,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2263,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,23,VISIT 23,0,0,14-09-2015,10:15,0,504,504,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2264,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,24,VISIT 24,0,0,15-09-2015,10:15,0,528,528,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2265,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,25,VISIT 25,0,0,16-09-2015,10:15,0,552,552,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2266,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,26,VISIT 26,0,0,17-09-2015,10:15,0,576,576,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2267,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,18-09-2015,10:11,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,0.54,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2268,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,27,VISIT 27,0,0,18-09-2015,10:15,0,600,600,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2269,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,28,VISIT 28,0,0,19-09-2015,10:15,0,624,624,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2270,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,29,VISIT 29,0,0,20-09-2015,10:15,0,648,648,Hours,Dose,Dose HS02,10000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2271,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,30,VISIT 30,0,0,22-09-2015,10:15,0,696,696,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2272,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,31,VISIT 31,0,0,26-09-2015,10:15,0,792,792,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2273,,X3402_0105_0225,HS02,X3402,MAD Study in Male HVs,1,0,105,225,Healthy Volunteers,10mg oral daily dosing for 28 days,10mg oral daily dosing for 28 days,32,VISIT 32,0,0,03-Oct-2015,10:15,0,960,960,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2274,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,24-08-2015,10:01,0,-168,-168.133,Hours,Demographics,Age,48,,Years,NaN,NaN,,NaN,NaN,NaN
2275,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,24-08-2015,10:01,0,-168,-168.133,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2276,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,31-08-2015,09:08,0,-1,-1,Hours,Body,BMI,25.65,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2277,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,31-08-2015,09:08,0,-1,-1,Hours,Body,Bodyweight,75,,kg,NaN,NaN,,NaN,NaN,NaN
2278,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,31-08-2015,09:08,0,-1,-1,Hours,Body,Height,171,,cm,NaN,NaN,,NaN,NaN,NaN
2279,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,10:04,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2280,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,10:08,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2281,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,10:13,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,12,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2282,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,10:38,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,49,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2283,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,11:08,0,1,1,Hours,Concentration,Plasma concentration HS02,43.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2284,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,12:08,0,2,2,Hours,Concentration,Plasma concentration HS02,43.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2285,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,14:08,0,4,4,Hours,Concentration,Plasma concentration HS02,20.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2286,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-08-2015,18:08,0,8,8,Hours,Concentration,Plasma concentration HS02,3.83,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2287,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,01-09-2015,10:04,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2288,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,01-09-2015,10:08,0,24,24,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2289,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,4,VISIT 4,0,0,02-09-2015,10:08,0,48,48,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2290,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,5,VISIT 5,0,0,03-09-2015,10:08,0,72,72,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2291,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,04-09-2015,10:04,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,1.04,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2292,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,04-09-2015,10:08,0,96,96,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2293,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,7,VISIT 7,0,0,05-09-2015,10:08,0,120,120,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2294,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,8,VISIT 8,0,0,06-09-2015,10:08,0,144,144,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2295,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,9,VISIT 9,0,0,07-09-2015,10:08,0,168,168,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2296,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,08-09-2015,10:04,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,0.83,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2297,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,08-09-2015,10:08,0,192,192,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2298,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,11,VISIT 11,0,0,09-09-2015,10:08,0,216,216,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2299,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,12,VISIT 12,0,0,10-09-2015,10:08,0,240,240,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2300,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,13,VISIT 13,0,0,11-09-2015,10:08,0,264,264,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2301,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,12-09-2015,10:04,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,1.54,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2302,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,12-09-2015,10:08,0,288,288,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2303,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,15,VISIT 15,0,0,13-09-2015,10:08,0,312,312,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2304,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,16,VISIT 16,0,0,14-09-2015,10:08,0,336,336,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2305,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,17,VISIT 17,0,0,15-09-2015,10:08,0,360,360,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2306,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,16-09-2015,10:04,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,1.31,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2307,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,16-09-2015,10:08,0,384,384,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2308,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,19,VISIT 19,0,0,17-09-2015,10:08,0,408,408,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2309,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,20,VISIT 20,0,0,18-09-2015,10:08,0,432,432,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2310,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,21,VISIT 21,0,0,19-09-2015,10:08,0,456,456,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2311,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-09-2015,10:04,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,1.35,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2312,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-09-2015,10:08,0,480,480,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2313,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-09-2015,10:13,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,13,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2314,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-09-2015,10:38,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,39.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2315,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-09-2015,11:08,0,481,481,Hours,Concentration,Plasma concentration HS02,53.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2316,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-09-2015,12:08,0,482,482,Hours,Concentration,Plasma concentration HS02,45.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2317,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-09-2015,14:08,0,484,484,Hours,Concentration,Plasma concentration HS02,21.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2318,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-09-2015,18:08,0,488,488,Hours,Concentration,Plasma concentration HS02,5.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2319,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,21-09-2015,10:04,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,1.92,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2320,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,21-09-2015,10:08,0,504,504,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2321,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,24,VISIT 24,0,0,22-09-2015,10:08,0,528,528,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2322,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,25,VISIT 25,0,0,23-09-2015,10:08,0,552,552,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2323,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,26,VISIT 26,0,0,24-09-2015,10:08,0,576,576,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2324,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,25-09-2015,10:04,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,0.58,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2325,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,25-09-2015,10:08,0,600,600,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2326,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,28,VISIT 28,0,0,26-09-2015,10:08,0,624,624,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2327,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,29,VISIT 29,0,0,27-09-2015,10:08,0,648,648,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2328,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,30,VISIT 30,0,0,29-09-2015,10:08,0,696,696,Hours,Concentration,Plasma concentration HS02,1.15,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2329,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,31,VISIT 31,0,0,03-Oct-2015,10:08,0,792,792,Hours,Concentration,Plasma concentration HS02,0.56,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2330,,X3402_0105_0226,HS02,X3402,MAD Study in Male HVs,1,0,105,226,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,32,VISIT 32,0,0,10-Oct-2015,10:08,0,960,960,Hours,Concentration,Plasma concentration HS02,0.79,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2331,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,27-07-2015,09:12,0,-168,-168.1996667,Hours,Demographics,Age,43,,Years,NaN,NaN,,NaN,NaN,NaN
2332,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,27-07-2015,09:12,0,-168,-168.1996667,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2333,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,03-08-2015,08:23,0,-1,-1,Hours,Body,BMI,27.64,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2334,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,03-08-2015,08:23,0,-1,-1,Hours,Body,Bodyweight,69,,kg,NaN,NaN,,NaN,NaN,NaN
2335,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,03-08-2015,08:23,0,-1,-1,Hours,Body,Height,158,,cm,NaN,NaN,,NaN,NaN,NaN
2336,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,09:19,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2337,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,09:23,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2338,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,09:28,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,12.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2339,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,09:53,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,41.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2340,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,10:23,0,1,1,Hours,Concentration,Plasma concentration HS02,63.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2341,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,11:23,0,2,2,Hours,Concentration,Plasma concentration HS02,59,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2342,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,13:23,0,4,4,Hours,Concentration,Plasma concentration HS02,33.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2343,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,03-08-2015,17:23,0,8,8,Hours,Concentration,Plasma concentration HS02,16.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2344,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,04-08-2015,09:19,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,0.65,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2345,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,04-08-2015,09:23,0,24,24,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2346,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,4,VISIT 4,0,0,05-08-2015,09:23,0,48,48,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2347,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,5,VISIT 5,0,0,06-08-2015,09:23,0,72,72,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2348,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,07-08-2015,09:19,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,1.43,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2349,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,07-08-2015,09:23,0,96,96,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2350,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,7,VISIT 7,0,0,08-08-2015,09:23,0,120,120,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2351,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,8,VISIT 8,0,0,09-08-2015,09:23,0,144,144,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2352,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,9,VISIT 9,0,0,10-08-2015,09:23,0,168,168,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2353,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,11-08-2015,09:19,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,1.72,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2354,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,11-08-2015,09:23,0,192,192,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2355,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,11,VISIT 11,0,0,12-08-2015,09:23,0,216,216,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2356,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,12,VISIT 12,0,0,13-08-2015,09:23,0,240,240,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2357,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,13,VISIT 13,0,0,14-08-2015,09:23,0,264,264,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2358,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,15-08-2015,09:19,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,2.85,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2359,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,15-08-2015,09:23,0,288,288,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2360,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,15,VISIT 15,0,0,16-08-2015,09:23,0,312,312,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2361,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,16,VISIT 16,0,0,17-08-2015,09:23,0,336,336,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2362,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,17,VISIT 17,0,0,18-08-2015,09:23,0,360,360,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2363,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,19-08-2015,09:19,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,2.71,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2364,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,19-08-2015,09:23,0,384,384,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2365,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,19,VISIT 19,0,0,20-08-2015,09:23,0,408,408,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2366,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,20,VISIT 20,0,0,21-08-2015,09:23,0,432,432,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2367,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,21,VISIT 21,0,0,22-08-2015,09:23,0,456,456,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2368,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,09:19,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,2.68,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2369,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,09:23,0,480,480,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2370,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,09:28,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,14.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2371,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,09:53,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,52.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2372,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,10:23,0,481,481,Hours,Concentration,Plasma concentration HS02,66,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2373,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,11:23,0,482,482,Hours,Concentration,Plasma concentration HS02,50.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2374,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,13:23,0,484,484,Hours,Concentration,Plasma concentration HS02,41.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2375,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,23-08-2015,17:23,0,488,488,Hours,Concentration,Plasma concentration HS02,17.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2376,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,24-08-2015,09:19,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,3.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2377,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,24-08-2015,09:23,0,504,504,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2378,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,24,VISIT 24,0,0,25-08-2015,09:23,0,528,528,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2379,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,25,VISIT 25,0,0,26-08-2015,09:23,0,552,552,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2380,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,26,VISIT 26,0,0,27-08-2015,09:23,0,576,576,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2381,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,28-08-2015,09:19,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,2.97,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2382,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,28-08-2015,09:23,0,600,600,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2383,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,28,VISIT 28,0,0,29-08-2015,09:23,0,624,624,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2384,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,29,VISIT 29,0,0,30-08-2015,09:23,0,648,648,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2385,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,30,VISIT 30,0,0,01-09-2015,09:23,0,696,696,Hours,Concentration,Plasma concentration HS02,2.94,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2386,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,31,VISIT 31,0,0,05-09-2015,09:23,0,792,792,Hours,Concentration,Plasma concentration HS02,2.21,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2387,,X3402_0105_0227,HS02,X3402,MAD Study in Male HVs,1,0,105,227,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,32,VISIT 32,0,0,12-09-2015,09:23,0,960,960,Hours,Concentration,Plasma concentration HS02,1.58,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2388,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,09-08-2015,09:17,0,-168,-168.133,Hours,Demographics,Age,50,,Years,NaN,NaN,,NaN,NaN,NaN
2389,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,09-08-2015,09:17,0,-168,-168.133,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2390,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,16-08-2015,08:24,0,-1,-1,Hours,Body,BMI,21.71,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2391,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,16-08-2015,08:24,0,-1,-1,Hours,Body,Bodyweight,62,,kg,NaN,NaN,,NaN,NaN,NaN
2392,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,16-08-2015,08:24,0,-1,-1,Hours,Body,Height,169,,cm,NaN,NaN,,NaN,NaN,NaN
2393,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,09:20,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2394,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,09:24,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2395,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,09:29,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,19.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2396,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,09:54,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,76.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2397,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,10:24,0,1,1,Hours,Concentration,Plasma concentration HS02,57.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2398,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,11:24,0,2,2,Hours,Concentration,Plasma concentration HS02,47.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2399,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,13:24,0,4,4,Hours,Concentration,Plasma concentration HS02,16.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2400,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,16-08-2015,17:24,0,8,8,Hours,Concentration,Plasma concentration HS02,2.01,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2401,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,17-08-2015,09:20,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2402,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,17-08-2015,09:24,0,24,24,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2403,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,4,VISIT 4,0,0,18-08-2015,09:24,0,48,48,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2404,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,5,VISIT 5,0,0,19-08-2015,09:24,0,72,72,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2405,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,20-08-2015,09:20,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,1.43,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2406,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,20-08-2015,09:24,0,96,96,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2407,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,7,VISIT 7,0,0,21-08-2015,09:24,0,120,120,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2408,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,8,VISIT 8,0,0,22-08-2015,09:24,0,144,144,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2409,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,9,VISIT 9,0,0,23-08-2015,09:24,0,168,168,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2410,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,24-08-2015,09:20,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,0.68,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2411,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,24-08-2015,09:24,0,192,192,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2412,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,11,VISIT 11,0,0,25-08-2015,09:24,0,216,216,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2413,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,12,VISIT 12,0,0,26-08-2015,09:24,0,240,240,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2414,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,13,VISIT 13,0,0,27-08-2015,09:24,0,264,264,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2415,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,28-08-2015,09:20,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,2.33,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2416,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,28-08-2015,09:24,0,288,288,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2417,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,15,VISIT 15,0,0,29-08-2015,09:24,0,312,312,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2418,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,16,VISIT 16,0,0,30-08-2015,09:24,0,336,336,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2419,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,17,VISIT 17,0,0,31-08-2015,09:24,0,360,360,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2420,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,01-09-2015,09:20,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,2.07,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2421,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,01-09-2015,09:24,0,384,384,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2422,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,19,VISIT 19,0,0,02-09-2015,09:24,0,408,408,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2423,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,20,VISIT 20,0,0,03-09-2015,09:24,0,432,432,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2424,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,21,VISIT 21,0,0,04-09-2015,09:24,0,456,456,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2425,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,09:20,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,1.29,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2426,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,09:24,0,480,480,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2427,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,09:29,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,23.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2428,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,09:54,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,73.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2429,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,10:24,0,481,481,Hours,Concentration,Plasma concentration HS02,50.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2430,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,11:24,0,482,482,Hours,Concentration,Plasma concentration HS02,44.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2431,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,13:24,0,484,484,Hours,Concentration,Plasma concentration HS02,14.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2432,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,05-09-2015,17:24,0,488,488,Hours,Concentration,Plasma concentration HS02,3.87,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2433,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,06-09-2015,09:20,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,2.08,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2434,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,06-09-2015,09:24,0,504,504,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2435,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,24,VISIT 24,0,0,07-09-2015,09:24,0,528,528,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2436,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,25,VISIT 25,0,0,08-09-2015,09:24,0,552,552,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2437,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,26,VISIT 26,0,0,09-09-2015,09:24,0,576,576,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2438,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,10-09-2015,09:20,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,1.62,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2439,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,10-09-2015,09:24,0,600,600,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2440,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,28,VISIT 28,0,0,11-09-2015,09:24,0,624,624,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2441,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,29,VISIT 29,0,0,12-09-2015,09:24,0,648,648,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2442,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,30,VISIT 30,0,0,14-09-2015,09:24,0,696,696,Hours,Concentration,Plasma concentration HS02,1.38,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2443,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,31,VISIT 31,0,0,18-09-2015,09:24,0,792,792,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2444,,X3402_0105_0228,HS02,X3402,MAD Study in Male HVs,1,0,105,228,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,32,VISIT 32,0,0,25-09-2015,09:24,0,960,960,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2445,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,28-08-2015,09:54,0,-168,-167.8163333,Hours,Demographics,Age,45,,Years,NaN,NaN,,NaN,NaN,NaN
2446,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,28-08-2015,09:54,0,-168,-167.8163333,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2447,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:42,0,-1,-1,Hours,Body,BMI,26.72,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2448,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:42,0,-1,-1,Hours,Body,Bodyweight,71,,kg,NaN,NaN,,NaN,NaN,NaN
2449,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:42,0,-1,-1,Hours,Body,Height,163,,cm,NaN,NaN,,NaN,NaN,NaN
2450,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:38,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2451,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:42,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2452,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:47,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,14.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2453,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:12,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,32.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2454,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:42,0,1,1,Hours,Concentration,Plasma concentration HS02,42.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2455,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,11:42,0,2,2,Hours,Concentration,Plasma concentration HS02,31.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2456,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,13:42,0,4,4,Hours,Concentration,Plasma concentration HS02,14.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2457,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,17:42,0,8,8,Hours,Concentration,Plasma concentration HS02,2.06,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2458,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,05-09-2015,09:38,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2459,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,05-09-2015,09:42,0,24,24,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2460,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,4,VISIT 4,0,0,06-09-2015,09:42,0,48,48,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2461,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,5,VISIT 5,0,0,07-09-2015,09:42,0,72,72,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2462,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,08-09-2015,09:38,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,1.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2463,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,08-09-2015,09:42,0,96,96,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2464,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,7,VISIT 7,0,0,09-09-2015,09:42,0,120,120,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2465,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,8,VISIT 8,0,0,10-09-2015,09:42,0,144,144,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2466,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,9,VISIT 9,0,0,11-09-2015,09:42,0,168,168,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2467,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,12-09-2015,09:38,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,0.96,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2468,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,12-09-2015,09:42,0,192,192,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2469,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,11,VISIT 11,0,0,13-09-2015,09:42,0,216,216,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2470,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,12,VISIT 12,0,0,14-09-2015,09:42,0,240,240,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2471,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,13,VISIT 13,0,0,15-09-2015,09:42,0,264,264,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2472,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,16-09-2015,09:38,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,1.41,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2473,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,16-09-2015,09:42,0,288,288,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2474,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,15,VISIT 15,0,0,17-09-2015,09:42,0,312,312,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2475,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,16,VISIT 16,0,0,18-09-2015,09:42,0,336,336,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2476,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,17,VISIT 17,0,0,19-09-2015,09:42,0,360,360,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2477,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,20-09-2015,09:38,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,1.64,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2478,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,20-09-2015,09:42,0,384,384,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2479,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,19,VISIT 19,0,0,21-09-2015,09:42,0,408,408,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2480,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,20,VISIT 20,0,0,22-09-2015,09:42,0,432,432,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2481,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,21,VISIT 21,0,0,23-09-2015,09:42,0,456,456,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2482,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,09:38,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,1.42,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2483,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,09:42,0,480,480,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2484,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,09:47,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,10.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2485,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,10:12,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,43.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2486,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,10:42,0,481,481,Hours,Concentration,Plasma concentration HS02,46.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2487,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,11:42,0,482,482,Hours,Concentration,Plasma concentration HS02,37.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2488,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,13:42,0,484,484,Hours,Concentration,Plasma concentration HS02,12.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2489,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,17:42,0,488,488,Hours,Concentration,Plasma concentration HS02,3.42,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2490,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,25-09-2015,09:38,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,1.13,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2491,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,25-09-2015,09:42,0,504,504,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2492,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,24,VISIT 24,0,0,26-09-2015,09:42,0,528,528,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2493,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,25,VISIT 25,0,0,27-09-2015,09:42,0,552,552,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2494,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,26,VISIT 26,0,0,28-09-2015,09:42,0,576,576,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2495,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,29-09-2015,09:38,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,0.78,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2496,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,29-09-2015,09:42,0,600,600,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2497,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,28,VISIT 28,0,0,30-09-2015,09:42,0,624,624,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2498,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,29,VISIT 29,0,0,01-Oct-2015,09:42,0,648,648,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2499,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,30,VISIT 30,0,0,03-Oct-2015,09:42,0,696,696,Hours,Concentration,Plasma concentration HS02,0.95,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2500,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,31,VISIT 31,0,0,07-Oct-2015,09:42,0,792,792,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2501,,X3402_0105_0229,HS02,X3402,MAD Study in Male HVs,1,0,105,229,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,32,VISIT 32,0,0,14-Oct-2015,09:42,0,960,960,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2502,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,20-08-2015,09:43,0,-168,-167.6163333,Hours,Demographics,Age,42,,Years,NaN,NaN,,NaN,NaN,NaN
2503,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,20-08-2015,09:43,0,-168,-167.6163333,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2504,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,27-08-2015,08:19,0,-1,-1,Hours,Body,BMI,25.04,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2505,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,27-08-2015,08:19,0,-1,-1,Hours,Body,Bodyweight,69,,kg,NaN,NaN,,NaN,NaN,NaN
2506,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,27-08-2015,08:19,0,-1,-1,Hours,Body,Height,166,,cm,NaN,NaN,,NaN,NaN,NaN
2507,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,09:15,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2508,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,09:19,0,0,0,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2509,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,09:24,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,12.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2510,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,09:49,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,43.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2511,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,10:19,0,1,1,Hours,Concentration,Plasma concentration HS02,38.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2512,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,11:19,0,2,2,Hours,Concentration,Plasma concentration HS02,33.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2513,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,13:19,0,4,4,Hours,Concentration,Plasma concentration HS02,8.25,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2514,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,27-08-2015,17:19,0,8,8,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2515,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,28-08-2015,09:15,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2516,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,3,VISIT 3,0,0,28-08-2015,09:19,0,24,24,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2517,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,4,VISIT 4,0,0,29-08-2015,09:19,0,48,48,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2518,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,5,VISIT 5,0,0,30-08-2015,09:19,0,72,72,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2519,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,31-08-2015,09:15,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,0.66,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2520,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,6,VISIT 6,0,0,31-08-2015,09:19,0,96,96,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2521,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,7,VISIT 7,0,0,01-09-2015,09:19,0,120,120,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2522,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,8,VISIT 8,0,0,02-09-2015,09:19,0,144,144,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2523,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,9,VISIT 9,0,0,03-09-2015,09:19,0,168,168,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2524,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,04-09-2015,09:15,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,1.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2525,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,10,VISIT 10,0,0,04-09-2015,09:19,0,192,192,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2526,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,11,VISIT 11,0,0,05-09-2015,09:19,0,216,216,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2527,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,12,VISIT 12,0,0,06-09-2015,09:19,0,240,240,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2528,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,13,VISIT 13,0,0,07-09-2015,09:19,0,264,264,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2529,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,08-09-2015,09:15,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2530,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,14,VISIT 14,0,0,08-09-2015,09:19,0,288,288,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2531,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,15,VISIT 15,0,0,09-09-2015,09:19,0,312,312,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2532,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,16,VISIT 16,0,0,10-09-2015,09:19,0,336,336,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2533,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,17,VISIT 17,0,0,11-09-2015,09:19,0,360,360,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2534,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,12-09-2015,09:15,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,1.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2535,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,18,VISIT 18,0,0,12-09-2015,09:19,0,384,384,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2536,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,19,VISIT 19,0,0,13-09-2015,09:19,0,408,408,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2537,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,20,VISIT 20,0,0,14-09-2015,09:19,0,432,432,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2538,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,21,VISIT 21,0,0,15-09-2015,09:19,0,456,456,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2539,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,16-09-2015,09:15,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,1.18,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2540,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,16-09-2015,09:19,0,480,480,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2541,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,16-09-2015,09:24,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,15.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2542,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,16-09-2015,09:49,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,51,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2543,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,16-09-2015,10:19,0,481,481,Hours,Concentration,Plasma concentration HS02,58.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2544,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,16-09-2015,11:19,0,482,482,Hours,Concentration,Plasma concentration HS02,26.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2545,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,16-09-2015,13:19,0,484,484,Hours,Concentration,Plasma concentration HS02,8.34,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2546,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,22,VISIT 22,0,0,16-09-2015,17:19,0,488,488,Hours,Concentration,Plasma concentration HS02,1.57,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2547,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,17-09-2015,09:15,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,0.59,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2548,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,23,VISIT 23,0,0,17-09-2015,09:19,0,504,504,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2549,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,24,VISIT 24,0,0,18-09-2015,09:19,0,528,528,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2550,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,25,VISIT 25,0,0,19-09-2015,09:19,0,552,552,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2551,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,26,VISIT 26,0,0,20-09-2015,09:19,0,576,576,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2552,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,21-09-2015,09:15,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2553,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,27,VISIT 27,0,0,21-09-2015,09:19,0,600,600,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2554,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,28,VISIT 28,0,0,22-09-2015,09:19,0,624,624,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2555,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,29,VISIT 29,0,0,23-09-2015,09:19,0,648,648,Hours,Dose,Dose HS02,20000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2556,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,30,VISIT 30,0,0,25-09-2015,09:19,0,696,696,Hours,Concentration,Plasma concentration HS02,1.03,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2557,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,31,VISIT 31,0,0,29-09-2015,09:19,0,792,792,Hours,Concentration,Plasma concentration HS02,0.81,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2558,,X3402_0105_0230,HS02,X3402,MAD Study in Male HVs,1,0,105,230,Healthy Volunteers,20mg oral daily dosing for 28 days,20mg oral daily dosing for 28 days,32,VISIT 32,0,0,06-Oct-2015,09:19,0,960,960,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2559,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,23-08-2015,09:02,0,-168,-168.8663333,Hours,Demographics,Age,38,,Years,NaN,NaN,,NaN,NaN,NaN
2560,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,23-08-2015,09:02,0,-168,-168.8663333,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2561,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,30-08-2015,08:53,0,-1,-1,Hours,Body,BMI,24.75,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2562,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,30-08-2015,08:53,0,-1,-1,Hours,Body,Bodyweight,61,,kg,NaN,NaN,,NaN,NaN,NaN
2563,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,30-08-2015,08:53,0,-1,-1,Hours,Body,Height,157,,cm,NaN,NaN,,NaN,NaN,NaN
2564,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,09:49,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2565,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,09:53,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2566,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,09:58,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,22.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2567,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,10:23,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,105,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2568,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,10:53,0,1,1,Hours,Concentration,Plasma concentration HS02,138,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2569,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,11:53,0,2,2,Hours,Concentration,Plasma concentration HS02,89.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2570,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,13:53,0,4,4,Hours,Concentration,Plasma concentration HS02,45,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2571,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,30-08-2015,17:53,0,8,8,Hours,Concentration,Plasma concentration HS02,6.54,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2572,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,31-08-2015,09:49,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,2.17,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2573,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,31-08-2015,09:53,0,24,24,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2574,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,4,VISIT 4,0,0,01-09-2015,09:53,0,48,48,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2575,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,5,VISIT 5,0,0,02-09-2015,09:53,0,72,72,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2576,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,03-09-2015,09:49,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,4.73,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2577,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,03-09-2015,09:53,0,96,96,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2578,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,7,VISIT 7,0,0,04-09-2015,09:53,0,120,120,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2579,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,8,VISIT 8,0,0,05-09-2015,09:53,0,144,144,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2580,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,9,VISIT 9,0,0,06-09-2015,09:53,0,168,168,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2581,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,07-09-2015,09:49,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,6.46,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2582,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,07-09-2015,09:53,0,192,192,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2583,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,11,VISIT 11,0,0,08-09-2015,09:53,0,216,216,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2584,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,12,VISIT 12,0,0,09-09-2015,09:53,0,240,240,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2585,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,13,VISIT 13,0,0,10-09-2015,09:53,0,264,264,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2586,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,11-09-2015,09:49,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,6.31,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2587,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,11-09-2015,09:53,0,288,288,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2588,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,15,VISIT 15,0,0,12-09-2015,09:53,0,312,312,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2589,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,16,VISIT 16,0,0,13-09-2015,09:53,0,336,336,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2590,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,17,VISIT 17,0,0,14-09-2015,09:53,0,360,360,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2591,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,15-09-2015,09:49,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,5.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2592,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,15-09-2015,09:53,0,384,384,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2593,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,19,VISIT 19,0,0,16-09-2015,09:53,0,408,408,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2594,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,20,VISIT 20,0,0,17-09-2015,09:53,0,432,432,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2595,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,21,VISIT 21,0,0,18-09-2015,09:53,0,456,456,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2596,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,09:49,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,5.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2597,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,09:53,0,480,480,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2598,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,09:58,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,43.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2599,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,10:23,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,109,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2600,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,10:53,0,481,481,Hours,Concentration,Plasma concentration HS02,154,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2601,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,11:53,0,482,482,Hours,Concentration,Plasma concentration HS02,133,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2602,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,13:53,0,484,484,Hours,Concentration,Plasma concentration HS02,42.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2603,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,19-09-2015,17:53,0,488,488,Hours,Concentration,Plasma concentration HS02,12.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2604,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,20-09-2015,09:49,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,8.16,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2605,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,20-09-2015,09:53,0,504,504,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2606,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,24,VISIT 24,0,0,21-09-2015,09:53,0,528,528,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2607,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,25,VISIT 25,0,0,22-09-2015,09:53,0,552,552,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2608,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,26,VISIT 26,0,0,23-09-2015,09:53,0,576,576,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2609,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,24-09-2015,09:49,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,5.04,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2610,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,24-09-2015,09:53,0,600,600,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2611,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,28,VISIT 28,0,0,25-09-2015,09:53,0,624,624,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2612,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,29,VISIT 29,0,0,26-09-2015,09:53,0,648,648,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2613,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,30,VISIT 30,0,0,28-09-2015,09:53,0,696,696,Hours,Concentration,Plasma concentration HS02,3.48,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2614,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,31,VISIT 31,0,0,02-Oct-2015,09:53,0,792,792,Hours,Concentration,Plasma concentration HS02,1.22,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2615,,X3402_0105_0231,HS02,X3402,MAD Study in Male HVs,1,0,105,231,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,32,VISIT 32,0,0,09-Oct-2015,09:53,0,960,960,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2616,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,10-08-2015,09:31,0,-168,-168.1663333,Hours,Demographics,Age,38,,Years,NaN,NaN,,NaN,NaN,NaN
2617,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,10-08-2015,09:31,0,-168,-168.1663333,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2618,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,17-08-2015,08:40,0,-1,-1,Hours,Body,BMI,27.48,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2619,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,17-08-2015,08:40,0,-1,-1,Hours,Body,Bodyweight,73,,kg,NaN,NaN,,NaN,NaN,NaN
2620,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,17-08-2015,08:40,0,-1,-1,Hours,Body,Height,163,,cm,NaN,NaN,,NaN,NaN,NaN
2621,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,09:36,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2622,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,09:40,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2623,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,09:45,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,13.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2624,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,10:10,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,54.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2625,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,10:40,0,1,1,Hours,Concentration,Plasma concentration HS02,62.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2626,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,11:40,0,2,2,Hours,Concentration,Plasma concentration HS02,78.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2627,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,13:40,0,4,4,Hours,Concentration,Plasma concentration HS02,53.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2628,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,17:40,0,8,8,Hours,Concentration,Plasma concentration HS02,16.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2629,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,18-08-2015,09:36,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2630,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,18-08-2015,09:40,0,24,24,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2631,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,4,VISIT 4,0,0,19-08-2015,09:40,0,48,48,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2632,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,5,VISIT 5,0,0,20-08-2015,09:40,0,72,72,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2633,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,21-08-2015,09:36,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,0.92,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2634,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,21-08-2015,09:40,0,96,96,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2635,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,7,VISIT 7,0,0,22-08-2015,09:40,0,120,120,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2636,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,8,VISIT 8,0,0,23-08-2015,09:40,0,144,144,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2637,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,9,VISIT 9,0,0,24-08-2015,09:40,0,168,168,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2638,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,25-08-2015,09:36,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,1.22,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2639,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,25-08-2015,09:40,0,192,192,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2640,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,11,VISIT 11,0,0,26-08-2015,09:40,0,216,216,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2641,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,12,VISIT 12,0,0,27-08-2015,09:40,0,240,240,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2642,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,13,VISIT 13,0,0,28-08-2015,09:40,0,264,264,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2643,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,29-08-2015,09:36,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,1.88,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2644,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,29-08-2015,09:40,0,288,288,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2645,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,15,VISIT 15,0,0,30-08-2015,09:40,0,312,312,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2646,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,16,VISIT 16,0,0,31-08-2015,09:40,0,336,336,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2647,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,17,VISIT 17,0,0,01-09-2015,09:40,0,360,360,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2648,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,02-09-2015,09:36,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,2.18,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2649,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,02-09-2015,09:40,0,384,384,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2650,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,19,VISIT 19,0,0,03-09-2015,09:40,0,408,408,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2651,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,20,VISIT 20,0,0,04-09-2015,09:40,0,432,432,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2652,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,21,VISIT 21,0,0,05-09-2015,09:40,0,456,456,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2653,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,09:36,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,2.62,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2654,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,09:40,0,480,480,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2655,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,09:45,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,12.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2656,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,10:10,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,66.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2657,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,10:40,0,481,481,Hours,Concentration,Plasma concentration HS02,75.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2658,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,11:40,0,482,482,Hours,Concentration,Plasma concentration HS02,69.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2659,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,13:40,0,484,484,Hours,Concentration,Plasma concentration HS02,48.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2660,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,17:40,0,488,488,Hours,Concentration,Plasma concentration HS02,16.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2661,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,07-09-2015,09:36,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,2.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2662,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,07-09-2015,09:40,0,504,504,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2663,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,24,VISIT 24,0,0,08-09-2015,09:40,0,528,528,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2664,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,25,VISIT 25,0,0,09-09-2015,09:40,0,552,552,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2665,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,26,VISIT 26,0,0,10-09-2015,09:40,0,576,576,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2666,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,11-09-2015,09:36,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,2.28,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2667,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,11-09-2015,09:40,0,600,600,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2668,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,28,VISIT 28,0,0,12-09-2015,09:40,0,624,624,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2669,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,29,VISIT 29,0,0,13-09-2015,09:40,0,648,648,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2670,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,30,VISIT 30,0,0,15-09-2015,09:40,0,696,696,Hours,Concentration,Plasma concentration HS02,1.47,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2671,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,31,VISIT 31,0,0,19-09-2015,09:40,0,792,792,Hours,Concentration,Plasma concentration HS02,1.33,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2672,,X3402_0105_0232,HS02,X3402,MAD Study in Male HVs,1,0,105,232,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,32,VISIT 32,0,0,26-09-2015,09:40,0,960,960,Hours,Concentration,Plasma concentration HS02,1.15,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2673,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,14-08-2015,09:20,0,-168,-167.983,Hours,Demographics,Age,42,,Years,NaN,NaN,,NaN,NaN,NaN
2674,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,14-08-2015,09:20,0,-168,-167.983,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2675,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,21-08-2015,08:18,0,-1,-1,Hours,Body,BMI,24.22,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2676,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,21-08-2015,08:18,0,-1,-1,Hours,Body,Bodyweight,62,,kg,NaN,NaN,,NaN,NaN,NaN
2677,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,21-08-2015,08:18,0,-1,-1,Hours,Body,Height,160,,cm,NaN,NaN,,NaN,NaN,NaN
2678,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,09:14,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2679,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,09:18,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2680,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,09:23,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,40.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2681,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,09:48,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,139,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2682,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,10:18,0,1,1,Hours,Concentration,Plasma concentration HS02,186,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2683,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,11:18,0,2,2,Hours,Concentration,Plasma concentration HS02,148,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2684,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,13:18,0,4,4,Hours,Concentration,Plasma concentration HS02,54.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2685,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,21-08-2015,17:18,0,8,8,Hours,Concentration,Plasma concentration HS02,11.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2686,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,22-08-2015,09:14,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,1.68,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2687,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,22-08-2015,09:18,0,24,24,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2688,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,4,VISIT 4,0,0,23-08-2015,09:18,0,48,48,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2689,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,5,VISIT 5,0,0,24-08-2015,09:18,0,72,72,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2690,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,25-08-2015,09:14,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,3.87,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2691,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,25-08-2015,09:18,0,96,96,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2692,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,7,VISIT 7,0,0,26-08-2015,09:18,0,120,120,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2693,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,8,VISIT 8,0,0,27-08-2015,09:18,0,144,144,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2694,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,9,VISIT 9,0,0,28-08-2015,09:18,0,168,168,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2695,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,29-08-2015,09:14,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,5.93,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2696,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,29-08-2015,09:18,0,192,192,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2697,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,11,VISIT 11,0,0,30-08-2015,09:18,0,216,216,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2698,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,12,VISIT 12,0,0,31-08-2015,09:18,0,240,240,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2699,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,13,VISIT 13,0,0,01-09-2015,09:18,0,264,264,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2700,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,02-09-2015,09:14,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,5.77,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2701,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,02-09-2015,09:18,0,288,288,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2702,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,15,VISIT 15,0,0,03-09-2015,09:18,0,312,312,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2703,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,16,VISIT 16,0,0,04-09-2015,09:18,0,336,336,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2704,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,17,VISIT 17,0,0,05-09-2015,09:18,0,360,360,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2705,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,06-09-2015,09:14,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,5.52,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2706,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,06-09-2015,09:18,0,384,384,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2707,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,19,VISIT 19,0,0,07-09-2015,09:18,0,408,408,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2708,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,20,VISIT 20,0,0,08-09-2015,09:18,0,432,432,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2709,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,21,VISIT 21,0,0,09-09-2015,09:18,0,456,456,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2710,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,10-09-2015,09:14,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,7.22,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2711,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,10-09-2015,09:18,0,480,480,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2712,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,10-09-2015,09:23,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,40.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2713,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,10-09-2015,09:48,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,124,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2714,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,10-09-2015,10:18,0,481,481,Hours,Concentration,Plasma concentration HS02,152,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2715,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,10-09-2015,11:18,0,482,482,Hours,Concentration,Plasma concentration HS02,146,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2716,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,10-09-2015,13:18,0,484,484,Hours,Concentration,Plasma concentration HS02,75.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2717,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,10-09-2015,17:18,0,488,488,Hours,Concentration,Plasma concentration HS02,18.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2718,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,11-09-2015,09:14,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,8.28,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2719,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,11-09-2015,09:18,0,504,504,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2720,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,24,VISIT 24,0,0,12-09-2015,09:18,0,528,528,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2721,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,25,VISIT 25,0,0,13-09-2015,09:18,0,552,552,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2722,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,26,VISIT 26,0,0,14-09-2015,09:18,0,576,576,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2723,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,15-09-2015,09:14,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,6.39,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2724,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,15-09-2015,09:18,0,600,600,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2725,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,28,VISIT 28,0,0,16-09-2015,09:18,0,624,624,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2726,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,29,VISIT 29,0,0,17-09-2015,09:18,0,648,648,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2727,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,30,VISIT 30,0,0,19-09-2015,09:18,0,696,696,Hours,Concentration,Plasma concentration HS02,6.15,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2728,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,31,VISIT 31,0,0,23-09-2015,09:18,0,792,792,Hours,Concentration,Plasma concentration HS02,2.36,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2729,,X3402_0105_0233,HS02,X3402,MAD Study in Male HVs,1,0,105,233,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,32,VISIT 32,0,0,30-09-2015,09:18,0,960,960,Hours,Concentration,Plasma concentration HS02,0.87,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2730,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,17-08-2015,09:07,0,-168,-168.183,Hours,Demographics,Age,47,,Years,NaN,NaN,,NaN,NaN,NaN
2731,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,17-08-2015,09:07,0,-168,-168.183,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2732,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,24-08-2015,08:17,0,-1,-1,Hours,Body,BMI,21.22,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2733,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,24-08-2015,08:17,0,-1,-1,Hours,Body,Bodyweight,55,,kg,NaN,NaN,,NaN,NaN,NaN
2734,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,24-08-2015,08:17,0,-1,-1,Hours,Body,Height,161,,cm,NaN,NaN,,NaN,NaN,NaN
2735,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,09:13,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2736,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,09:17,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2737,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,09:22,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,40.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2738,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,09:47,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,190,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2739,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,10:17,0,1,1,Hours,Concentration,Plasma concentration HS02,172,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2740,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,11:17,0,2,2,Hours,Concentration,Plasma concentration HS02,121,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2741,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,13:17,0,4,4,Hours,Concentration,Plasma concentration HS02,51,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2742,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,24-08-2015,17:17,0,8,8,Hours,Concentration,Plasma concentration HS02,6.58,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2743,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,25-08-2015,09:13,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,0.92,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2744,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,25-08-2015,09:17,0,24,24,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2745,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,4,VISIT 4,0,0,26-08-2015,09:17,0,48,48,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2746,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,5,VISIT 5,0,0,27-08-2015,09:17,0,72,72,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2747,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,28-08-2015,09:13,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,2.98,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2748,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,28-08-2015,09:17,0,96,96,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2749,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,7,VISIT 7,0,0,29-08-2015,09:17,0,120,120,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2750,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,8,VISIT 8,0,0,30-08-2015,09:17,0,144,144,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2751,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,9,VISIT 9,0,0,31-08-2015,09:17,0,168,168,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2752,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,01-09-2015,09:13,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,4.88,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2753,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,01-09-2015,09:17,0,192,192,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2754,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,11,VISIT 11,0,0,02-09-2015,09:17,0,216,216,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2755,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,12,VISIT 12,0,0,03-09-2015,09:17,0,240,240,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2756,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,13,VISIT 13,0,0,04-09-2015,09:17,0,264,264,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2757,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,05-09-2015,09:13,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,5.52,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2758,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,05-09-2015,09:17,0,288,288,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2759,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,15,VISIT 15,0,0,06-09-2015,09:17,0,312,312,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2760,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,16,VISIT 16,0,0,07-09-2015,09:17,0,336,336,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2761,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,17,VISIT 17,0,0,08-09-2015,09:17,0,360,360,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2762,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,09-09-2015,09:13,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,7.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2763,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,09-09-2015,09:17,0,384,384,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2764,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,19,VISIT 19,0,0,10-09-2015,09:17,0,408,408,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2765,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,20,VISIT 20,0,0,11-09-2015,09:17,0,432,432,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2766,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,21,VISIT 21,0,0,12-09-2015,09:17,0,456,456,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2767,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,09:13,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,6.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2768,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,09:17,0,480,480,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2769,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,09:22,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,56.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2770,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,09:47,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,183,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2771,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,10:17,0,481,481,Hours,Concentration,Plasma concentration HS02,181,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2772,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,11:17,0,482,482,Hours,Concentration,Plasma concentration HS02,149,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2773,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,13:17,0,484,484,Hours,Concentration,Plasma concentration HS02,50.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2774,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,13-09-2015,17:17,0,488,488,Hours,Concentration,Plasma concentration HS02,9.71,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2775,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,14-09-2015,09:13,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,6.51,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2776,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,14-09-2015,09:17,0,504,504,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2777,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,24,VISIT 24,0,0,15-09-2015,09:17,0,528,528,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2778,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,25,VISIT 25,0,0,16-09-2015,09:17,0,552,552,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2779,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,26,VISIT 26,0,0,17-09-2015,09:17,0,576,576,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2780,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,18-09-2015,09:13,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,6.19,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2781,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,18-09-2015,09:17,0,600,600,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2782,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,28,VISIT 28,0,0,19-09-2015,09:17,0,624,624,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2783,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,29,VISIT 29,0,0,20-09-2015,09:17,0,648,648,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2784,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,30,VISIT 30,0,0,22-09-2015,09:17,0,696,696,Hours,Concentration,Plasma concentration HS02,5.51,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2785,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,31,VISIT 31,0,0,26-09-2015,09:17,0,792,792,Hours,Concentration,Plasma concentration HS02,3.95,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2786,,X3402_0105_0234,HS02,X3402,MAD Study in Male HVs,1,0,105,234,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,32,VISIT 32,0,0,03-Oct-2015,09:17,0,960,960,Hours,Concentration,Plasma concentration HS02,1.23,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2787,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,10-08-2015,09:33,0,-168,-168.483,Hours,Demographics,Age,55,,Years,NaN,NaN,,NaN,NaN,NaN
2788,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,10-08-2015,09:33,0,-168,-168.483,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2789,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,17-08-2015,09:01,0,-1,-1,Hours,Body,BMI,21.36,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2790,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,17-08-2015,09:01,0,-1,-1,Hours,Body,Bodyweight,54,,kg,NaN,NaN,,NaN,NaN,NaN
2791,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,17-08-2015,09:01,0,-1,-1,Hours,Body,Height,159,,cm,NaN,NaN,,NaN,NaN,NaN
2792,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,09:57,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2793,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,10:01,0,0,0,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2794,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,10:06,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,38.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2795,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,10:31,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,142,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2796,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,11:01,0,1,1,Hours,Concentration,Plasma concentration HS02,120,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2797,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,12:01,0,2,2,Hours,Concentration,Plasma concentration HS02,74.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2798,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,14:01,0,4,4,Hours,Concentration,Plasma concentration HS02,17.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2799,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,17-08-2015,18:01,0,8,8,Hours,Concentration,Plasma concentration HS02,1.95,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2800,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,18-08-2015,09:57,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2801,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,3,VISIT 3,0,0,18-08-2015,10:01,0,24,24,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2802,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,4,VISIT 4,0,0,19-08-2015,10:01,0,48,48,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2803,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,5,VISIT 5,0,0,20-08-2015,10:01,0,72,72,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2804,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,21-08-2015,09:57,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,0.69,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2805,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,6,VISIT 6,0,0,21-08-2015,10:01,0,96,96,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2806,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,7,VISIT 7,0,0,22-08-2015,10:01,0,120,120,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2807,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,8,VISIT 8,0,0,23-08-2015,10:01,0,144,144,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2808,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,9,VISIT 9,0,0,24-08-2015,10:01,0,168,168,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2809,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,25-08-2015,09:57,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,0.54,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2810,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,10,VISIT 10,0,0,25-08-2015,10:01,0,192,192,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2811,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,11,VISIT 11,0,0,26-08-2015,10:01,0,216,216,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2812,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,12,VISIT 12,0,0,27-08-2015,10:01,0,240,240,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2813,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,13,VISIT 13,0,0,28-08-2015,10:01,0,264,264,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2814,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,29-08-2015,09:57,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,1.14,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2815,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,14,VISIT 14,0,0,29-08-2015,10:01,0,288,288,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2816,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,15,VISIT 15,0,0,30-08-2015,10:01,0,312,312,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2817,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,16,VISIT 16,0,0,31-08-2015,10:01,0,336,336,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2818,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,17,VISIT 17,0,0,01-09-2015,10:01,0,360,360,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2819,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,02-09-2015,09:57,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,0.92,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2820,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,18,VISIT 18,0,0,02-09-2015,10:01,0,384,384,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2821,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,19,VISIT 19,0,0,03-09-2015,10:01,0,408,408,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2822,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,20,VISIT 20,0,0,04-09-2015,10:01,0,432,432,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2823,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,21,VISIT 21,0,0,05-09-2015,10:01,0,456,456,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2824,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,09:57,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,1.82,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2825,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,10:01,0,480,480,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2826,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,10:06,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,38,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2827,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,10:31,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,103,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2828,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,11:01,0,481,481,Hours,Concentration,Plasma concentration HS02,114,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2829,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,12:01,0,482,482,Hours,Concentration,Plasma concentration HS02,77.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2830,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,14:01,0,484,484,Hours,Concentration,Plasma concentration HS02,17.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2831,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,22,VISIT 22,0,0,06-09-2015,18:01,0,488,488,Hours,Concentration,Plasma concentration HS02,2.69,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2832,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,07-09-2015,09:57,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,2.18,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2833,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,23,VISIT 23,0,0,07-09-2015,10:01,0,504,504,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2834,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,24,VISIT 24,0,0,08-09-2015,10:01,0,528,528,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2835,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,25,VISIT 25,0,0,09-09-2015,10:01,0,552,552,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2836,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,26,VISIT 26,0,0,10-09-2015,10:01,0,576,576,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2837,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,11-09-2015,09:57,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,1.86,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2838,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,27,VISIT 27,0,0,11-09-2015,10:01,0,600,600,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2839,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,28,VISIT 28,0,0,12-09-2015,10:01,0,624,624,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2840,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,29,VISIT 29,0,0,13-09-2015,10:01,0,648,648,Hours,Dose,Dose HS02,50000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2841,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,30,VISIT 30,0,0,15-09-2015,10:01,0,696,696,Hours,Concentration,Plasma concentration HS02,2.04,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2842,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,31,VISIT 31,0,0,19-09-2015,10:01,0,792,792,Hours,Concentration,Plasma concentration HS02,0.61,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2843,,X3402_0105_0235,HS02,X3402,MAD Study in Male HVs,1,0,105,235,Healthy Volunteers,50mg oral daily dosing for 28 days,50mg oral daily dosing for 28 days,32,VISIT 32,0,0,26-09-2015,10:01,0,960,960,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2844,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,01-08-2015,09:35,0,-168,-168.0163333,Hours,Demographics,Age,44,,Years,NaN,NaN,,NaN,NaN,NaN
2845,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,01-08-2015,09:35,0,-168,-168.0163333,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2846,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,08-08-2015,08:35,0,-1,-1,Hours,Body,BMI,22.14,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2847,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,08-08-2015,08:35,0,-1,-1,Hours,Body,Bodyweight,61,,kg,NaN,NaN,,NaN,NaN,NaN
2848,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,08-08-2015,08:35,0,-1,-1,Hours,Body,Height,166,,cm,NaN,NaN,,NaN,NaN,NaN
2849,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,09:31,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2850,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,09:35,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2851,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,09:40,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,87,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2852,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,10:05,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,357,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2853,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,10:35,0,1,1,Hours,Concentration,Plasma concentration HS02,427,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2854,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,11:35,0,2,2,Hours,Concentration,Plasma concentration HS02,294,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2855,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,13:35,0,4,4,Hours,Concentration,Plasma concentration HS02,108,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2856,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,17:35,0,8,8,Hours,Concentration,Plasma concentration HS02,11.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2857,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,09-08-2015,09:31,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,2.33,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2858,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,09-08-2015,09:35,0,24,24,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2859,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,4,VISIT 4,0,0,10-08-2015,09:35,0,48,48,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2860,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,5,VISIT 5,0,0,11-08-2015,09:35,0,72,72,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2861,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,12-08-2015,09:31,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,6.24,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2862,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,12-08-2015,09:35,0,96,96,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2863,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,7,VISIT 7,0,0,13-08-2015,09:35,0,120,120,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2864,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,8,VISIT 8,0,0,14-08-2015,09:35,0,144,144,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2865,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,9,VISIT 9,0,0,15-08-2015,09:35,0,168,168,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2866,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,16-08-2015,09:31,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,9.34,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2867,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,16-08-2015,09:35,0,192,192,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2868,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,11,VISIT 11,0,0,17-08-2015,09:35,0,216,216,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2869,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,12,VISIT 12,0,0,18-08-2015,09:35,0,240,240,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2870,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,13,VISIT 13,0,0,19-08-2015,09:35,0,264,264,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2871,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,20-08-2015,09:31,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,9.58,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2872,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,20-08-2015,09:35,0,288,288,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2873,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,15,VISIT 15,0,0,21-08-2015,09:35,0,312,312,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2874,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,16,VISIT 16,0,0,22-08-2015,09:35,0,336,336,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2875,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,17,VISIT 17,0,0,23-08-2015,09:35,0,360,360,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2876,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,24-08-2015,09:31,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,10.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2877,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,24-08-2015,09:35,0,384,384,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2878,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,19,VISIT 19,0,0,25-08-2015,09:35,0,408,408,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2879,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,20,VISIT 20,0,0,26-08-2015,09:35,0,432,432,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2880,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,21,VISIT 21,0,0,27-08-2015,09:35,0,456,456,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2881,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,09:31,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,11.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2882,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,09:35,0,480,480,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2883,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,09:40,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,121,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2884,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,10:05,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,356,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2885,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,10:35,0,481,481,Hours,Concentration,Plasma concentration HS02,419,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2886,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,11:35,0,482,482,Hours,Concentration,Plasma concentration HS02,361,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2887,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,13:35,0,484,484,Hours,Concentration,Plasma concentration HS02,91.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2888,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,17:35,0,488,488,Hours,Concentration,Plasma concentration HS02,19.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2889,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,29-08-2015,09:31,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,12,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2890,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,29-08-2015,09:35,0,504,504,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2891,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,24,VISIT 24,0,0,30-08-2015,09:35,0,528,528,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2892,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,25,VISIT 25,0,0,31-08-2015,09:35,0,552,552,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2893,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,26,VISIT 26,0,0,01-09-2015,09:35,0,576,576,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2894,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,02-09-2015,09:31,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,10.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2895,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,02-09-2015,09:35,0,600,600,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2896,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,28,VISIT 28,0,0,03-09-2015,09:35,0,624,624,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2897,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,29,VISIT 29,0,0,04-09-2015,09:35,0,648,648,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2898,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,30,VISIT 30,0,0,06-09-2015,09:35,0,696,696,Hours,Concentration,Plasma concentration HS02,11,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2899,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,31,VISIT 31,0,0,10-09-2015,09:35,0,792,792,Hours,Concentration,Plasma concentration HS02,3.71,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2900,,X3402_0105_0236,HS02,X3402,MAD Study in Male HVs,1,0,105,236,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,32,VISIT 32,0,0,17-09-2015,09:35,0,960,960,Hours,Concentration,Plasma concentration HS02,0.91,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2901,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,24-07-2015,09:27,0,-168,-168.283,Hours,Demographics,Age,51,,Years,NaN,NaN,,NaN,NaN,NaN
2902,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,24-07-2015,09:27,0,-168,-168.283,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2903,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,31-07-2015,08:43,0,-1,-1,Hours,Body,BMI,21.87,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2904,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,31-07-2015,08:43,0,-1,-1,Hours,Body,Bodyweight,56,,kg,NaN,NaN,,NaN,NaN,NaN
2905,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,31-07-2015,08:43,0,-1,-1,Hours,Body,Height,160,,cm,NaN,NaN,,NaN,NaN,NaN
2906,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-07-2015,09:39,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2907,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-07-2015,09:43,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2908,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-07-2015,09:48,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,79.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2909,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-07-2015,10:13,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,339,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2910,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-07-2015,10:43,0,1,1,Hours,Concentration,Plasma concentration HS02,425,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2911,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-07-2015,11:43,0,2,2,Hours,Concentration,Plasma concentration HS02,233,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2912,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-07-2015,13:43,0,4,4,Hours,Concentration,Plasma concentration HS02,76.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2913,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,31-07-2015,17:43,0,8,8,Hours,Concentration,Plasma concentration HS02,5.94,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2914,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,01-08-2015,09:39,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,1.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2915,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,01-08-2015,09:43,0,24,24,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2916,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,4,VISIT 4,0,0,02-08-2015,09:43,0,48,48,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2917,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,5,VISIT 5,0,0,03-08-2015,09:43,0,72,72,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2918,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,04-08-2015,09:39,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,6.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2919,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,04-08-2015,09:43,0,96,96,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2920,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,7,VISIT 7,0,0,05-08-2015,09:43,0,120,120,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2921,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,8,VISIT 8,0,0,06-08-2015,09:43,0,144,144,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2922,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,9,VISIT 9,0,0,07-08-2015,09:43,0,168,168,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2923,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,08-08-2015,09:39,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,9.04,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2924,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,08-08-2015,09:43,0,192,192,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2925,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,11,VISIT 11,0,0,09-08-2015,09:43,0,216,216,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2926,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,12,VISIT 12,0,0,10-08-2015,09:43,0,240,240,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2927,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,13,VISIT 13,0,0,11-08-2015,09:43,0,264,264,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2928,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,12-08-2015,09:39,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,9.18,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2929,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,12-08-2015,09:43,0,288,288,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2930,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,15,VISIT 15,0,0,13-08-2015,09:43,0,312,312,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2931,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,16,VISIT 16,0,0,14-08-2015,09:43,0,336,336,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2932,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,17,VISIT 17,0,0,15-08-2015,09:43,0,360,360,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2933,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,16-08-2015,09:39,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,9.38,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2934,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,16-08-2015,09:43,0,384,384,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2935,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,19,VISIT 19,0,0,17-08-2015,09:43,0,408,408,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2936,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,20,VISIT 20,0,0,18-08-2015,09:43,0,432,432,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2937,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,21,VISIT 21,0,0,19-08-2015,09:43,0,456,456,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2938,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-08-2015,09:39,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,9.36,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2939,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-08-2015,09:43,0,480,480,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2940,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-08-2015,09:48,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,124,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2941,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-08-2015,10:13,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,358,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2942,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-08-2015,10:43,0,481,481,Hours,Concentration,Plasma concentration HS02,381,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2943,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-08-2015,11:43,0,482,482,Hours,Concentration,Plasma concentration HS02,294,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2944,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-08-2015,13:43,0,484,484,Hours,Concentration,Plasma concentration HS02,66.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2945,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,20-08-2015,17:43,0,488,488,Hours,Concentration,Plasma concentration HS02,12.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2946,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,21-08-2015,09:39,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,10.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2947,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,21-08-2015,09:43,0,504,504,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2948,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,24,VISIT 24,0,0,22-08-2015,09:43,0,528,528,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2949,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,25,VISIT 25,0,0,23-08-2015,09:43,0,552,552,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2950,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,26,VISIT 26,0,0,24-08-2015,09:43,0,576,576,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2951,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,25-08-2015,09:39,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,9.63,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2952,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,25-08-2015,09:43,0,600,600,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2953,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,28,VISIT 28,0,0,26-08-2015,09:43,0,624,624,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2954,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,29,VISIT 29,0,0,27-08-2015,09:43,0,648,648,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2955,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,30,VISIT 30,0,0,29-08-2015,09:43,0,696,696,Hours,Concentration,Plasma concentration HS02,7.76,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2956,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,31,VISIT 31,0,0,02-09-2015,09:43,0,792,792,Hours,Concentration,Plasma concentration HS02,2.82,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2957,,X3402_0105_0237,HS02,X3402,MAD Study in Male HVs,1,0,105,237,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,32,VISIT 32,0,0,09-09-2015,09:43,0,960,960,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2958,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,28-08-2015,09:19,0,-168,-168.5663333,Hours,Demographics,Age,52,,Years,NaN,NaN,,NaN,NaN,NaN
2959,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,28-08-2015,09:19,0,-168,-168.5663333,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
2960,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:52,0,-1,-1,Hours,Body,BMI,19.26,,kg/m2,NaN,NaN,,NaN,NaN,NaN
2961,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:52,0,-1,-1,Hours,Body,Bodyweight,55,,kg,NaN,NaN,,NaN,NaN,NaN
2962,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,04-09-2015,08:52,0,-1,-1,Hours,Body,Height,169,,cm,NaN,NaN,,NaN,NaN,NaN
2963,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:48,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2964,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:52,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2965,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,09:57,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,79.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2966,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:22,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,217,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2967,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,10:52,0,1,1,Hours,Concentration,Plasma concentration HS02,252,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2968,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,11:52,0,2,2,Hours,Concentration,Plasma concentration HS02,210,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2969,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,13:52,0,4,4,Hours,Concentration,Plasma concentration HS02,81.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2970,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,04-09-2015,17:52,0,8,8,Hours,Concentration,Plasma concentration HS02,9.74,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2971,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,05-09-2015,09:48,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,2.46,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2972,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,05-09-2015,09:52,0,24,24,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2973,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,4,VISIT 4,0,0,06-09-2015,09:52,0,48,48,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2974,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,5,VISIT 5,0,0,07-09-2015,09:52,0,72,72,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2975,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,08-09-2015,09:48,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,10.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2976,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,08-09-2015,09:52,0,96,96,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2977,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,7,VISIT 7,0,0,09-09-2015,09:52,0,120,120,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2978,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,8,VISIT 8,0,0,10-09-2015,09:52,0,144,144,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2979,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,9,VISIT 9,0,0,11-09-2015,09:52,0,168,168,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2980,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,12-09-2015,09:48,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,13,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2981,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,12-09-2015,09:52,0,192,192,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2982,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,11,VISIT 11,0,0,13-09-2015,09:52,0,216,216,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2983,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,12,VISIT 12,0,0,14-09-2015,09:52,0,240,240,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2984,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,13,VISIT 13,0,0,15-09-2015,09:52,0,264,264,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2985,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,16-09-2015,09:48,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,13.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2986,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,16-09-2015,09:52,0,288,288,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2987,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,15,VISIT 15,0,0,17-09-2015,09:52,0,312,312,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2988,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,16,VISIT 16,0,0,18-09-2015,09:52,0,336,336,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2989,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,17,VISIT 17,0,0,19-09-2015,09:52,0,360,360,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2990,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,20-09-2015,09:48,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,15,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2991,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,20-09-2015,09:52,0,384,384,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2992,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,19,VISIT 19,0,0,21-09-2015,09:52,0,408,408,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2993,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,20,VISIT 20,0,0,22-09-2015,09:52,0,432,432,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2994,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,21,VISIT 21,0,0,23-09-2015,09:52,0,456,456,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2995,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,09:48,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,16.7,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2996,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,09:52,0,480,480,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
2997,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,09:57,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,93.6,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2998,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,10:22,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,258,,ng/ml,NaN,0.5,,NaN,NaN,NaN
2999,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,10:52,0,481,481,Hours,Concentration,Plasma concentration HS02,359,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3000,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,11:52,0,482,482,Hours,Concentration,Plasma concentration HS02,203,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3001,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,13:52,0,484,484,Hours,Concentration,Plasma concentration HS02,75.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3002,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,24-09-2015,17:52,0,488,488,Hours,Concentration,Plasma concentration HS02,24.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3003,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,25-09-2015,09:48,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,16.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3004,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,25-09-2015,09:52,0,504,504,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3005,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,24,VISIT 24,0,0,26-09-2015,09:52,0,528,528,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3006,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,25,VISIT 25,0,0,27-09-2015,09:52,0,552,552,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3007,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,26,VISIT 26,0,0,28-09-2015,09:52,0,576,576,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3008,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,29-09-2015,09:48,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,13.5,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3009,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,29-09-2015,09:52,0,600,600,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3010,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,28,VISIT 28,0,0,30-09-2015,09:52,0,624,624,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3011,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,29,VISIT 29,0,0,01-Oct-2015,09:52,0,648,648,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3012,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,30,VISIT 30,0,0,03-Oct-2015,09:52,0,696,696,Hours,Concentration,Plasma concentration HS02,11.9,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3013,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,31,VISIT 31,0,0,07-Oct-2015,09:52,0,792,792,Hours,Concentration,Plasma concentration HS02,4.53,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3014,,X3402_0105_0238,HS02,X3402,MAD Study in Male HVs,1,0,105,238,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,32,VISIT 32,0,0,14-Oct-2015,09:52,0,960,960,Hours,Concentration,Plasma concentration HS02,0.93,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3015,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,01-08-2015,09:31,0,-168,-168.1496667,Hours,Demographics,Age,44,,Years,NaN,NaN,,NaN,NaN,NaN
3016,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,01-08-2015,09:31,0,-168,-168.1496667,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
3017,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,08-08-2015,08:39,0,-1,-1,Hours,Body,BMI,27.1,,kg/m2,NaN,NaN,,NaN,NaN,NaN
3018,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,08-08-2015,08:39,0,-1,-1,Hours,Body,Bodyweight,83,,kg,NaN,NaN,,NaN,NaN,NaN
3019,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,08-08-2015,08:39,0,-1,-1,Hours,Body,Height,175,,cm,NaN,NaN,,NaN,NaN,NaN
3020,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,09:35,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3021,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,09:39,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3022,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,09:44,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,53.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3023,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,10:09,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,215,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3024,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,10:39,0,1,1,Hours,Concentration,Plasma concentration HS02,248,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3025,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,11:39,0,2,2,Hours,Concentration,Plasma concentration HS02,211,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3026,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,13:39,0,4,4,Hours,Concentration,Plasma concentration HS02,97.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3027,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,08-08-2015,17:39,0,8,8,Hours,Concentration,Plasma concentration HS02,13.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3028,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,09-08-2015,09:35,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,1.48,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3029,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,09-08-2015,09:39,0,24,24,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3030,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,4,VISIT 4,0,0,10-08-2015,09:39,0,48,48,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3031,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,5,VISIT 5,0,0,11-08-2015,09:39,0,72,72,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3032,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,12-08-2015,09:35,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,2.41,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3033,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,12-08-2015,09:39,0,96,96,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3034,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,7,VISIT 7,0,0,13-08-2015,09:39,0,120,120,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3035,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,8,VISIT 8,0,0,14-08-2015,09:39,0,144,144,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3036,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,9,VISIT 9,0,0,15-08-2015,09:39,0,168,168,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3037,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,16-08-2015,09:35,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,3.74,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3038,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,16-08-2015,09:39,0,192,192,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3039,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,11,VISIT 11,0,0,17-08-2015,09:39,0,216,216,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3040,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,12,VISIT 12,0,0,18-08-2015,09:39,0,240,240,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3041,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,13,VISIT 13,0,0,19-08-2015,09:39,0,264,264,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3042,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,20-08-2015,09:35,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,4.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3043,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,20-08-2015,09:39,0,288,288,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3044,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,15,VISIT 15,0,0,21-08-2015,09:39,0,312,312,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3045,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,16,VISIT 16,0,0,22-08-2015,09:39,0,336,336,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3046,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,17,VISIT 17,0,0,23-08-2015,09:39,0,360,360,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3047,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,24-08-2015,09:35,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,4.49,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3048,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,24-08-2015,09:39,0,384,384,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3049,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,19,VISIT 19,0,0,25-08-2015,09:39,0,408,408,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3050,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,20,VISIT 20,0,0,26-08-2015,09:39,0,432,432,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3051,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,21,VISIT 21,0,0,27-08-2015,09:39,0,456,456,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3052,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,09:35,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,4.99,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3053,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,09:39,0,480,480,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3054,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,09:44,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,64.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3055,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,10:09,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,216,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3056,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,10:39,0,481,481,Hours,Concentration,Plasma concentration HS02,281,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3057,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,11:39,0,482,482,Hours,Concentration,Plasma concentration HS02,223,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3058,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,13:39,0,484,484,Hours,Concentration,Plasma concentration HS02,91,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3059,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,28-08-2015,17:39,0,488,488,Hours,Concentration,Plasma concentration HS02,16.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3060,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,29-08-2015,09:35,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,5.74,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3061,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,29-08-2015,09:39,0,504,504,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3062,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,24,VISIT 24,0,0,30-08-2015,09:39,0,528,528,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3063,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,25,VISIT 25,0,0,31-08-2015,09:39,0,552,552,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3064,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,26,VISIT 26,0,0,01-09-2015,09:39,0,576,576,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3065,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,02-09-2015,09:35,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,5.06,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3066,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,02-09-2015,09:39,0,600,600,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3067,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,28,VISIT 28,0,0,03-09-2015,09:39,0,624,624,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3068,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,29,VISIT 29,0,0,04-09-2015,09:39,0,648,648,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3069,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,30,VISIT 30,0,0,06-09-2015,09:39,0,696,696,Hours,Concentration,Plasma concentration HS02,4.33,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3070,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,31,VISIT 31,0,0,10-09-2015,09:39,0,792,792,Hours,Concentration,Plasma concentration HS02,1.63,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3071,,X3402_0105_0239,HS02,X3402,MAD Study in Male HVs,1,0,105,239,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,32,VISIT 32,0,0,17-09-2015,09:39,0,960,960,Hours,Concentration,Plasma concentration HS02,0.72,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3072,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,04-08-2015,09:59,0,-168,-167.5163333,Hours,Demographics,Age,38,,Years,NaN,NaN,,NaN,NaN,NaN
3073,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,1,VISIT 1 - Screening,0,1,04-08-2015,09:59,0,-168,-167.5163333,Hours,Demographics,Gender,2,female,.,NaN,NaN,,NaN,NaN,NaN
3074,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,11-08-2015,08:29,0,-1,-1,Hours,Body,BMI,27.39,,kg/m2,NaN,NaN,,NaN,NaN,NaN
3075,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,11-08-2015,08:29,0,-1,-1,Hours,Body,Bodyweight,71,,kg,NaN,NaN,,NaN,NaN,NaN
3076,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,1,0,11-08-2015,08:29,0,-1,-1,Hours,Body,Height,161,,cm,NaN,NaN,,NaN,NaN,NaN
3077,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,09:25,0,-0.083333333,-0.083,Hours,Concentration,Plasma concentration HS02,0,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3078,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,09:29,0,0,0,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3079,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,09:34,0,0.083333333,0.083,Hours,Concentration,Plasma concentration HS02,76.4,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3080,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,09:59,0,0.5,0.5,Hours,Concentration,Plasma concentration HS02,237,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3081,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,10:29,0,1,1,Hours,Concentration,Plasma concentration HS02,181,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3082,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,11:29,0,2,2,Hours,Concentration,Plasma concentration HS02,183,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3083,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,13:29,0,4,4,Hours,Concentration,Plasma concentration HS02,69.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3084,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,2,VISIT 2 - BASELINE / FIRST DOSING DAY,0,0,11-08-2015,17:29,0,8,8,Hours,Concentration,Plasma concentration HS02,9.47,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3085,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,12-08-2015,09:25,0,23.91666667,23.917,Hours,Concentration,Plasma concentration HS02,1.07,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3086,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,3,VISIT 3,0,0,12-08-2015,09:29,0,24,24,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3087,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,4,VISIT 4,0,0,13-08-2015,09:29,0,48,48,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3088,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,5,VISIT 5,0,0,14-08-2015,09:29,0,72,72,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3089,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,15-08-2015,09:25,0,95.91666667,95.917,Hours,Concentration,Plasma concentration HS02,3.12,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3090,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,6,VISIT 6,0,0,15-08-2015,09:29,0,96,96,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3091,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,7,VISIT 7,0,0,16-08-2015,09:29,0,120,120,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3092,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,8,VISIT 8,0,0,17-08-2015,09:29,0,144,144,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3093,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,9,VISIT 9,0,0,18-08-2015,09:29,0,168,168,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3094,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,19-08-2015,09:25,0,191.9166667,191.917,Hours,Concentration,Plasma concentration HS02,5.26,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3095,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,10,VISIT 10,0,0,19-08-2015,09:29,0,192,192,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3096,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,11,VISIT 11,0,0,20-08-2015,09:29,0,216,216,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3097,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,12,VISIT 12,0,0,21-08-2015,09:29,0,240,240,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3098,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,13,VISIT 13,0,0,22-08-2015,09:29,0,264,264,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3099,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,23-08-2015,09:25,0,287.9166667,287.917,Hours,Concentration,Plasma concentration HS02,4.3,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3100,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,14,VISIT 14,0,0,23-08-2015,09:29,0,288,288,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3101,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,15,VISIT 15,0,0,24-08-2015,09:29,0,312,312,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3102,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,16,VISIT 16,0,0,25-08-2015,09:29,0,336,336,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3103,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,17,VISIT 17,0,0,26-08-2015,09:29,0,360,360,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3104,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,27-08-2015,09:25,0,383.9166667,383.917,Hours,Concentration,Plasma concentration HS02,4.16,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3105,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,18,VISIT 18,0,0,27-08-2015,09:29,0,384,384,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3106,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,19,VISIT 19,0,0,28-08-2015,09:29,0,408,408,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3107,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,20,VISIT 20,0,0,29-08-2015,09:29,0,432,432,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3108,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,21,VISIT 21,0,0,30-08-2015,09:29,0,456,456,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3109,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,31-08-2015,09:25,0,479.9166667,479.917,Hours,Concentration,Plasma concentration HS02,5.45,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3110,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,31-08-2015,09:29,0,480,480,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3111,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,31-08-2015,09:34,0,480.0833333,480.083,Hours,Concentration,Plasma concentration HS02,74.1,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3112,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,31-08-2015,09:59,0,480.5,480.5,Hours,Concentration,Plasma concentration HS02,209,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3113,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,31-08-2015,10:29,0,481,481,Hours,Concentration,Plasma concentration HS02,265,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3114,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,31-08-2015,11:29,0,482,482,Hours,Concentration,Plasma concentration HS02,163,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3115,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,31-08-2015,13:29,0,484,484,Hours,Concentration,Plasma concentration HS02,68.8,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3116,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,22,VISIT 22,0,0,31-08-2015,17:29,0,488,488,Hours,Concentration,Plasma concentration HS02,13.2,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3117,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,01-09-2015,09:25,0,503.9166667,503.917,Hours,Concentration,Plasma concentration HS02,5.77,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3118,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,23,VISIT 23,0,0,01-09-2015,09:29,0,504,504,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3119,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,24,VISIT 24,0,0,02-09-2015,09:29,0,528,528,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3120,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,25,VISIT 25,0,0,03-09-2015,09:29,0,552,552,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3121,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,26,VISIT 26,0,0,04-09-2015,09:29,0,576,576,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3122,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,05-09-2015,09:25,0,599.9166667,599.917,Hours,Concentration,Plasma concentration HS02,5.72,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3123,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,27,VISIT 27,0,0,05-09-2015,09:29,0,600,600,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3124,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,28,VISIT 28,0,0,06-09-2015,09:29,0,624,624,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3125,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,29,VISIT 29,0,0,07-09-2015,09:29,0,648,648,Hours,Dose,Dose HS02,100000,,ug,NaN,NaN,oral,NaN,NaN,NaN
3126,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,30,VISIT 30,0,0,09-09-2015,09:29,0,696,696,Hours,Concentration,Plasma concentration HS02,4.16,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3127,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,31,VISIT 31,0,0,13-09-2015,09:29,0,792,792,Hours,Concentration,Plasma concentration HS02,0.91,,ng/ml,NaN,0.5,,NaN,NaN,NaN
3128,,X3402_0105_0240,HS02,X3402,MAD Study in Male HVs,1,0,105,240,Healthy Volunteers,100mg oral daily dosing for 28 days,100mg oral daily dosing for 28 days,32,VISIT 32,0,0,20-09-2015,09:29,0,960,960,Hours,Concentration,Plasma concentration HS02,0.67,,ng/ml,NaN,0.5,,NaN,NaN,NaN
